PART II – INFORMATION REQUIRED IN OFFERING CIRCULAR
The information in this preliminary offering circular is subject to change. The securities described hereunder may not be sold until this offering circular is filed with the Securities and Exchange Commission (the “SEC”) and is qualified by the SEC. This preliminary offering circular is not an offer to sell, nor does it seek an offer to buy the securities described hereunder in any jurisdiction where the offer and sale of such securities are not permitted.
Subject to Completion, Dated January 6, 2022
Offering Circular

Creci Inc.
Maximum Offering: $70,000,000 in 5% Notes
Creci Inc., a Delaware corporation, (“Creci,” the “Company,” “we,” or “us”), is an early-stage financial technology company that intends to operate an online platform that enables investors to buy the Company’s “Creci Notes” as described below. We plan to use investor capital from this offering to provide loans and other credit products to small businesses in the United States and Latin America that are furthering social impact and sustainability goals as set forth by the United Nations Sustainable Development Goals (“SDGs”). These goals include activities that promote decent work and economic growth, good health, quality education, and affordable and clean energy. We intend to use the proceeds of this offering to fund these credit products and for general corporate purposes, including, without limitation, the costs of this offering.
Creci’s goal is to close the small business credit gap using technology and the power of crowdfunding to provide fair, affordable, and transparent funding to underserved small businesses, including women- and minority-owned businesses, throughout the United States and Latin America that are working to better our communities. Since our founding, we have won our startup pitch category at the 2019 Innovate Finance Global Summit in London, we were selected as a top three fintech startup in Village Capital’s Finance Forward Latin America 2020 Accelerator (an accelerator program that Village Capital conducts in collaboration with the MetLife Foundation, Paypal Holdings, Inc., and Moody’s Corporation) resulting in a $16,000 grant award, and our chief executive officer was awarded Northwestern University’s Kellogg School of Management’s 2020 Social Entrepreneurship Award, which came with a $70,000 grant award to support Creci.
Creci plans to offer and sell, on a continuous basis, its Creci Notes described in this offering circular. This offering circular describes some of the general terms that may apply to the Creci Notes and the general way they may be offered. It follows the Form 1-A disclosure format.
The Creci Notes:
| ● | are priced at $10.00 each; |
| ● | shall bear interest at 5% per annum, compounded monthly, credited monthly to the investor’s account; |
| ● | have three-year terms, after which a holder may demand full repayment at any time; |
| ● | represent a full and unconditional obligation of the Company; |
| ● | are not payment dependent on any individual underlying loan or credit product; |
| ● | are unsecured; |
| ● | are not expected to be convertible or exchangeable into any other securities; and |
| ● | shall be generally callable, redeemable, and prepayable at any time by the Company, subject to the limitation set forth in the Creci Notes. |
Please also see “Securities Being Offered” for a more fulsome description of the Creci Notes.
Our officers and directors (primarily Andres Idarraga, our Chief Executive Officer) intend to offer the Creci Notes on a continuing basis directly through our Creci website located at www.crecinotes.com. In this offering circular, we also refer to our website as our online platform, and we use the terms “website” and “platform” interchangeably. At the present time, we do not anticipate using any underwriters to offer our securities. We may partner with registered investment advisers or broker-dealers, who may offer Creci Notes on their platforms, from time to time, although we do not currently have any agreement with any broker-dealer or advisor for such purpose.
No more than once each fiscal quarter, and with at least 30 days’ notice prior to the end of such fiscal quarter, an investor may submit a request to withdraw up to $500, or 10% of the investor’s principal and accrued interest, whichever is greater, to be paid within 10 days following the end of such fiscal quarter, and subject to available funds from loans made and other cash available to the Company, accounting for the Company’s maintenance of sufficient operating capital (such funds, “Available Cash”). If the aggregate amount of all withdrawal requests received by the Company in a given fiscal quarter exceeds the Available Cash in such fiscal quarter, the amounts paid out under such withdrawal requests shall be pro-rated proportionally to the amount of each request. If the Company has no Available Cash in a given fiscal quarter, no withdrawal requests will be paid. The Company retains discretion to allow investors to withdraw additional amounts, subject to the availability of additional funds. The Company also retains the discretion to limit withdrawal requests prior to maturity, and we reserve the right to wait until the maturity date to pay all accrued interest. Investors should be prepared to hold their Creci Notes to maturity.
The aggregate offering amount of the Creci Notes being offered and sold hereunder will not exceed $70,000,000 in any 12-month period. This offering is being conducted on a “best efforts” basis, which means that there is no guarantee that any minimum amount will be sold in this offering.
Creci was incorporated in Delaware on January 11, 2019. Our principal address is 1201 North Market Street, Suite 111, Wilmington, Delaware 19801. Our phone number is (302) 202-9150.
Investing in our securities involves a high degree of risk, including the risk that you could lose all of your investment. Please read the section entitled “Risk Factors” beginning on page 3 of this offering circular about the risks you should consider before investing.
| Price to Public | Underwriting Discount and Commissions | Proceeds to Issuer | Proceeds to Other Persons | |||||||||||||
| Per Note | $ | 10 | $ | 0 | $ | 10 | $ | 0 | ||||||||
| Maximum Amount of Notes | $ | 70,000,000 | $ | 0 | $ | 70,000,000 | $ | 0 | ||||||||
Generally, no sale may be made to non-accredited investors in this offering if the aggregate purchase price you pay is more than 10% of the greater of your annual income or net worth. Different rules apply to accredited investors and non-natural persons. Before making any representation that your investment does not exceed applicable thresholds, we encourage you to review Rule 251(d)(2)(i)(C) of Regulation A. For general information on investing, we encourage you to refer to www.investor.gov.
We are offering to sell, and seeking offers to buy, Creci Notes only in jurisdictions where such offers and sales are permitted. You should rely only on the information contained in this offering circular. We have not authorized anyone to provide you with any information other than the information contained in this offering circular. The information contained in this offering circular is accurate only as of its date, regardless of the time of its delivery or of any sale or delivery of our securities. Neither the delivery of this offering circular nor any sale or delivery of our securities shall, under any circumstances, imply that there has been no change in our affairs since the date of this offering circular. This offering circular will be updated and made available for delivery to the extent required by the federal securities laws.
For investors outside the United States: We have not done anything that would permit this offering or possession or distribution of this offering circular in any jurisdiction where action for that purpose is required, other than the United States. You are required to inform yourselves about and to observe any restrictions relating to the offering and the distribution of this offering circular.
The United States Securities and Exchange Commission does not pass upon the merits of or give its approval to any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering circular or other selling literature. These securities are being offered pursuant to an exemption from registration with the commission. However, the commission has not made an independent determination that the securities offered hereunder are exempt from registration.
The approximate date of the proposed sale to the public will be within two calendar days from the date on which the offering is qualified and on a continuous basis thereafter until the maximum amount (i.e., $70,000,000) of Creci Notes are sold. Funds received will not be placed in escrow, meaning that the Company may immediately access and use the proceeds in this offering as such proceeds become available to the Company.
Table of Contents
i
| Securities offered by us | Up to $70,000,000 in Creci Notes | |
| Creci Notes | The Creci Notes: | |
| ● | are priced at $10.00 each; | |
| ● | shall bear interest at 5% per annum, compounded monthly, credited monthly to the investor’s account; | |
| ● | have three-year terms, after which a holder may demand full repayment at any time; | |
| ● | represent a full and unconditional obligation of the Company; | |
| ● | are not payment dependent on any individual underlying loan or credit product; | |
| ● | are unsecured; | |
| ● | are not expected to be convertible or exchangeable into any other securities; and | |
| ● | shall be generally callable, redeemable, and prepayable at any time by the Company, subject to limitations set forth in the Creci Notes. | |
| Interest Rate of Creci Notes: | The Creci Notes will bear interest at 5% per annum, compounded monthly. All terms, conditions and details regarding the interest rate of Creci Notes will be provided by the Company to the investor prior to purchase by the investor and made available on the Creci website at www.crecinotes.com. | |
| Principal amount of Creci Notes: | We will not issue securities hereby having gross proceeds in excess of $70,000,000 during any 12-month period. The securities we offer hereby will be offered on a continuous basis, commencing promptly after qualification of this circular. | |
| Regulation A Tier: | Tier 2 | |
| Creci Note Purchasers: | Accredited investors pursuant to Rule 501 and non-accredited investors. Pursuant to Rule 251(d)(2)(C), non-accredited investors who are natural persons may only invest the greater of 10% of their annual income or net worth. Non-natural non-accredited persons may invest up to 10% of the greater of their net assets or revenues for the most recently completed fiscal year. | |
1
| Manner of offering: | Our officers and directors (primarily Andres Idarraga, our chief executive officer) intend to offer the Creci Notes on a continuing basis directly through our Creci website located at www.crecinotes.com. See also section titled “Plan of Distribution” beginning on page 34. |
| How to invest: | Directly on www.crecinotes.com. |
| Investor Withdrawals: | No more than once each fiscal quarter, and with at least 30 days’ notice prior to the end of such fiscal quarter, an investor may submit a request to withdraw up to $500, or 10% of the investor’s principal and accrued interest, whichever is greater, to be paid within 10 days following the end of such fiscal quarter, and subject to available funds from loans made and other cash available to the Company, accounting for the Company’s maintenance of sufficient operating capital (such funds, “Available Cash”). If the aggregate amount of all withdrawal requests received by the Company in a given fiscal quarter exceeds the Available Cash in such fiscal quarter, the amounts paid out under such withdrawal requests shall be pro-rated proportionally to the amount of each request. If the Company has no Available Cash in a given fiscal quarter, no withdrawal requests will be paid. Management retains discretion to allow investors to withdraw additional amounts, subject to the availability of additional funds. The Company also retains the discretion to limit withdrawal requests prior to maturity, and we reserve the right to wait until the maturity date to pay all accrued interest. Investors should be prepared to hold their Creci Notes to maturity. |
| Use of proceeds: | If we sell $70,000,000 of gross proceeds from the sale of our securities under this offering circular, we estimate our net proceeds, after deducting estimated commissions and expenses, will be approximately $69,900,000, assuming our offering expenses are $100,000. We intend to use the proceeds from this offering to fund loans and for general corporate purposes including, without limitation, the costs of this offering. See also “Use of Proceeds.” |
| Risk factors: | See the section titled “Risk Factors” beginning on page 3 of this offering statement for a discussion of factors that you should read and consider before investing in our Securities. |
2
Investing in our securities involves a high degree of risk. Before deciding whether to invest, you should consider carefully the risks and uncertainties described below, our financial statements and related notes, and all of the other information in this offering circular. If any of the following risks actually occurs, our business, financial condition, results of operations, and prospects could be adversely affected. As a result, the value of our securities could decline, and you could lose part or all of your investment.
Risks Related to Our Industry
Worsening economic conditions may result in decreased demand for loans, cause borrowers’ default rates to increase, and harm our operating results.
Uncertainty and negative trends in general economic conditions in the United States and in Latin America, including significant tightening of credit markets, historically have created a difficult environment for companies in the lending industry. Many factors, including factors that are beyond our control, may have a detrimental impact on our operating performance. These factors include general economic conditions, unemployment levels, energy costs and interest rates, as well as events such as natural disasters, acts of war, terrorism, pandemics such as the recent COVID-19 one, and catastrophes.
Our borrowers are small businesses. Accordingly, our borrowers have historically been, and may in the future remain, more likely to be affected or more severely affected than large enterprises by adverse economic conditions. These conditions may result in a decline in the demand for loans by potential borrowers or higher default rates by borrowers.
There can be no assurance that economic conditions will remain favorable for our business or that demand for loans we intend to make or default rates by borrowers will remain at current levels. Reduced demand for loans would negatively impact our growth and revenue, while increased default rates by borrowers may inhibit our access to capital and negatively impact our profitability. Further, if an insufficient number of qualified small businesses apply for loans, our growth and revenue would be negatively impacted.
The COVID-19 outbreak may adversely affect our operating results.
In January 2020, the World Health Organization declared the COVID-19 outbreak a “Public Health Emergency of International Concern.” In March 2020, it declared it to be a pandemic. Actions taken around the world to help mitigate the spread of the COVID-19 include restrictions on travel, quarantines in certain areas, and forced closures for certain types of public places and businesses. COVID-19, and actions taken to mitigate it, have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which we operate and plan to operate.
The Company entered into a loan agreement with Mentel LLC pursuant to which we loaned Mentel LLC $150,000 to originate loans to small businesses in Colombia. We also finalized an agreement on March 1, 2021 with the Colombia subsidiary of the same company, through our Colombian subsidiary, to purchase an existing portfolio of loans made to Colombian small businesses. During COVID-19, some of the small businesses in the portfolio have experienced delays in sourcing supplies; less in-person demand as a result of health concerns and quarantine measures; and delays of invoice payments. As a result, the related company worked with those businesses to institute grace periods and interest-only payment periods to help them manage cash flows issues and better position them to meet their loan obligations. We purchased only those loans in the portfolio which are current.
3
To date, we have not experienced any delays in payments of principal or interest attributable to COVID-19. However, the ultimate disruption which may be caused by the pandemic is uncertain, and it may result in a material adverse impact on the Company’s loans, financial position, operations and cash flows. COVID-19 may result in a decline in the demand for loans by potential borrowers; higher default rates by borrowers; higher redemption rates of holders of the Creci Notes. At this time, we are unable to predict the extent or nature of these impacts to our future financial condition and results of operations.
Increases in market interest rates could negatively affect the amount of loans facilitated by us and cost of funds provided to borrowers.
Borrowers’ costs of borrowing mainly consist of interest rates and transaction costs. An increase in prevailing interest rates could result in an increase in the interest rates of loans we facilitate, and borrowers may be less likely to accept such adjusted terms. If borrowers decide not to use the products or services we offer, because of an increase in market interest rates, our ability to retain existing borrowers and engage prospective borrowers as well as our competitive position may be severely impaired. If we are unable to effectively manage such market interest rate risks, our business, profitability, results of operations and financial condition could be materially and adversely affected.
Our overall funding costs may fluctuate with market interest rates while the interest rates for existing loans are fixed during the terms of the loans. As a result, an increase in the market interest rates may negatively impact the availability and cost of our funding, which may have a material adverse impact on our profitability and results of operations.
Competition for employees is intense, and we may not be able to attract and retain the highly skilled employees whom we need to support our business.
Competition for highly skilled personnel, especially data analytics personnel, is extremely intense, and we could face difficulty identifying and hiring qualified individuals in many areas of our business. We may not be able to hire and retain such personnel. Many of the companies with which we compete for experienced employees have greater resources than we have and may be able to offer more attractive terms of employment. In addition, we intend to invest significant time and expense in training our employees, which increases their value to competitors who may seek to recruit them. If we fail to retain our employees, we could incur significant expenses in hiring and training their replacements and the quality of our services and our ability to serve borrowers could diminish, resulting in a material adverse effect on our business.
The lending industry is highly regulated. Changes in regulations or in the way regulations are applied to our business could adversely affect our business.
Changes in laws or regulations or the regulatory application or judicial interpretation of the laws and regulations applicable to us could adversely affect our ability to operate in the manner in which we intend to conduct business or make it more difficult or costly for us to originate or otherwise make loans, or for us to collect payments on loans by subjecting us to additional licensing, registration, and other regulatory requirements in the future or otherwise. A material failure to comply with any such laws or regulations could result in regulatory actions, lawsuits, and damage to our reputation, which could have a material adverse effect on our business and financial condition and our ability to originate and service loans and perform our obligations to investors and other constituents.
4
The initiation of a proceeding relating to one or more allegations or findings of any violation of such laws could result in modifications in our methods of doing business that could impair our ability to collect payments on our loans or to acquire additional loans or could result in the requirement that we pay damages and/or cancel the balance or other amounts owing under loans associated with such violation. We cannot assure you that such claims will not be asserted against us in the future.
Risks Related to Our Company
We are an early-stage startup with a short operating history, and we may never become profitable.
We do not expect to be profitable for the foreseeable future. If we are unable to obtain or maintain profitability, we may not be able to attract investment, compete, or maintain operations.
Our management has raised substantial doubt about our ability to continue as a going concern and our independent registered public accounting firm has included an explanatory paragraph relating to our ability to continue as a going concern in its audit report with respect to our audited consolidated financial statements for the period from January 11, 2019 (inception) to December 31, 2020.
We are an early-stage startup with a short operating history, and we may never become profitable. Our management has raised substantial doubt about our ability to continue as a going concern and our independent registered public accounting firm has included an explanatory paragraph in their opinion on our audited consolidated financial statements for the period from January 11, 2019 (inception) to December 31, 2020 that states that there is substantial doubt about our ability to continue as a going concern. The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, even though there is substantial doubt about our ability to continue as a going concern. No assurances can be given that we will generate sufficient revenue or obtain necessary financing to continue as a going concern. No assurances can be given that we will achieve success in selling the Creci Notes.
We may need additional capital, and financing may not be available on terms acceptable to us, or at all.
Although we believe that our current cash and cash equivalents, anticipated cash flows from operating activities and the proceeds from this offering will be sufficient to meet our anticipated working capital requirements and capital expenditures in the ordinary course of business for at least twelve months following this offering, we may need additional cash resources in the future if we experience changes in business conditions or other developments. We may also need additional cash resources in the future if we find and wish to pursue opportunities for investment, acquisition, capital expenditure or similar actions. If we determine that our cash requirements exceed the amount of cash and cash equivalents we have on hand at the time, we may seek to issue equity or debt securities or obtain credit facilities. The incurrence of indebtedness would result in increased fixed obligations and could result in operating covenants that would restrict our operations. We cannot assure you that financing will be available in amounts or on terms acceptable to us, if at all.
5
We have a limited operating history in a rapidly evolving industry, which makes it difficult to evaluate our future prospects and may increase the risk that we will not be successful.
We have a limited operating history in an evolving industry that may not develop as expected. Assessing our business and future prospects is challenging in light of the risks and difficulties we may encounter. These risks and difficulties include our ability to:
| ● | increase the number and total volume of loans and other credit products extended to borrowers; |
| ● | improve the terms on which loans are made to borrowers as our business becomes more efficient; |
| ● | increase the effectiveness of our direct marketing and lead generation through referral sources; |
| ● | successfully develop and deploy new products; |
| ● | favorably compete with other companies that are currently in, or may in the future enter, the business of lending to small businesses; |
| ● | successfully navigate economic conditions and fluctuations in the credit market; |
| ● | effectively manage the growth of our business; and |
| ● | successfully expand our business into adjacent markets. |
We may not be able to successfully address these risks and difficulties, which could harm our business and cause our operating results to suffer.
Our risk management efforts may not be effective.
We could incur substantial losses, and our business operations could be disrupted if we are unable to effectively identify, manage, monitor, and mitigate financial risks, such as credit risk, interest rate risk, liquidity risk, and other market-related risk, as well as operational risks related to our business, assets, and liabilities. To the extent our models used to assess the creditworthiness of potential borrowers do not adequately identify potential risks, the risk profile of such borrowers could be higher than anticipated. Our risk management policies, procedures, and techniques are based to some degree on the subjective judgment of the Company’s management, and may not be sufficient to identify all of the risks to which we are exposed, mitigate the risks that we have identified, or identify concentrations of risk or additional risks to which we may become subject in the future.
We may recognize unexpected losses if our models, estimations, and judgments regarding the credit risk posed by potential borrowers prove to be inadequate or incorrect.
We have developed and use a variety of models and other analytical and judgment-based estimations to measure, monitor and implement controls related to the evaluation of the creditworthiness of potential borrowers. These models and estimations are based on a variety of assumptions and historical trends, and are periodically reviewed and modified as necessary. These models and estimations may not be effective in all cases to identify, observe, and mitigate the credit risk posed by potential borrowers due to a variety of factors, such as:
| ● | reliance on historical trends that may not accurately predict future events, including assumptions underlying the models and estimations which predict correlation among certain market indicators or asset prices; |
| ● | inherent limitations associated with forecasting uncertain economic and financial outcomes; |
| ● | historical trend information may be incomplete, or may not anticipate severely negative market conditions such as extreme volatility, dislocation or lack of liquidity; |
| ● | models and estimations may contain erroneous data, valuations, formulas or algorithms; and | |
| ● | review processes may fail to detect flaws in models and estimations. | |
| ● | technology that is introduced to run models or estimations may not perform as expected, or may not be well understood by the personnel using the technology; |
6
We are reliant on the efforts of Andres Idarraga and Pravin Rodrigues, the loss of either of which could have a material impact on our business.
We rely on our management team and need additional key personnel to grow our business, and the loss of key employees or inability to hire key personnel could harm our business. We believe our success has depended, and continues to depend, on the efforts and talents of our executives and employees, including Andres Idarraga, our Chief Executive Officer, and Pravin Rodrigues, our Chief Operating Officer and Chief Social Impact Officer. Mr. Idarraga and Mr. Rodrigues have expertise that could not be easily replaced if we were to lose either or both of their services.
Our intended loans to small business in Latin American expose us to market, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States.
We intend to make loans to small businesses in Latin America, beginning in Colombia. Loans made to Latin American small businesses involve risks including: (i) multiple, conflicting and changing laws and regulations such as tax laws, privacy laws, employment laws, regulatory requirements and other governmental approvals, permits and licenses; (ii) complexities associated with managing multiple payment processing methods; (iii) natural disasters, political and economic instability, including wars, terrorism, political unrest, outbreak of disease, protests, boycotts, curtailment of trade and other market restrictions; (iv) exchange-rate risk, and (iv) regulatory and compliance risks that relate to maintaining accurate information and control over activities subject to regulation under the United States Foreign Corrupt Practices Act of 1977 (“FCPA”) and comparable laws and regulations in other countries.
Loans made in our first market, Colombia, are subject to risks such as economic instability, including economic instability caused or accelerated by the COVID-19 pandemic. From March 2020 to March 2021, the unemployment rate in Colombia increased from 10.6% to 14.9%; the economy contracted by 6.8%; and the Colombian peso depreciated by 22% against the U.S. dollar. In response to the worsening fiscal situation, the Colombian President’s party introduced a fiscal reform plan on April 15, 2021 in the country’s Congress. The plan included tax increases targeting low-to-middle income households. This sparked national protests that were met with government force, resulting in street confrontations. The fiscal reform plan was withdrawn on May 2, 2021; however, the protests continued through the end of May. On May 20, 2021, S&P Global Ratings downgraded the country’s credit rating from BBB-minus to BB-plus. While the protests ebbed in June, the country continues to experience pockets of social unrest, and the government continues to contend with the fiscal difficulties. S&P Global Ratings has stated that its outlook on the country is stable.
Generally, economic instability in Colombia, other Latin American countries, and emerging market countries has been caused by many different factors, including the following: high interest rates; changes in currency values; high levels of inflation; exchange controls; wage and price controls; changes in economic or tax policies; the imposition of trade barriers; and internal security issues. Emerging-market operations generally pose a greater degree of risk than operations in more mature market economies because the economies in the developing world are more susceptible to destabilization resulting from domestic and international developments. A significant decline in the economic growth of any of Colombia’s major trading partners, such as the United States or the European Union, could have a material adverse impact on Colombia’s economic growth and on its small businesses. In addition, because international investors’ reactions to the events occurring in one emerging market country may demonstrate a “contagion” effect, in which an entire region or class of investments is disfavored by international investors, Colombia could be adversely affected by negative economic or financial developments occurring in other emerging market countries.
7
There can be no assurance that any crises such as those described above or similar events will not negatively affect the principal countries in Latin America, including Colombia, and thus our operations.
We are dependent on our information technology and telecommunications systems and third-party servicers, and systems failures, interruptions or breaches of security could have a material adverse effect on us.
Our business is highly dependent on the successful and uninterrupted functioning of our information technology and telecommunications systems and third-party servicers. We outsource many of our major systems, such as data hosting, data processing, payment processing, and know-your-client and anti-money laundering diligence. The failure of these systems, or the termination of a third-party software license or service agreement on which any of these systems is based, could interrupt our operations. Because our information technology and telecommunications systems interface with and depend on third-party systems, we could experience service denials if demand for such services exceeds capacity or such third-party systems fail or experience interruptions. If significant, sustained or repeated, a system failure or service denial could compromise our ability to operate effectively, damage our reputation, result in a loss of customer business, and/or subject us to additional regulatory scrutiny and possible financial liability, any of which could have a material adverse effect on our business, financial condition and results of operations.
In addition, we plan to provide our users with the ability to purchase and sell the Notes remotely, both over the internet and on mobile devices. The storage and transmission of confidential information with our network could be vulnerable to cyber-attacks, cyber-espionage, unauthorized access, computer viruses, phishing schemes and other security breaches that could expose us to claims, regulatory scrutiny, litigation and other possible liabilities. Our inability to prevent such security breaches to our network could also cause existing customers to lose confidence in our systems and could materially and adversely affect our business, financial condition and results of operations.
To date, we have not experienced any material losses relating to cyber-attacks or other information security breaches, but there can be no assurance that we will not suffer material losses from such cyber-attacks or other information security breaches in the future. Our risk and exposure to these matters remains heightened because of, among other things, the evolving nature of these threats, our plans to continue to implement internet and mobile services to meet customer demand, and the current economic and political environment. As cyber and other data security threats continue to evolve, we may be required to expend significant additional resources to continue to modify and enhance our protective measures or to investigate and remediate any security vulnerabilities.
Our assets at risk for cyber-attacks include financial assets and confidential information belonging to users. While we employ preventive and detective controls to protect our assets and provide mandatory recurring information security training to all employees, there can be no assurance that such controls will prevent any cyber-attacks. The Company also maintains certain insurance coverage to prevent material financial loss from cyber-attacks; however, there can be no assurance such insurance will be available to cover any such financial loss we may incur.
8
Additionally, financial products and services have become increasingly technology driven. Our ability to meet the needs of our customers competitively, and in a cost-efficient manner, is dependent on the ability to keep pace with technological advances and to invest in new technology as it becomes available. Many of our competitors have greater resources to invest in technology than we do and may be better equipped to market new technology-driven products and services. The ability to keep pace with technological change is important, and the failure to do so could have a material adverse impact on our business and therefore on our financial condition and results of operations.
We rely on data centers to deliver our services. Any disruption of service at these data centers could interrupt or delay our ability to deliver our service to our customers.
We currently serve our customers from third-party data center hosting facilities. The continuous availability of our service depends on the operations of these facilities, on a variety of network service providers, on third-party vendors, and on data center operations staff. In addition, we depend on the ability of our third-party providers to protect the facilities against damage or interruption from natural disasters, power or telecommunications failures, criminal acts, data breaches, and similar events. If there are any lapses of service or damage to the facilities, we could experience lengthy interruptions in our service as well as delays and additional expenses in arranging new facilities and services. Even with current disaster recovery arrangements, our business could be harmed.
If any of the primary information provided by borrowers and data obtained from third-party external sources we use for credit and risk assessment is inaccurate or fraudulently provided, our assessment may not sufficiently capture the credit risk of the loan.
Our loan decisions are based partly on information provided to us by loan applicants and third-party external sources that we use for credit and risk assessment. To the extent that these applicants or third-party sources provide information to us that is not true or in a manner that we are unable to verify, we may not be able to accurately assess the associated risk. In addition, data provided by third-party sources is a significant component of our underwriting process, and this data may contain inaccuracies or falsehoods. Inaccurate analysis of credit data that could result from false loan application information could harm our reputation, business, and operating results.
Although we take steps to verify potential borrower data and identities, the potential borrower information may nevertheless be inaccurate or incomplete. In the event of fraud or inaccuracy, our assessment of the creditworthiness of particular borrowers may be flawed, leading us to extend credit in cases where it would not otherwise be extended. In this eventuality, our expected returns from such loans may not materialize, harming our reputation, business, and operating results.
Our loans may be unsecured obligations of our borrowers, the default of which could leave us with little recourse or remedy, which could adversely affect the results of our operations.
We anticipate that some of our loans will be unsecured obligations of the borrowers. This means that, for those loans, we will not be able to foreclose on any assets of our borrowers in the event that they default. This limits our recourse in the event of a default. We may also attract borrowers who have fewer assets and may be engaged in less developed businesses than our peers. If we are unable to access collateral on our loans that default, our results of operations may be adversely impacted.
9
We intend to originate relatively small-dollar loans which means we need to originate more loans to make as much money as competitors that originate larger-dollar loans.
We anticipate that substantially all of our loans will be under $100,000. Some of competitors who offer larger dollar loan products require origination of fewer loans than we do in order to reach the same amount of dollars loaned. If our per-loan origination costs are too high, our results of operations will be adversely impacted.
Any negative publicity with respect to us, our employees, the marketplace lending industry in general or our business partners may materially and adversely affect our business and results of operations.
The reputation of our brand is critical to our business and competitiveness. Factors that are vital to our reputation include, but are not limited to, our ability to:
| ● | maintain the quality and reliability of our platform; | |
| ● | provide borrowers and investors with a superior experience on our platform; | |
| ● | enhance and improve our risk management system; | |
| ● | effectively manage and resolve borrower and investor complaints; and | |
| ● | effectively protect personal information and privacy of borrowers and investors. |
Any malicious or negative allegation made by the media or other parties about the foregoing or other aspects of our company, including, but not limited to, our management, employees, business, compliance with law, financial condition or prospects, whether with merit or not, could severely compromise our reputation and harm our business and operating results.
We will face increasing competition and, if we do not compete effectively, our operating results could be harmed.
We compete with other companies that lend to small businesses. These companies include traditional banks, merchant cash advance providers, and newer, technology-enabled lenders. In addition, other technology companies that lend primarily to individual consumers have already begun to focus, or may in the future focus, their efforts on lending to small businesses.
Many of these competitors have significantly more resources and greater brand recognition than we do and may be able to attract borrowers more effectively than we do.
When new competitors seek to enter one of our markets, or when existing market participants seek to increase their market share, they sometimes undercut the pricing and/or credit terms prevalent in that market, which could adversely affect our potential market share or ability to explore new market opportunities. Our pricing and credit terms could deteriorate if we act to meet these competitive challenges. Further, to the extent that the fees we pay to any strategic partners or borrower referral sources are not competitive with those paid by our competitors, whether on new loans or renewals or both, these partners and sources may choose to direct their business elsewhere. All of the foregoing could adversely affect our business, results of operations, financial condition, and future growth.
10
The collection, processing, storage, use, and disclosure of personal data on our website could give rise to liabilities as a result of governmental regulation, conflicting legal requirements, or differing views of personal privacy rights.
We receive, collect, process, transmit, store, and use a large volume of personally identifiable information and other sensitive data from borrowers and purchasers of the Creci Notes and services. There are federal, state, and foreign laws regarding privacy, recording telephone calls, and the storing, sharing, use, disclosure, and protection of personally identifiable information and sensitive data. Specifically, personally identifiable information is increasingly subject to legislation and regulations to protect the privacy of personal information that is collected, processed, and transmitted. Any violations of these laws and regulations may require us to change our business practices or operational structure, address legal claims, and sustain monetary penalties, or other harms to our business.
The regulatory framework for privacy issues in the United States and internationally is constantly evolving and is likely to remain uncertain for the foreseeable future. The interpretation and application of such laws is often uncertain, and such laws may be interpreted and applied in a manner inconsistent with other binding laws or with our current policies and practices. If either we or our third-party service providers are unable to address any privacy concerns, even if unfounded, or to comply with applicable laws and regulations, it could result in additional costs and liability, damage our reputation, and harm our business.
We rely on various referral sources and other borrower lead generation sources, the loss of which could have a material impact on our business.
Unlike banks and other larger competitors with significant resources, we intend to rely on our smaller-scale marketing efforts, affinity groups, partners, and loan referral services to acquire borrowers. We do not have exclusive rights to referral services, and we cannot control which loans or the volume of loans we are sent. In addition, our competitors may enter into exclusive or reciprocal arrangements with their own referral services, which might significantly reduce the number of borrowers we are referred. Any significant reduction in borrower referrals could have an adverse impact on our loan volume, which will have a correspondingly adverse impact on our operations and our company.
If we fail to promote and maintain our brand in an effective and cost-efficient way, our business and results of operations may be harmed.
We believe that developing and maintaining awareness of our brand effectively is critical to attracting new and retaining existing borrowers and investors to our marketplace. Successful promotion of our brand and our ability to attract qualified borrowers and sufficient investors depend largely on the effectiveness of our marketing efforts and the success of the channels we use to promote our marketplace. Our efforts to build our brand have caused us to incur significant expenses, and it is likely that our future marketing efforts will require us to incur significant additional expenses. These efforts may not result in increased revenues in the immediate future or at all and, even if they do, any increases in revenues may not offset the expenses incurred. If we fail to successfully promote and maintain our brand while incurring substantial expenses, our results of operations and financial condition would be adversely affected, which may impair our ability to grow our business.
11
Investors must consent to the jurisdiction of the State of Delaware for most claims, which could inconvenience or prejudice investors in the pursuit of legal claims against the Company.
The Form of Creci Note requires investors to consent to the jurisdiction of the state courts located within New Castle County, Delaware. Investors located outside the State of Delaware may have difficulty bringing any legal claim against us due to geographic limitations and may find it difficult and costly to respond to claims. This choice of forum provision may limit a holder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage such lawsuits against us and our directors, officers and employees. Alternatively, a court could find this provision of our Form of Creci Note to be inapplicable or unenforceable in respect of one or more of the specified types of actions or proceedings, which may require us to incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition.
This exclusive forum provision would not apply to suits brought to enforce a duty or liability created by the Securities Act, Exchange Act, or any other claim for which the U.S. federal courts have exclusive jurisdiction.
By purchasing Creci Notes in this Offering, unless you opt-out in accordance with the terms of the Creci Note Investor Agreement, you are bound by the arbitration provisions contained in our Creci Note Investor Agreement to be used for subscriptions in this offering which limits your ability to bring class action lawsuits or seek remedies on a class basis and waives the right to a trial by jury.
By purchasing shares in this Offering, unless you opt out in accordance with the terms of the Creci Note Investor Agreement, you agree to be bound by the arbitration, jury waiver and class action waiver provisions contained in Section 6 of our Creci Note Investor Agreement to be used for subscriptions on this offering. Pursuant to the terms of the Creci Note Investor Agreement, the holders of Creci Notes and the Company will agree to (i) resolve disputes of the holders of Creci Notes through binding arbitration or small claims court, instead of through courts of general jurisdiction or through a class action and (ii) waive the right to a trial by jury and to participate in any class action, except in cases that involve personal injury. Pursuant to the terms of the Creci Note Investor Agreement, if a holder of Creci Notes does not agree to the terms of the arbitration provision, the holder of Creci Notes may opt-out of the arbitration provision by sending an arbitration opt-out notice to the Company within thirty (30) days of the holder’s first electronic acceptance of the Creci Note Investor Agreement. If the opt-out notice is not received within thirty (30) days, the holder of Creci Notes will be deemed to have accepted all terms of the arbitration provision, including the class action and jury waiver. If the investor opts out of the arbitration provision, the investor has also opted out of the jury trial and class action waivers. As arbitration provisions in commercial agreements have generally been respected by federal courts and state courts of Delaware, we believe that the arbitration provision in the Creci Note Investor Agreement is enforceable under federal law and the laws of the State of Delaware. Although holders of Creci Notes will be subject to the arbitration provisions of the Creci Note Investor Agreement, the arbitration provisions do not preclude holders of Creci Notes from pursuing claims under the U.S. federal securities laws in federal courts.
The arbitration provision of the Creci Note Investor Agreement is not intended to be construed as, and shall not be deemed, a waiver by any holder of Creci Notes of the company’s compliance with the U.S. federal securities laws and the rules and regulations promulgated thereunder. The arbitration provision of the Creci Note Investor agreement does not apply to claims brought under the Exchange Act and Securities Act.
12
The Creci Note Investor Agreement provides that, to the extent permitted by law, each party to the Creci Note Investor Agreement waives the right to a jury trial or class action of any claim they may have against us arising out of or relating to our Creci Notes or the Creci Note Investor Agreement. If we were to oppose a jury trial or class action demand based on such waiver, the court would determine whether the waiver was enforceable based upon the facts and circumstances of that case in accordance with applicable state and federal law, including whether a party knowingly, intelligently, and voluntarily waived the right to a jury trial or class action. The holders of Creci Notes will be subject to these provisions of the Creci Note Investor Agreement to the extent permitted by applicable law.
The waiver of the right to a jury trial and class action contained in the Creci Note Investor Agreement is not intended to be deemed a waiver by any holder of Creci Notes of the Company’s compliance with the U.S. federal securities laws and the rules and regulations promulgated thereunder. The jury waiver and class action waiver provisions of the Creci Note Investor Agreement do not apply to claims brought under the Exchange Act and Securities Act.
If the investor opts out of the arbitration provision, the investor has also opted out of the jury trial and class action waivers. In the event that an investor does not opt-out, as described above, the rights of the adverse bond holder to seek redress in court would be severely limited. These restrictions on the ability to bring a class action lawsuit may result in increased costs and/or reduced remedies, to individual investors who wish to pursue claims against the Company.
Compliance with Regulation A and reporting to the SEC could be costly, which could adversely affect our results of operations.
Our legal and financial staff may need to be increased in order to comply with Regulation A. Compliance with Regulation A may also require greater expenditures on outside counsel, outside auditors, and financial printers in order to remain in compliance. Failure to remain in compliance with Regulation A may subject us to sanctions, penalties, and reputational damage and would adversely affect our results of operations.
Risks Related to Creci Notes
The characteristics of the Creci Notes, including the interest rate, lack of collateral security or guarantee, and lack of liquidity, may not satisfy your investment objectives.
The Creci Notes may not be a suitable investment for you, and we advise you to consult your investment, tax and other professional financial advisors prior to purchasing Creci Notes. The characteristics of the Creci Notes, including being redeemable by us, the interest rate, lack of collateral security or guarantee, and lack of liquidity, may not satisfy your investment objectives. In addition, the Creci Notes will be subordinated to secured and senior debt as necessary to procure additional financing for the company, and are currently subordinated to the SAFEs and convertible notes described in further detail in “Management’s Discussion and Analysis of Financial Condition and Results of Operations -- Liquidity and Capital Resources” of this offering circular. The Creci Notes may not be a suitable investment for you based on your ability to withstand a loss of interest or principal or other aspects of your financial situation, including your income, net worth, financial needs, investment risk profile, return objectives, investment experience and other factors. Prior to purchasing any Creci Notes, you should consider your investment allocation with respect to the amount of your contemplated investment in the Creci Notes in relation to your other investment holdings and the diversity of those holdings.
13
The Creci Notes are unsecured obligations.
The Creci Notes do not represent an ownership interest in any specific Creci loans, their proceeds, or their assets. The Creci Notes are unsecured general obligations of Creci only and not any borrower in Creci’s loan portfolio. The Creci Notes will be general unsecured obligations, and will rank equally with all of our other unsecured debt unless such debt is senior to or subordinate to the Creci Notes by their terms. We may issue secured debt at our sole discretion without notice to or consent from the holders of Creci Notes. Therefore, as unsecured obligations, there is no security to be provided to the holders of the Creci Notes.
There is no public market for Creci Notes, and none is expected to develop.
Creci Notes are newly issued securities. Although under Regulation A the securities are not restricted, Creci Notes are still, and are expected to be, highly illiquid securities. No public market has developed nor is expected to develop for Creci Notes.
Holders of Creci Notes are exposed to the credit risk of the Company.
Creci Notes are our full and unconditional obligations. If we are unable to make payments required by the terms of the Creci Notes, holders of Creci Notes will have an unsecured claim against us. Holders of Creci Notes are therefore subject to non-payment by the Company in the event of our bankruptcy or insolvency. In an insolvency proceeding, there can be no assurances that you will recover any remaining funds. Moreover, your claim may be subordinate to that of any senior creditors and any secured creditors to the extent of the value of their security.
Holders of the Creci Notes will have no voting rights and will have no ability to direct or control the Company.
The Creci Notes do not carry any voting rights and therefore the holders of the Creci Notes will not be able to vote on or otherwise control any matters regarding the operation of the Company. As a noteholder purchaser in this offering, you will have no right to vote upon or receive notice of any corporate actions we may undertake which you might otherwise have if you owned equity in our Company.
Because the Creci Notes will have no sinking fund, insurance, or guarantee, you could lose all or a part of your investment if we do not have enough cash to pay.
There is no sinking fund, insurance or guarantee of our obligation to make payments on the Creci Notes. We will not contribute funds to a separate account, commonly known as a sinking fund, to make interest or principal payments on the Creci Notes. The Creci Notes are not certificates of deposit or similar obligations of, and are not guaranteed or insured by, any depository institution, the Federal Deposit Insurance Corporation, the Securities Investor Protection Corporation, or any other governmental or private fund or entity. Therefore, if you invest in the Creci Notes, you will have to rely only on our cash flow from operations and possible funding from third-party investors for repayment of principal and interest upon repayment requests, maturity of the notes, or upon redemption by us. If our cash flow from operations and possible funding from investors are not sufficient to pay any amounts owed under the Creci Notes, then you may lose all or part of your investment
Because the Creci Notes represent debt and confer no equity upon the holder, you will not receive any dividend distributions from the Company.
The Creci Notes are debt instruments and do not represent any equity in the Company. The Company has not and has no plans to issue dividends to its equity holders. However, in the event that it does so, you are not entitled to any dividends or similar payments beyond the interest and principal due to you under the Creci Note pursuant to the terms of the Creci Note and the Creci Note Investor Agreement.
14
Cautionary Note Regarding Forward-Looking Statements
This offering circular contains forward-looking statements that are based on our beliefs and assumptions and on information currently available to us. The forward-looking statements are contained principally in “Offering Circular Summary,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Description of Business.” Forward-looking statements include information concerning our possible or assumed future results of operations and expenses, business strategies and plans, competitive position, business environment, and potential growth opportunities. Forward-looking statements include all statements that are not historical facts. In some cases, forward-looking statements can be identified by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “seeks,” “should,” “will,” “would,” or similar expressions and the negatives of those terms.
Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Those risks include those described in “Risk Factors” and elsewhere in this offering circular. Given these uncertainties, you should not place undue reliance on any forward-looking statements in this offering circular. Also, forward-looking statements represent our beliefs and assumptions only as of the date of this offering circular. You should read this offering circular and the documents that we have filed as exhibits to the Form 1-A of which this offering circular is a part, completely and with the understanding that our actual future results may be materially different from what we expect.
Any forward-looking statement made by us in this offering circular speaks only as of the date on which it is made. Except as required by law, we disclaim any obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. All forward-looking statements are expressly qualified in their entirety by the foregoing cautionary statements.
15
If we sell $70,000,000 of gross proceeds from the sale of our securities under this offering circular, we estimate our net proceeds, after deducting estimated commissions and expenses, will be approximately $69,900,000, assuming our expenses are $100,000 for this offering. We intend to use approximately 95% of the net proceeds from this offering to fund loans and approximately 5% of the net proceeds for general corporate purposes. If we do not reach the maximum offering amount, the ratio of funds used for funding loans to funds used for general corporate purposes is likely to decrease due to the fixed costs associated with the general corporate purposes.
| Use of Proceeds | % of Proceeds if $25,000,000 Raised | Amount if $25,000,000 Raised | % of Proceeds if $50,000,000 Raised | Amount if $50,000,000 Raised | % of Proceeds if $70,000,000 Raised | Amount if $70,000,000 Raised | ||||||||||||||||||
| Cost of offering | 0.40 | % | $ | 100,000 | 0.20 | % | $ | 100,000 | 0.14 | % | $ | 100,000 | ||||||||||||
| Lending | 94.60 | % | $ | 23,650,000 | 95.80 | % | $ | 47,900,000 | 96.11 | % | $ | 67,275,000 | ||||||||||||
| General Corporate Purposes | 5.00 | % | $ | 1,250,000 | 4.00 | % | $ | 2,000,000 | 3.75 | % | $ | 2,625,000 | ||||||||||||
| Totals | 100.00 | % | $ | 25,000,000 | 100.00 | % | $ | 50,000,000 | 100.00 | % | $ | 70,000,000 | ||||||||||||
General corporate purposes include, but are not limited to, our legal and accounting expenses, rent, utilities, computer hardware and software expenses, and promotion and marketing expenses. Our management has sole discretion regarding the use of proceeds from the sale of Creci Notes. Pending use of the net proceeds from this offering, we may invest in short and intermediate term interest-bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S. government. Our directors and management team do not currently receive a salary or other compensation from the company, and does not expect to in the short term, but depending on the performance of the company, it is possible that general corporate purposes may include director, officer or employee salaries or other compensation in the intermediate term.
16
Background
Creci is an early-stage financial technology company whose mission is to lend to and empower social impact small businesses throughout the United States and Latin America a working to solve some of the world’s most pressing problems. We are building an online platform containing online tools that allow companies to identify, measure, and report their impact so that we can profile that impact and in turn enable us to more easily attract funding for those small businesses.
We define social impact small businesses as those that work to further at least one of the seventeen United Nations Sustainable Development Goals, which include goals such as decent work and economic growth, good health, quality education, and affordable and clean energy. We intend to offer retail debt securities (the Creci Notes) hereunder and with the proceeds, provide these small businesses with financing solutions and investors with opportunities to earn a fixed-return on funds invested. We plan to offer term loans, lines of credit, credit cards, equipment financing, and accounts receivable financing to small businesses.
Our goal is to close the small business credit gap described below using technology and the power of crowdfunding to provide fair, affordable, and transparent funding to underserved small businesses, including women- and minority-owned businesses, throughout the United States and Latin America that are working to better our communities. We believe that traditional banking institutions are underserving this segment for various reasons, leaving a small business credit gap of at least $87 billion and up to $465 billion in the United States and of up to $250 billion in Latin America. Notably, over 80% of these small businesses are pursuing or have the potential to pursue at least one of the SDGs, our benchmark for impact, but they lack easy to use tools that allow them to identify, measure, and report their impact. We believe that if they had these tools to better profile the positive impact they generate, small businesses could attract funding from the 85% of investors and 95% of millennials who state that they want to invest for impact and financial return.
Andres Idarraga, our chief executive officer, initially developed the idea and business model as described above through a pre-existing United States entity, Mentel LLC, and its wholly owned subsidiary in Colombia, Mentel Colombia SAS, where initial loans by Mentel Colombia SAS were made. On January 11, 2019, Mr. Idarraga established Creci Inc. in the United States, and in November 2019 Creci Inc. formed a wholly owned subsidiary in Colombia, Creci Finance Colombia S.A.S. Both were established to take over, develop, and operate the Company’s current business model. Creci Inc. and Mentel LLC have recently finalized the transfer of Mentel’s current loan portfolio that relates to the above business model. The value of the transaction is $325,000. Creci, Inc. paid for the transaction by issuing a $175,000 convertible note to Mentel LLC and by cancelling a note receivable of $150,000 which Mentel LLC issued to Creci Inc. on September 29, 2019.
Through the Mentel entities, since the second half of 2018 and through December 31, 2020, sixty-one loans totaling $325,000 have been originated in Colombia. The average loan amount is approximately $5,325. The companies to which these loans have been made, among other things, are furthering 13 of the United Nations’ Sustainable Development Goals, have provided over 100 jobs to indigenous and rural workers, helped over 50 farmers employ more efficient farming methods, provided empowerment training to over 300 women in low-income areas, are treating over 72,000 liters of water per day and have manufactured over 10,000 units of personal protective equipment in response to COVID-19.
17
Creci’s current goals are to continue expanding business operations in Colombia, expand our lending into the United States, and then expand throughout the Americas, beginning with Mexico. Since our founding, we have won our startup pitch category at the 2019 Innovate Finance Global Summit in London, were selected as a top three fintech startup in Village Capital’s Finance Forward Latin America 2020 Accelerator (an accelerator program that Village Capital conducts in collaboration with the MetLife Foundation, Paypal Holdings, Inc., and Moody’s Corporation) resulting in a $16,000 grant award; and our chief executive officer was awarded Northwestern University’s Kellogg School of Management’s 2020 Social Entrepreneurship Award, which came with a $70,000 grant award to support Creci.
Creci Notes
We plan to make Creci Notes, the subject of this offering circular, available to retail investors via Creci’s website, located at www.crecinotes.com. Our business model is centered around using the funds from the sale of Creci Notes to originate loans, extend lines of credit, and provide other debt-based financing to small businesses. The proceeds from Creci Notes may be aggregated with funds from the Company’s direct lending account, institutional capital providers, and accredited investors, which collectively may fund the lending products.
Creci Notes are being offered on a continuous basis, which allows for sale of debt securities to be made over time. The active acceptance of new investors in Creci Notes, whether via the Creci platform or otherwise, may at times be briefly paused, or the ability to subscribe may be periodically restricted to allow the Company time to effectively and accurately process and settle subscriptions that have been received. The Company may discontinue this offering at any time.
Creci Notes are being offered to both “accredited investors” as defined under Rule 501 of the Securities Act of 1933, as amended, and non-accredited investors. Pursuant to Rule 251(d)(2)(C), non-accredited investors who are natural persons may only invest the greater of 10% of their annual income or net worth. Non-natural non-accredited persons may invest up to 10% of the greater of their net assets or revenues for the most recently completed fiscal year.
No more than one each fiscal quarter, and with at least 30 days’ notice prior to the end of such fiscal quarter, an investor may submit a request to withdraw up to $500, or 10% of the investor’s principal and accrued interest, whichever is greater, to be paid within 10 days following the end of such fiscal quarter, and subject to available funds from loans made and other cash available to the Company, accounting for the Company’s maintenance of sufficient operating capital (such funds, “Available Cash”). If the aggregate amount of all withdrawal requests received by the Company in a given fiscal quarter exceeds the Available Cash in such fiscal quarter, the amounts paid out under such withdrawal requests shall be pro-rated proportionally to the amount of each request. If the Company has no Available Cash in a given fiscal quarter, no withdrawal requests will be paid. Management retains discretion to allow investors to withdraw additional amounts, subject to the availability of additional funds. The Company also retains the discretion to limit withdrawal requests prior to maturity, and we reserve the right to wait until the maturity date to pay all accrued interest. Investors should be prepared to hold their Creci Notes to maturity.
18
Although Creci intends to primarily use the proceeds of this offering to make loans and offer other credit products to small businesses and for general corporate purposes as described in “Use of Proceeds”, above, management retains discretion to use funds from this offering for additional purposes, including operating and general corporate expenses. Creci expects to pay interest on the Notes a monthly basis, although we reserve our right to wait until a repayment demand by the holder of the Notes to pay all (or any portion of) accrued interest. The Company retains the discretion to limit withdrawal requests. Creci Notes are the general obligations of the Company. We reserve the right to assign our obligations under the Creci Notes without first obtaining investor consent. Creci Notes will not be assignable by the noteholder without the prior written consent of the Company.
Interest Rate
The Creci Notes will bear interest at 5%. All terms, conditions and details regarding the interest rate of Creci Notes will be provided by the Company to the Investor prior to purchase by the Investor and made available on the Creci website at www.crecinotes.com.
Creci Website
We intend to offer the Creci Notes on our online website www.crecinotes.com. The Creci Notes are full recourse to us, regardless of payments received from any individual borrower. Prospective Creci Note investors will create a username and password on our website and agree to our terms and conditions and privacy policies.
We plan to implement the following features for our Creci Note investors through our website:
| ● | set up an account to purchase Creci Notes directly from us through our website, including with funds electronically withdrawn from their checking accounts, by a wire transfer, or by other means agreed to in advance by Creci and the investors; |
| ● | purchase Creci Notes in $10 increments and build an investment balance over time; |
| ● | view investment balances, returns, and transaction history and receive required tax documents regarding their investment; and |
| ● | sign up for webinars and educational programming regarding social impact and financial topics. |
We will not charge our Creci Note investors any commission or fees to purchase Creci Notes through our website. However, other unaffiliated financial intermediaries which are registered broker-dealers, if and when engaged, may charge them customary commissions or fees.
We plan to make the following features available to small business borrowers:
| ● | set up an account to use our social impact identification, measurement, and reporting tools; |
| ● | request a loan, view current loans, view loan balances, and make payments on loans; and |
| ● | sign up for webinars and educational programming regarding social impact and financial topics. |
19
Social Impact Overview
The United Nations has established the SDGs to promote sustainable development. Through them, businesses have been encouraged to have a more positive impact on society and to identify, measure, and report that impact. However, according to the University of North Carolina’s Kenan-Flagler’s Center for Sustainable Enterprise and New York University’s Center for Sustainable Businesses, small businesses typically do not have the time for higher level strategic thinking on sustainability. But if they did, they would be surprised how “good” their companies already are and how “small tweaks” can make them better, especially as consumers are looking for brands that make a “difference”. Creci’s social impact tool is designed to help small businesses report their impact, thereby helping to unlock investment capital from the growing number of investors that want to invest for sustainability and financial return.
Competitive Strengths
We believe we benefit from the following competitive strengths when compared to our competitors:
We are part of the fast-growing impact investment industry. Morgan Stanley reports that nearly 85% of Americans, including 95% of millennials, have moderate to high interest in sustainable investing. However, most impact investment opportunities are reserved for accredited or institutional investors. We intend to provide retail investors with the opportunity to align their investments with their values while earning a reasonable return.
We are part of the fast-growing fintech lending industry that is attending to underserved markets. Technology-enabled lending platforms, such as Creci, have successfully met market demand that banks either have decided they cannot, or do not want to, serve. These platforms often have lower overhead costs, making it easier and cheaper for them to originate loans to small businesses.
We focus on an underserved banking sector. Due to their higher costs, we believe that banks cannot profitably serve the small business lending market for commercial loans below $100,000. Indeed, traditional banks have been exiting the small business loan market for over a decade. We believe our underwriting model and borrower acquisition strategy will enable us to profitably originate loans at these levels.
Strategy
We intend to pursue the following strategies:
| ● | Attract top talent in operations, credit and risk assessment, data analytics, technology, and marketing. |
| ● | Market our Creci Notes to the impact investing community through various online and offline channels, such as social media platforms and alternative or social impact investing conferences. |
| ● | Attract small businesses to our platform by providing our social impact tool free of charge to businesses who sign up for an account. |
| ● | Establish strategic relationships with small business networks, such as chambers of commerce, so that we are top of mind loan providers to the small businesses in those networks. |
| ● | Develop and refine top underwriting standards to ensure the sound origination and maintenance of loans. |
20
Business Model
Under our business model, we intend to generate revenue from fees charged to borrowers and from interest generated from the loans that we originate, lines of credit we extend, and other forms of debt-based financing we provide to small businesses. It is Creci’s intention to request either personal guarantees or asset-based collateral for the loans it makes.
We plan to generate our gross profit from the spread between the interest rate paid to Creci Note investors and other debt investors, such as institutional debt investors, and the interest rate we plan to charge small businesses. Creci management intends to review the mentioned rates on a quarterly or semi-annual basis to take into account competitive conditions, including the general interest rate environment, cost of capital averages for small businesses, and the economic conditions facing the company.
In order to borrow on our platform, small businesses will provide information such as time in business, revenue, financial and credit variables, and tax returns so that we can assess their repayment capability. When loans are personally guaranteed, we plan to request financial information from the guarantor to assess his or her ability to meet the guarantee. We also will assess any asset-based collateral on a case-by-case basis. Generally, we intend for our loans to be fully amortized and repaid on a monthly basis.
At present, we employ three persons, two of which are full-time, and all of which are officers of the Company. As of September 1, 2021, our Colombian subsidiary employs ten (10) full-time employees.
For a discussion of distinctive or special characteristics of our operation and industry that may have a material impact on our future performance, see the Risks Related to Our Industry and Risks Related to Our Company sections under the Risk Factors heading, above.
We are currently a fully remote team as a result of the COVID-19 pandemic. Our Chief Executive Officer works from his home office located in Fort Lauderdale, Florida; our Chief Technology Officer works from his home office located in Attleboro, Massachusetts; and our Chief Operating Officer and Chief Social Impact Officer works from his home office located in Oakville, Ontario, in Canada. We rent a virtual office in Wilmington, Delaware, our place of incorporation. We previously sub-leased office space in Hollywood, Florida. We own no physical properties. We may lease office space in different locations as needed once the COVID-19 pandemic subsides. We anticipate locating such office space without difficulty.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements, the related notes, and other financial information included elsewhere in this offering circular. Some of the information contained in this discussion and analysis, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should review the “Risk Factors” section of this offering circular for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.
21
Overview
We are an early-stage fintech company incorporated in Delaware on January 11, 2019 that intends to make loans to small business in the United States and Latin America that are furthering at least one of the seventeen United Nations Sustainable Development Goals, which include goals such as decent work and economic growth, good health, quality education, and affordable and clean energy.
Operating Results
Since inception (January 11, 2019) we have engaged largely in organizational activities. Expenses related to these organizational activities through December 30, 2020 have been $49,925. The largest share of these expenses consists of technology-related expenses for developing our online platform and for developing our risk assessment frameworks. We also loaned $150,000 to a related party to originate loans in Colombia and earned $12,340 in interest in 2020 as a result. In 2020, we received $88,000 in grant award income.
Liquidity and Capital Resources
To date, we have funded our operations through venture capital equity financings and grant awards. As of December 30, 2020, we raised $250,000 through Simple Agreements for Future Equity (“SAFEs”) and $222,000 through convertible notes and earned $88,000 through grant awards. The SAFEs and convertible notes shall convert to preferred stock upon our issuance of preferred stock during a future equity raise at a price to be determined relative to either the percentage discounts or to the valuation caps set by the Company on the SAFEs and the convertible notes, or may convert into either preferred stock, common stock, or a right to receive payment, at the election of the holders, in the event we undergo a change of control transaction or initial public offering prior to an equity financing. The convertible notes have a three-year maturity, require at least $500,000 to be raised during the equity financing to trigger conversion, and at the election of the holders may convert to preferred stock in the event we do not reach the $500,000 threshold or do not raise an equity round prior to maturity.
We expect to meet our anticipated cash operating expense and capital expenditure requirements for our Company’s near-term growth plan through one or more equity financings. If those funds are insufficient to satisfy our liquidity requirements, we intend to seek additional equity or debt financings. We may require additional capital beyond our currently anticipated amounts and additional capital may not be available on reasonable terms, or at all.
These conditions raise substantial doubt about the Company’s ability to continue as a going concern and our management has raised substantial doubt about our ability to continue as a going concern and our independent registered public accounting firm has included an explanatory paragraph relating to our ability to continue as a going concern in its audit report with respect to our audited consolidated financial statements for the period from January 11, 2019 (inception) to December 31, 2020. We expect to generate income from the difference between the interest rates we charge borrowers or otherwise make from our permissible investments, including loan origination fees paid by borrowers, and the interest we will pay to the holders of Creci Notes. We also expect to use approximately 5% of the proceeds from sales of Creci Notes to provide working capital for our company until such time as our revenues are sufficient to pay our operating expenses.
22
Plan of Operations
We were organized in 2019 and are an early-stage company. Since inception, we have largely worked on organizational and development matters. We have engaged software developers to build our online platform and financial professionals to build our risk assessment model. We also have participated in loans originated by a related, pre-existing party through which the chief executive officer initially tested the business model.
During the twelve months following the commencement of this offering, we plan to explore sources of equity funding for our working capital. During that same period, we will seek to sell our Creci Notes and use the proceeds to originate small business loans in our initial lending market, Colombia. As part of our selling and marketing efforts, we plan to market our Creci Notes at alternative investment conferences, to groups interested in impact investing, and through relevant online channels. Given the uncertainty of the amount of Creci Notes that we will sell, it is difficult to provide a plan of operations in greater detail. We also plan to start working on the necessary approvals to begin lending in our second lending market, the United States. We will determine further lending markets after operations have been fully established in our first two markets.
Trend Information
The Company’s growth will depend on investment in the Creci Notes, other types of debt, and the equity of the Company, in addition to identifying and attracting small, impact business lending clients. We plan to increase our marketing and sales spending to attract both investors and lending clients. We expect to rely on social media, traditional media, impact investing affinity networks, impact business affinity networks, partnerships, and conferences to drive investor and client growth.
The core elements of our go-to-market and growth strategy include attracting new investors and small business clients, broadening distribution capabilities through strategic partnerships, extending user and customer lifetime value, expanding product offerings, broadening technology functionality for note investors and our small businesses clients, and enhancing data and due diligence analytical capabilities for internal use. The Company plans to invest significant resources to accomplish these goals. These investments are intended to contribute to long-term growth, but they may affect short-term profitability.
The COVID-19 pandemic continues to be a cause of concern worldwide, especially as the rise of the Delta and other variants have resulted in a resurgence of infections. We recently acquired a portfolio of small business loans in Colombia and are monitoring any cash flow issues of our borrower companies to remain proactive in servicing the loans and in identifying any that could become late or enter default.
Significant Accounting Policies
Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with US GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported period. In accordance with US GAAP, we base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.
23
The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Estimates which are particularly significant to the financial statements include estimates relating to the determination of any accrued liabilities or filing costs associated with establishing the Company.
Cash and cash equivalents
The Company considers short-term interest-bearing investments with initial maturities of three months or less to be cash equivalents.
Income taxes
The Company accounts for income taxes in accordance with ASC Section 740, Accounting for Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws.
Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which they operate, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax- planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of ASC Section 740.
The Company accounts for uncertain tax position in accordance with ASC 740-10, Accounting for Uncertainty in Income Taxes. As required by the relevant guidance, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would, more likely than not, sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company has applied the guidance to all tax positions for which the statute of limitations remained open.
The Company is subject to income taxes in the United States Federal jurisdiction, was subject to taxes in Florida, and may be subject to taxes in other states, including Florida or Delaware, in the future. The Company recognizes interest and penalty accrued related to unrecognized tax benefits in its income tax expense. No interest or penalties have been accrued for all periods presented.
Risks and uncertainties
The Company’s business could be impacted by continuing price pressure on its operating costs; acceptance of its products or services in the market place; new competitors; changing federal and/or state legislation; and new technologies and other factors. Adverse changes in these areas could negatively impact the Company’s financial position, results of operations and cash flows.
24
Our current executive officers and directors, and ages are as follows:
| Name | Age | Position | Term of Office | |||
| Andres Idarraga | 43 | Chief Executive Officer, Co-Founder, Director | Since inception | |||
| Pravin Rodrigues | 54 | Chief Operating Officer, Chief Social Impact Officer, Co-Founder | April 2021 | |||
| Carlos Ruiz | 39 | Chief Technology Officer | Since inception |
Andres Idarraga. Mr. Idarraga co-founded Creci and has served as chief executive officer and director since January 11, 2019. Before founding Creci, from August 2016 to July 2018, he was Chief Operating Officer and General Counsel of FlexFunds, a fast-growing asset securitization startup with over $2 billion dollars in assets under administration, based in Miami, Florida and with an international presence, including in Latin America. In that role, Mr. Idarraga was responsible for devising and implementing operational and legal frameworks across the company and overseeing company litigation. From September 2011 to July 2016, Mr. Idarraga was an attorney at Boies Schiller Flexner, one of leading law firms in the United States. There, he worked on antitrust, securities and complex commercial litigation matters. Mr. Idarraga also co-founded the Transcending Through Education Foundation in 2012, a non-profit that supports the higher education efforts of people in prison. He received bachelor’s degrees in Economics and Comparative Literature from Brown University, a law degree from Yale Law School, and an Executive MBA degree from Northwestern’s Kellogg School of Management.
Pravin Rodrigues. Mr. Rodrigues has worked with Creci as an investor and advisor since August 2020 and in May 2021 joined as a co-founder, Chief Operating Officer, and Chief Social Impact officer. For the 15 years prior to joining Creci, he operated Mentis Solutions, a boutique consulting firm in Canada providing advisory services for large-scale transformation initiatives in the financial services sector, including for the Royal Bank of Canada, TD Banks, Scotiabank and IGM Financial. Such programs included product introductions, AML and other regulatory programs for personal and commercial credit, technical and culture change implementations in wealth management and operational integration of acquisitions. Programs ranged in size, with budgets between $5 million and $40 million and teams of up to 250. He founded Espera Ventures in 2017 to invest in social and environmental ventures and Path and Purpose, a program which encourages youth accountability for their own success through experiential learning. He received a bachelor’s degree in Economics from Western University and an MBA from Queen’s University, both in Canada. He also holds a master’s degree in Sustainability Leadership from the University of Cambridge in England.
Carlos Ruiz. Mr. Ruiz has served as Creci’s part-time Chief Technology Officer since January 11, 2019. From September 2016 to September 2018, he was a Senior Software Engineer at Engie, a multinational electric company, where he worked to develop technology that makes commercial buildings more efficient. In January 2019, he joined Pulsify, also as a Senior Software Engineer. Pulsify was an early-stage company that developed a human resource management platform and was acquired. Previously, Mr. Ruiz was a lead software engineer at Meditech, a public company. At Meditech, he was the lead developer for the Argonaut Project, a joint project by several medical and technology organizations (including Apple and Microsoft) that advanced the interoperability standards for sharing health records and health information technology. Many years later, Mr. Ruiz’s core, foundational work for the Argonaut Project is still in place. He is a summa cum laude graduate of Northeastern University, where he received a bachelor’s degree.
25
Family Relationships
None.
Conflicts of Interest
Except as set forth below, we do not believe that we are a party to any transactions that contain or give rise to a conflict of interest between any of our directors, officers and 5% or greater stockholders on the one hand, and Creci Inc., on the other hand.
Our chief executive officer has invested $470,000 in Creci Inc. through two SAFEs and two convertible notes issued by the Company to two entities controlled by him. These transactions provided initial and follow-on capital for the Company. Our COO also has invested $62,000 in Creci Inc. through two convertible notes issued by the Company to an entity controlled by him.
Creci also has loaned $150,000 to a related party controlled by our chief executive officer to originate loans in Colombia. Further information is provided in the section “Interest of Management and Others in Certain Transactions” and in the consolidated financial statements. In addition, Creci has recently finalized a transaction wherein the Company has acquired the loan portfolio of the Mentel entities. Our CEO is the ultimate owner of 100% of the equity of the Mentel entities.
Involvement in Certain Legal Proceedings
None. From time to time, we may become party to various lawsuits, claims and other legal proceedings that arise in the ordinary course of our business. We are not currently a party, as plaintiff or defendant, nor are we aware of any threatened or pending legal proceedings, that we believe to be material or which, individually or in the aggregate, would be expected to have a material effect on our business, financial condition or results of operation if determined adversely to us.
Compensation of Directors and Executive Officers
| Name | Fiscal Year | Capacity in which compensation was received | Cash Compensation | Other Compensation | Total Compensation | ||||||||||||
| Veronica Pena | 2020 | Chief Operating Officer | $ | 16,500 | $ | 0 | $ | 16,500 | |||||||||
Mr. Idarraga and Mr. Ruiz were not paid during the 2019 or 2020 fiscal years. From January 11, 2019 through October 14, 2020, Veronica Pena served as executive officer and director of the Company. She unexpectedly passed away on October 14, 2020. Ms. Pena was paid $16,500 during the 2020 fiscal year for her services. Mr. Rodrigues joined Creci as director and executive officer in April 2021. He is not currently earning a salary in any capacity.
26
There are no other executive officers or directors.
Security Ownership of Management and Certain Security Holders
| Common Stock | ||||||||||||
| Name and Address of Beneficial Owner | Stock Amount of beneficial ownership as of September 1, 2021 | Options Amount of beneficial ownership acquirable as of September 1, 2021 | Percent of Class | |||||||||
| Andres Idarraga | 7,000,000 | 0 | 70.00 | % | ||||||||
| Pravin Rodrigues | 0 | 2,000,000 | 20.00 | % | ||||||||
| Carlos Ruiz | 0 | 500,000 | 5.00 | % | ||||||||
| All Directors and Officers, as a group (3 persons) | 7,000,000 | 2,500,000 | 95.00 | % | ||||||||
| Equity Incentive Plan | 0 | 500,000 | 5.00 | % | ||||||||
Unless otherwise noted, the address of each executive officer or director is Creci Inc.,1201 North Market Street, Suite 111, Wilmington, Delaware 19801.
Creci currently has in place an equity compensation plan for employees, contractors, and advisors (hereafter, “beneficiaries”). To date, beneficiaries have been awarded Restricted Stock Units (“RSUs”) under the plan. Each RSU awarded entitles the recipient to receive one common share according to a vesting schedule and subject to other terms and conditions that are set forth in each particular RSU agreement. RSUs have no voting rights and beneficiaries are responsible for any taxes that become due as a result of the granting or vesting of the RSUs. RSUs are awarded at the discretion of management and the board of directors.
Interest of Management and Others in Certain Transactions
In May 2019, the Company issued a $130,000 SAFE to Creci Inc. 401(k) Trust, a simplified 401(k) profit sharing plan set up for the Company. The plan will allow current and future employees of the company to save for retirement through a tax-advantaged account that will allow them to invest in various investment products, including securities issues by the Company. The initial $130,000 was proceeds transferred by Andres Idarraga from a previous employer’s 401(k) plan. In June 2019, the Company issued a $120,000 SAFE to Mentel LLC, a limited liability company of which Andres Idarraga is the Managing Member. The terms of the SAFEs are the same. They shall convert to preferred stock upon our issuance of preferred stock during a future equity raise at a stock price to be determined relative to either a 20% discount to the valuation agreed to during that equity raise or a $2,000,000 post-money valuation cap, or they may convert into either common stock or a right to receive payment, at the election of the holders, in the event we undergo a change of control transaction or initial public offering prior to an equity financing.
In August 2020, the Company issued a $17,000 convertible note to Espera Ventures Green Economy I LP, a limited partnership of which Pravin Rodrigues is the Managing Partner, during our Pre-Seed fundraising round that raised $222,000 via convertible notes. All notes were issued with the same terms. They have a three-year maturity and convert to preferred stock upon our issuance of preferred stock during a future equity raise of at least $500,000 (a “qualified financing”) at a stock price to be determined relative to either a 20% discount to the valuation agreed to during that equity raise or a $2,000,000 pre-money valuation cap, or they may convert into either preferred stock or a right to receive payment, at the election of the holders, in the event we do not raise a qualified equity round prior to maturity or undergo a change of control transaction or initial public offering prior to an equity financing.
27
We plan to make Creci Notes available on our website in electronic form and not to list them on any securities exchange. We intend to make the Creci Notes viewable at any time by accessing a “My Documents” tab in an investor’s account, where the Notes will only be accessible by the individual investor and cannot be accessed unless the investor enters login-credentials.
Fees
We do not currently plan to charge Creci Note investors a servicing fee or commission for their investments. However, if we believe it reasonably necessary to make use of a third-party broker-dealer to conduct the offering or any parts of the offering, we may charge a servicing fee on any transactions pursuant to which a fee must be paid to such broker-dealer solely to offset such broker-dealer fees.
Use of Proceeds
We will use the proceeds of this offering primarily to originate loans, extend lines of credit, and provide other debt-based financing to small businesses, such as credit cards, equipment financing, and accounts receivable financing. We also may use the proceeds for general corporate purposes, including the costs of this offering. See “Use of Proceeds.”
Establishing an Account
The first step to being able to purchase Creci Notes on our website will be for a user to set up an investor account. In order to set up a Creci Note account, prospective investors must complete the following steps:
| ● | if the investor is an individual, by registering and providing the investor’s name, email address, social security number, the type of account and other specified information; |
| ● | if the investor is an organization, by registering and providing the name of the organization, the type of organization, email address, tax identification number, type of account and other specified information; and |
| ● | in either case, the investor must agree to our terms of use, privacy policy and subscription agreement, which provide for the general terms and conditions of using our website and purchasing the Creci Notes and other applicable terms and conditions. |
As part of these terms and conditions and by registering to purchase Creci Notes, the investor will be required to certify to us that:
| ● | the investor has had the opportunity to download and view this offering circular and any offering circular supplement through our website each time the investor purchases Creci Notes; |
| ● | if the investor is an individual investor, the investor’s purchase order has been submitted for and on behalf of the investor’s account; |
| ● | if the investor is an organization, the investor’s purchase order has been submitted by an officer or agent who is authorized to bind the organization; |
28
| ● | the investor is making the investor’s own investment decision and understand the risk of investing in Creci Notes; |
| ● | we are not providing the investor with any investment advice nor are we acting as or registered as a broker, dealer, investment adviser or other fiduciary; and |
| ● | the investor’s purchase order and all other consents submitted through our website constitute legal, valid and enforceable contracts. |
The investor must agree to receive all notifications required by law or regulation or provided for by our website electronically at the investor’s last electronic address the investor provided to us.
After the investor successfully registers on our website, the investor will receive a confirmation of the investor’s successful registration and may view available Creci Note offerings. Please note that the investor is not obligated to submit a purchase order for any Creci Notes simply because the investor has registered on our website.
Once the investor specifies an investment amount and sets up a payment method, such as connecting a bank account, the investor will complete a purchase order for Creci Notes, payment will be processed, and the equivalent amount of Creci Notes will be issued to the investor upon receipt of payment.
Creci Notes may not be a suitable investment for a potential investor, even if the potential investor qualifies to purchase them. Moreover, even if a potential investor qualifies to purchase Creci Notes and places a purchase order, such investor may not receive an allocation of Creci Notes for a number of reasons, including that we have reached the maximum offering amount pursuant to this offering statement or that more than three years have elapsed since the initial qualification of this offering statement.
If an investor has difficulty opening an account or otherwise using our website, an investor may use the live help button on our website to connect with one of our customer service representatives. Customer service representatives will help investors with technical and technology issues related to their use of our website. However, customer service representatives will not provide investors with any investment advice, nor will they provide investors with any information as to the Creci Notes, how much to invest in Creci Notes, or the merits of investing or not investing in Creci Notes.
How to Purchase Creci Notes
An investor may submit purchase orders for Creci Notes by:
| ● | indicating the amount of Creci Notes that the investor wishes to purchase; |
| ● | reviewing the applicable offering circular for Creci Notes; |
| ● | submitting a purchase order by clicking the confirmation button; |
| ● | choosing payment method by following the requested steps to provide the necessary funds; and |
| ● | reviewing the purchase order to ensure accuracy, checking the box to confirm accuracy, and confirming the purchase order by clicking the confirmation button. |
29
Investors will not be able to purchase Creci Notes unless they have completed all the above steps.
Once an investor submits a purchase order to our website, the investor’s purchase order will constitute an offer to purchase Creci Notes. For purposes of an electronic order process on our website, the time as maintained on our website will constitute the official time of a purchase order.
Website Operation
We are currently building the note investing segment of our website and will test it to confirm its functionality and ability to handle numerous purchase orders and prospective investors. However, we cannot predict the response of our website to any particular issuance of Creci Notes pursuant to this offering circular. Investors should be aware that if a large number of investors try to access our website at the same time and submit their purchase orders simultaneously, there could be a delay in receiving and/or processing their purchase orders. Investors should also be aware that general communications and internet delays or failures unrelated to our website, as well as website capacity limits or failures, may prevent purchase orders from being received on a timely basis by our website. We cannot guarantee our investors that any of their submitted purchase orders will be received, processed and accepted during the offering process.
Orders are typically processed on the business day following the order. Investors may not withdraw the amount of their purchase orders, unless the listing is withdrawn or cancelled. Once a purchase order is accepted and processed, it is irrevocable. Interest does not accrue until the purchase funds have cleared.
Prior to submitting a purchase order, an investor will be required to acknowledge receipt of the offering documents for the Creci Notes that the investor wishes to purchase. In the case of an entity investor, the prospective investor will be required to make representations regarding the authority of the signatory to enter into the agreement and make representations on behalf of the entity.
The minimum purchase order that an investor will be able to submit for any particular offering of Creci Notes is $10, and subject to consideration there is no maximum purchase order that may be submitted, except for non-accredited investors, whose purchases will be subject to the following limits pursuant to SEC Rule 251(d)(2)(C):
| ● | natural non-accredited persons may only invest the greater of 10% of their annual income or net worth; and |
| ● | non-natural non-accredited persons may invest up to 10% of the greater of their net assets or revenues for the most recently completed fiscal year. |
Auto-Invest Program
Following investors’ initial purchases of Creci Notes, we plan to allow them to affirmatively elect to participate in an auto-invest program (the “Auto-Invest Program”) that allows them to automatically invest in additional Creci Notes on a recurring basis (e.g., monthly or quarterly) subject to an amount (in minimum denominations of $10) and frequency that they designate.
30
If investors affirmatively elect to participate in the Auto-Invest Program, we will automatically place orders for Creci Notes that match the amount and parameters they designate. Upon affirmatively electing to participate in the Auto-Invest Program, the investor will be asked to agree to the terms and conditions of the Creci Note Investor Agreement. Upon each “auto-investment” being made, we will send a confirmatory email to the investor denoting the amount invested. The terms of the Creci Notes which will be acquired with the proceeds of the Auto-Invest Program will be those in effect as of the date of each reinvestment as set forth in this offering circular, as revised from time to time by supplements filed with the SEC. Investors will be asked to identify the bank account from which the funds would be drawn for purposes of the Auto-Invest Program. Upon affirmatively electing to participate in the Auto-Invest Program, Investors will be asked to make an ongoing representation and warranty that, if they are non-accredited investors, they will not exceed the ownership limitations set forth under Rule 251(d)(2)(C) of Regulation A. Accordingly, each investor must determine from the outset of participation in the auto-invest program that the aggregate amount the investor elects invest through the program will not exceed the Regulation A investment thresholds and if, in the future, the investor’s circumstances change, it should alert the Company and discontinue participation is the representation and warranty can no longer be made.
Creci intends to treat any sales of Creci Notes made pursuant to the Auto-Invest Program as sales chargeable against the aggregate total of offered securities pursuant to this offering circular and to include such sales when calculating the $70 million aggregate offering amount being offered and sold hereunder. We plan to allow investors to cancel their participation in the auto-invest program any time from their Creci investor account dashboard.
Tax and Legal Treatment
Holders of Creci Notes will receive interest income. At the end of the calendar year, investors with over $10 of realized interest will receive a form 1099-INT. These will need to be filed in accordance with the United States Tax Code. Investors’ tax situations will likely vary greatly and all tax and accounting questions should be directed towards Investors’ certified public accountants. Investors should also consult with their own personal tax advisors.
In the United States, we expect that our lending activities will be regulated state-by-state as a nonbank, commercial lender and that we will need to obtain licenses and registrations where required in each state where we lend. We believe that most states will not require us to obtain licenses for our commercial lending activities, as currently structured. As a lender, we anticipate that we will generally be subject to the lending laws of our home state of Delaware and possibly the home state of the borrower.
In Colombia, our first lending market, we expect that our lending activities will be regulated at the federal level as a nonbank, commercial lender. At the moment, we believe that we do not need to obtain any licenses for our commercial lending activities, as currently structured.
31
Following is a summary of the terms of the Creci Notes, which will be offered on the Creci website.
General. We may (through our officers and directors) offer Creci Notes for total gross proceeds of up to $70,000,000 on a continuous basis under this offering circular. We will not issue more than $70,000,000 of such debt securities pursuant to this offering circular in any 12-month period.
The Creci Notes:
| ● | are priced at $10.00 each; |
| ● | shall bear interest at 5% per annum, compounded monthly, credited monthly to the investor’s account; |
| ● | have three-year terms, after which a holder may demand full repayment at any time; |
| ● | represent a full and unconditional obligation of the Company; |
| ● | are not payment dependent on any individual underlying loan or credit product; |
| ● | are unsecured; |
| ● | are not expected to be convertible or exchangeable into any other securities; and |
| ● | shall be generally callable, redeemable, and prepayable at any time by the Company, subject to limitations set forth in the Creci Notes. |
No more than one each fiscal quarter, and with at least 30 days’ notice prior to the end of such fiscal quarter, an investor may submit a request to withdraw up to $500, or 10% of the investor’s principal and accrued interest, whichever is greater, to be paid within 10 days following the end of such fiscal quarter, and subject to available funds from loans made and other cash available to the Company, accounting for the Company’s maintenance of sufficient operating capital (such funds, “Available Cash”). If the aggregate amount of all withdrawal requests received by the Company in a given fiscal quarter exceeds the Available Cash in such fiscal quarter, the amounts paid out under such withdrawal requests shall be pro-rated proportionally to the amount of each request. If the Company has no Available Cash in a given fiscal quarter, no withdrawal requests will be paid. Management retains discretion to allow investors to withdraw additional amounts, subject to the availability of additional funds. The Company also retains the discretion to limit withdrawal requests prior to maturity, and we reserve the right to wait until the maturity date to pay all accrued interest. Investors should be prepared to hold their Creci Notes to maturity.
Ranking. The Creci Notes will be general unsecured obligations of the Company and will rank equally with all of our other unsecured debt unless such debt is senior to or subordinate to the Creci Notes by their terms. The Notes would rank junior to any future secured debt.
Form and Custody. Creci Notes will be issued by computer-generated program on our website and electronically signed by the Company in favor of the investor. The Creci Notes will be stored by the Company and will remain in the Company’s custody for ease of administration. Except during periodic system maintenance, investors will be able to view their Creci Notes through their online dashboard.
Prepayment. Creci Notes will be subject to redemption by the Company at any time at face value plus any accrued but unpaid interest.
32
Conversion or Exchange Rights. The Creci Notes will not be convertible or exchangeable into any other securities.
Events of Default. The following will be events of default under the Creci Notes:
| ● | if we fail to pay interest when due and our failure continues for 90 days and the time for payment has not been extended or deferred; |
| ● | if we fail to pay the principal, or premium, if any, when due; and |
| ● | if we cease operations, file, or have an involuntary case filed against us, for bankruptcy, are insolvent or make a general assignment in favor of our creditors. |
The occurrence of an event of default of Creci Notes may constitute an event of default under any bank credit agreements we may have in existence from time to time. In addition, the occurrence of certain events of default may constitute an event of default under certain of our other indebtedness outstanding from time to time.
Governing Law. Each Creci Note and the Creci Note Investor Agreement will be governed and construed in accordance with the laws of the State of Delaware.
Exclusive Forum Provision. Section 9 of our Form of Creci Note provides that “[t]his Note shall be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to principles of conflict of laws. In the event that the dispute resolution procedures in Section 8 are found not to apply to a given claim, any judicial proceeding will be brought in the state courts of New Castle County, Delaware. Both parties hereto consent to venue and personal jurisdiction there.”
THIS EXCLUSIVE FORUM PROVISION WOULD NOT APPLY TO SUITS BROUGHT TO ENFORCE A DUTY OR LIABILITY CREATED BY THE SECURITIES ACT, EXCHANGE ACT OR ANY OTHER CLAIM FOR WHICH THE U.S. FEDERAL COURTS HAVE EXCLUSIVE JURISDICTION.
This choice of forum provision may limit a holder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and employees. Alternatively, a court could find this provision of our Form of Creci Note to be inapplicable or unenforceable in respect of one or more of the specified types of actions or proceedings, which may require us to incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition.
Arbitration. Pursuant to the terms of the Creci Note Investor Agreement, the holders of Creci Notes and the Company will agree to (i) resolve disputes of the holders of Creci Notes through binding arbitration or small claims court, instead of through courts of general jurisdiction or through a class action and (ii) waive the right to a trial by jury and to participate in any class action, except in cases that involve personal injury.
Pursuant to the terms of the Creci Note Investor Agreement, if a holder of Creci Notes does not agree to the terms of the arbitration provision, the holder of Creci Notes may opt-out of the arbitration provision by sending an arbitration opt-out notice to the Company within thirty (30) days of the holder’s first electronic acceptance of the Creci Note Investor Agreement. If the opt-out notice is not received within thirty (30) days, the holder of Creci Note will be deemed to have accepted all terms of the arbitration provision, including the class action and jury waiver. If the investor opts out of the arbitration provision, the investor has also opted out of the jury trial and class action waivers.
33
As arbitration provisions in commercial agreements have generally been respected by federal courts and state courts of Delaware, we believe that the arbitration provision in the Creci Note Investor Agreement is enforceable under federal law and the laws of the State of Delaware. Although holders of Creci Notes will be subject to the arbitration provisions of the Creci Note Investor Agreement, the arbitration provisions do not preclude holders of Creci Notes from pursuing claims under the Exchange Act and Securities Act in federal courts.
THE ARBITRATION PROVISION OF THE CRECI NOTE INVESTOR AGREEMENT IS NOT INTENDED TO BE DEEMED A WAIVER BY ANY HOLDER OF CRECI NOTES OF THE COMPANY’S COMPLIANCE WITH THE U.S. FEDERAL SECURITIES LAWS AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER. THE ARBITRATION PROVISION OF THE CRECI NOTE INVESTOR AGREEMENT DO NOT APPLY TO CLAIMS BROUGHT UNDER THE EXCHANGE ACT AND SECURITIES ACT.
Jury Trial and Class Action Waiver. The Creci Note Investor Agreement provides that, to the extent permitted by law, each party to the Creci Note Investor Agreement waives the right to a jury trial or class action of any claim they may have against us arising out of or relating to our Creci Notes or the Creci Note Investor Agreement. If we were to oppose a jury trial or class action demand based on such waiver, the court would determine whether the waiver was enforceable based upon the facts and circumstances of that case in accordance with applicable state and federal law, including whether a party knowingly, intelligently, and voluntarily waived the right to a jury trial or class action. The bondholders of Creci Notes will be subject to these provisions of the Creci Note Investor Agreement to the extent permitted by applicable law. THE WAIVER OF THE RIGHT TO A JURY TRIAL AND CLASS ACTION CONTAINED IN THE CRECI NOTE INVESTOR AGREEMENT IS NOT INTENDED TO BE DEEMED A WAIVER BY ANY HOLDER OF CRECI NOTES OF THE COMPANY’S COMPLIANCE WITH THE U.S. FEDERAL SECURITIES LAWS AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER. THE JURY WAIVER AND CLASS ACTION WAIVER PROVISIONS OF THE CRECI NOTE INVESTOR AGREEMENT DO NOT APPLY TO CLAIMS BROUGHT UNDER THE EXCHANGE ACT AND SECURITIES ACT. If the investor opts out of the arbitration provision, the investor has also opted out of the jury trial and class action waivers.
No Personal Liability of Directors, Officers, Employees and Stockholders. No incorporator, stockholder, employee, agent, officer, director or subsidiary of ours will have any liability for any obligations of ours due to the issuance of any Creci Notes.
Subscribing for Creci Notes
We are offering up to $70,000,000 in Creci Notes pursuant to this offering circular. Creci Notes being offered hereby will be offered directly by the Company’s officers and directors through the Creci website at www.crecinotes.com. We reserve the right, however, to engage a registered broker-dealer or advisory firm to offer these Notes, which may charge a customary fee or commission for their services, in which case we may charge a servicing fee solely to offset such fee or commission (see “Fees” above). We may also engage the services of a registered broker-dealer portal to offer these Creci Notes. This offering circular will be furnished to prospective investors via electronic format before or at the time of all written offers and will be available for viewing and download on the Creci Notes website, as well as on the SEC’s website at www.sec.gov.
34
In order to subscribe to purchase Creci Notes, a prospective investor must electronically complete, sign and deliver to us an executed Creci Note Investor Agreement and provide funds for its subscription amount set forth therein in accordance with the instructions provided therein.
We may also engage the services of a registered broker-dealer who may offer, sell and process subscriptions for the Creci Notes. If any broker-dealer or other agent/person is engaged to sell our Creci Notes, we will file a post-qualification amendment disclosing the names and compensation arrangements prior to any sales by such persons.
This offering is being conducted on a “best efforts” basis, which means that there is no guarantee that any minimum amount will be sold in this offering. Sales of the Creci Notes will be made on a continuous basis until the maximum amount of Creci Notes (i.e., $70,000,000) are sold. Due to the “best efforts” and continuous nature of this offering, funds received will not be placed in escrow, nor have we made any other arrangements for the return of funds if the maximum amount (i.e., $70,000,000) is not reached.
State Law Exemption and Offerings to “Qualified Purchasers”
Our Creci Notes are being offered and sold only to “qualified purchasers” (as defined in Regulation A under the Securities Act of 1933). As a Tier 2 offering pursuant to Regulation A under the Securities Act, this offering will be exempt from state “Blue Sky” law review, subject to certain state filing requirements and anti-fraud provisions, to the extent that our Creci Notes offered hereby are offered and sold only to “qualified purchasers” or at a time when our Creci Notes are listed on a national securities exchange.
“Qualified purchasers” include: (i) “accredited investors” under Rule 501(a) of Regulation D and (ii) all other investors so long as their investment in our Creci Notes does not represent more than 10% of the greater of their annual income or net worth (for natural persons), or 10% of the greater of annual revenue or net assets at fiscal year-end (for non-natural persons). Accordingly, we reserve the
right to reject any investor’s subscription in whole or in part for any reason, including if we determine in our sole and absolute discretion that such investor is not a “qualified purchaser” for purposes of Regulation A.
Physical Creci Notes Will Not be Issued
We will not issue Creci Notes in physical or paper form. Instead, our Creci Notes will be issued electronically, and recorded and maintained on an internal register.
35
Advertising, Sales and other Promotional Materials
In addition to this offering circular, subject to limitations imposed by and in compliance with applicable securities laws, we expect to use additional advertising, sales and other promotional materials in connection with this offering to better understand possible demand for the Creci Note product. These “test-the-waters” materials may include information relating to our Company, this offering, any past performance of loan transactions, articles and publications concerning social impact small businesses and small business lending, or public advertisements and audio-visual materials, in each case only as authorized by us. All such materials will contain disclaimers required by, and be disseminated in a fashion permitted by, Regulation A. Although these materials will not contain information in conflict with the information provided by this offering circular and will be prepared with a view to presenting a balanced discussion of risk and reward with respect to our Notes, these materials will not give a complete understanding of this offering, us or our Notes and are not to be considered part of this offering circular. This offering is made only by means of this offering circular and prospective investors must read and rely on the information provided in this offering circular in connection with their decision to invest in our Notes. To be clear, all investors will be furnished with a copy of a current offering circular before or at the time of all written offers.
Certain legal matters regarding the securities being offered by this offering circular have been passed upon for us by K&L Gates LLP.
Our audited financial statements as of and for the period from January 11, 2019 (inception) through December 31, 2020 have been audited by Cherry Bekaert LLP, our independent public accounting firm, given on the authority of that Firm as experts in accounting and auditing.
36
Creci, Inc.
Financial Statements
Table of Contents
F-1

To the Board of Directors and Members
Creci, Inc.
Fort Lauderdale, Florida
We have audited the accompanying financial statements of Creci, Inc. (a Delaware corporation), which comprise the balance sheets as of December 31, 2020 and 2019, and the related statements of operations, stockholder’s deficit, and cash flows for the year ended December 31, 2020 and for the period from January 11, 2019 (inception) through December 31, 2019, and the related notes to the financial statements.
Management’s Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.
Auditor’s Responsibility
Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Opinion
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Creci, Inc. as of December 31, 2020 and 2019, and the results of its operations and its cash flows for the year ended December 31, 2020 and for the period from January 11, 2019 (inception) through December 31, 2019, in accordance with accounting principles generally accepted in the United States of America.
Substantial Doubt about the Company’s Ability to Continue as a Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s plans regarding those matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to that matter.

Fort Lauderdale, Florida
October 12, 2021
cbh.com
F-2
Balance Sheets
as of December 31, 2020 and 2019
| 2020 | 2019 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | $ | 94,209 | $ | 49,635 | ||||
| Prepaid Legal Expenses | 8,053 | 15,000 | ||||||
| Other Receivable - Related Party | - | 45 | ||||||
| Accrued Interest Receivable - Related Party | 8,500 | - | ||||||
| Grant Receivable | 35,000 | - | ||||||
| Total Current Assets | 145,762 | 64,680 | ||||||
| Fixed Assets | ||||||||
| Software Development Costs | 26,728 | 26,728 | ||||||
| Accumulated Amortization | (10,691 | ) | (5,346 | ) | ||||
| Total Fixed Assets | 16,037 | 21,382 | ||||||
| Other Assets | ||||||||
| Loans Receivable - Related Party | 150,000 | 50,000 | ||||||
| Total Other Assets | 150,000 | 50,000 | ||||||
| TOTAL ASSETS | $ | 311,799 | $ | 136,062 | ||||
| LIABILITIES AND SHAREHOLDER’S DEFICIT | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accrued Payable and Accrued Liabilities | $ | 7,472 | $ | 1,379 | ||||
| Total Current Liabilities | 7,472 | 1,379 | ||||||
| Long-Term Liabilities | ||||||||
| Convertible Notes | 222,000 | 15,000 | ||||||
| Contingent Obligations to Issue Future Equity (“SAFEs”) - Related Parties | 250,000 | 250,000 | ||||||
| Total Long-Term Liabilities | 472,000 | 265,000 | ||||||
| Total Liabilities | 479,472 | 266,379 | ||||||
| Shareholder’s Deficit | ||||||||
| Preferred Stock, par value $0.00001, 5,000,000 shares authorized, and 0 shares issued and outstanding as of December 31, 2020 and December 31, 2019. | ||||||||
| Common Stock, par value $0.00001, 10,000,000 shares authorized, and 7,000,000 shares issued and outstanding as of December 31, 2020 and December 31, 2019. | 70 | 70 | ||||||
| Accumulated Deficit | (167,743 | ) | (130,387 | ) | ||||
| Total Shareholder’s Deficit | (167,673 | ) | (130,317 | ) | ||||
| TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT | $ | 311,799 | $ | 136,062 | ||||
See accompanying notes to the financial statements
F-3
Statements of Operations
for the Year Ended December 31, 2020 and for the Period
January 11, 2019 (inception) through December 31, 2019
| 2020 | 2019 | |||||||
| INCOME | ||||||||
| Grant Income | $ | 88,000 | $ | - | ||||
| Interest Income - Related Party | 12,340 | - | ||||||
| TOTAL INCOME | 100,340 | - | ||||||
| OPERATING EXPENSES | ||||||||
| Advertising and Promotion | 2,846 | 196 | ||||||
| Computer and Internet Expenses | 10,199 | 386 | ||||||
| Professional Fees | 14,404 | 10,964 | ||||||
| Software Development Expenses | 53,375 | 21,228 | ||||||
| Organizational Costs | - | 49,925 | ||||||
| Interest Expense | 6,028 | 37 | ||||||
| Other Expenses | 7,941 | 15,236 | ||||||
| General and Administrative Expenses | 37,557 | 27,665 | ||||||
| TOTAL OPERATING EXPENSES | 132,350 | 125,637 | ||||||
| OPERATING LOSS | (32,010 | ) | (125,637 | ) | ||||
| OTHER INCOME (EXPENSES) | ||||||||
| Other Income | - | 596 | ||||||
| Amortization | (5,346 | ) | (5,346 | ) | ||||
| TOTAL OTHER EXPENSES | (5,346 | ) | (4,750 | ) | ||||
| Less Provision for Income Taxes | - | - | ||||||
| NET LOSS | $ | (37,356 | ) | $ | (130,387 | ) | ||
| Weighted average common shares outstanding (basic and diluted) | 7,000,000 | 7,000,000 | ||||||
| Basic and diluted net loss per share | $ | (0.005337 | ) | $ | (0.018627 | ) | ||
See accompanying notes to the financial statements
F-4
Statements of Stockholder’s Deficit
for the Year Ended December 31, 2020 and for the Period
January 11, 2019 (inception) through December 31, 2019
| Common Stock | Total | |||||||||||||||
| Shares Issued | Cash Paid for Shares | Accumulated Deficit | Stockholder’s Deficit | |||||||||||||
| Balance at January 1, 2019 | - | $ | - | $ | - | $ | - | |||||||||
| Net Loss | (130,387 | ) | (130,387 | ) | ||||||||||||
| Balance at December 31, 2019 | 7,000,000 | 70 | (130,387 | ) | (130,317 | ) | ||||||||||
| Net Loss | - | - | (37,356 | ) | (37,356 | ) | ||||||||||
| Balance at December 31, 2020 | 7,000,000 | $ | 70 | $ | (167,743 | ) | $ | (167,673 | ) | |||||||
See accompanying notes to the financial statements
F-5
Statements of Cash Flows
for the Year Ended December 31, 2020 and for the Period
January 11, 2019 (inception) through December 31, 2019
| 2020 | 2019 | |||||||
| CASH FLOW FROM OPERATING ACTIVITIES | ||||||||
| Net Loss | $ | (37,356 | ) | $ | (130,387 | ) | ||
| Adjustments to reconcile Net Loss to Net Cash used in Operating Activities | ||||||||
| Amortization | 5,346 | 5,346 | ||||||
| Other Receivable - Related Party | 45 | (45 | ) | |||||
| Accrued Interest Receivable - Related Party | (8,500 | ) | — | |||||
| Grant Receivable | (35,000 | ) | — | |||||
| Accrued Receivable and Prepaid Expenses | 6,947 | (15,000 | ) | |||||
| Accrued Payable and Accrued Liabilities | 6,092 | 1,379 | ||||||
| Total Adjustments to reconcile Net Income to Net Cash provided by operations: | (25,070 | ) | (8,320 | ) | ||||
| Net Cash Used in Operating Activities | (62,426 | ) | (138,707 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Software Development Costs | — | (26,728 | ) | |||||
| Loans Receivable - Related Party | (100,000 | ) | (50,000 | ) | ||||
| Net Cash Used in Investing Activities | (100,000 | ) | (76,728 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Issuance of Convertible Notes | 207,000 | 15,000 | ||||||
| Issuance of Simple Agreements for Future Equity (“SAFEs”) - Related Parties | — | 250,000 | ||||||
| Issuance of Capital Stock | — | 70 | ||||||
| Net Cash Provided by Financing Activities | 207,000 | 265,070 | ||||||
| Increase or Decrease in Cash and Cash Equivalents | 44,574 | 49,635 | ||||||
| Cash and Cash Equivalents, beginning balance | 49,635 | — | ||||||
| Cash and Cash Equivalents, ending balance | $ | 94,209 | $ | 49,635 | ||||
| Supplemental Disclosures of Cash Flow Information | ||||||||
| Cash Paid for Income Taxes | $ | — | $ | — | ||||
| Cash Paid for Interest Expense | $ | — | $ | — | ||||
See accompanying notes to the financial statements
F-6
Notes to the Financial Statements
Note 1. Organization and Nature of Operations
Creci, Inc., a Delaware corporation, (“Creci” or the “Company”) was founded on January 11, 2019. Creci is an early-stage company that intends to establish an online platform to make loans and provide credit-based products to small businesses in the United States and Latin America that are furthering social impact goals. In November 2019, Creci Inc. formed a wholly owned subsidiary in Colombia, Creci Finance Colombia SAS. Colombia will be the Company’s first market for its credit products. As of December 31, 2020 and 2019, the subsidiary had no operations. The subsidiary is not material to the financial statements.
For Creci, social impact small businesses are those that work to further at least one of the seventeen United Nations Sustainable Development Goals (“SDGs”), which include goals such as decent work and economic growth, good health, quality education, and affordable and clean energy. Creci will provide small businesses with financing solutions and investors with opportunities to support its portfolio of social impact small businesses by allowing investors to purchase Creci Notes that the Company will issue and that are the subject of this Offering Circular. Creci will pay a 5% annual interest rate on the Creci Notes it will issue and use the funds raised from the sale of the Creci Notes to offer term loans, lines of credit, credit cards, equipment financing, and accounts receivable financing to small businesses. The Company will earn revenues from the difference between the interest rate it pays to its noteholders and other lenders and the interest rate it charges on its credit products to small businesses. The difference, or spread, between the rates will constitute the primary component of the Company’s gross profits, before other direct costs of revenues, such as web site costs, customer support costs, and operating expenses.
Creci’s goal is to close the small business credit gap, using technology and the power of the crowd to provide fair, affordable, and transparent funding to underserved small businesses, including women- and minority-owned businesses, that are working to better their communities. The Company intends to offer the Creci Notes in $10.00 increments on a continuous basis directly through its Creci website. The Company intends to offer Creci Note investors higher rates of return on their Creci Note investments than are available to them through more traditional low-risk investment vehicles such as savings accounts, money market accounts, and certificates of deposit.
Creci is still in the very early stages of developing its business. Accordingly, risks associated with startup, early-stage companies apply to the Company. Such risks include, but are not limited to, the need to raise additional funding, the need to generate additional revenues, the need to develop ongoing relationships with additional lenders and borrowers, the need to hire skilled employees, the need to comply with regulatory requirements, and the need to achieve profitability and sustainability.
Management Plans and Going Concern
The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. To date, the Company has not generated significant revenues from principal operations and has not yet proved the viability of its business model. Because losses will continue until such time that profitable operations can be obtained, Creci is reliant on financing to support operations. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern within one year after the date that the financial statements are issued.
F-7
During the next 12 months, the Company intends to fund its operations through the sale of common stock and/or debt to third parties and related parties, as well as an increase in operating revenues. If Creci cannot raise additional short-term capital, the Company may consume all of its cash reserved for operations. There are no assurances that management will be able to raise capital on terms acceptable to the Company or increase revenues and margins enough to sustain operations. If Creci is unable to obtain sufficient amounts of additional capital, the Company may be required to reduce the scope of its planned operations, which could harm its business, financial condition and operating results. The financial statements do not include any adjustments that might result from these uncertainties.
Note 2. Summary of Significant Accounting Policies
Use of Estimates
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results, which may be material, could differ from those estimates. Estimates which are particularly significant to the financial statements include estimates relating to the valuation of Simple Agreements for Future Equity (“SAFEs”), convertible promissory notes (“convertible notes”), and startup and software development costs associated with establishing the Company.
Cash and Cash Equivalents
The Company maintains its cash on deposit with a well-established and widely known bank headquartered in California, which management considers to be financially stable and credit worthy. Deposited cash balances are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, the Company may maintain balances in excess of the federally insured limits.
The Company considers short-term interest-bearing investments with initial maturities of three months or less to be cash equivalents. The Company has no cash equivalents at December 31, 2020 and 2019.
Fair Value of Financial Instruments
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors that market participants would use in valuing the asset or liability. There are three levels of inputs that may be used to measure fair value:
Level 1 – Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 – Include other inputs that are directly or indirectly observable in the marketplace.
Level 3 – Unobservable inputs which are supported by little or no market activity.
F-8
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2020 and 2019. The respective carrying value of all financial instruments approximated their fair values. These financial instruments include SAFEs and convertible notes. Fair values of these items have been determined to approximate their carrying values because the instruments have been outstanding for a very short time, and market circumstances have not changed materially since the instruments were originated. SAFEs are considered Level 3 liabilities; however, during the current period there was no change in the carrying value of these liabilities based on management estimates.
Organizational Costs
In accordance with Accounting Standards Codification (“ASC”) 720, the Company expenses all costs incurred in connection with the startup and organization of the Company.
Internal Use Software
The Company incurs software development costs to develop software programs to be used solely to meet its internal needs and cloud-based applications used to deliver its services. In accordance with ASC 350-40, Internal-Use Software, Creci capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed, the software will be used to perform the function intended, and the value will be recoverable. Reengineering costs, minor modifications and enhancements that do not significantly improve the overall functionality of the software are expensed as incurred. Capitalized development costs are amortized over the estimated useful life of the software, which is five years.
Simple Agreements for Future Equity (“SAFEs”)
The Company issued several Simple Agreements for Future Equity “SAFEs” in exchange for cash financing. These funds have been classified as long-term liabilities (see Note 4). The Company has accounted for its SAFE investments as liability derivatives under the Financial Accounting Standards Board (“FASB”) ASC 815-40 and ASC 815-10. If any changes in the fair value of the SAFEs occur, the Company will record such changes through earnings, under the guidance prescribed by ASC 825-10. As of December 31, 2020 and 2019, the fair values of the SAFEs are equal to their face amounts that are the amounts of initial investment, as evidenced by the terms of the SAFEs, which are with related parties, being similar to the terms of the convertible notes (discussed below) that were transacted in arm’s length transactions with unrelated parties.
Under the SAFEs, the funds contributed by the investors will convert to shares of preferred stock in a priced preferred stock financing round, at a conversion price per share equal to the lesser of:
| (i) | the price per share of the newly issued preferred stock multiplied by the Discount Rate; or | |
| (ii) | the Valuation Cap, as defined by the various agreements and described below, divided by the number of shares and potential shares of Common Stock, on a fully diluted basis, outstanding immediately prior to the preferred stock financing. |
F-9
The Discount Rate is 80%, and the Post-Money Valuation Cap is $2,000,000 for the SAFEs the Company has issued.
If the Company undergoes a change of control, defined as a majority of outstanding equity shares being sold to parties other than the current stockholders, while the SAFEs remain outstanding, each SAFE holder will have the option of receiving his or her cash investment amount returned or receiving the number of shares of Common Stock purchased with his or her SAFE investment amount at the same price at which other shares of Common Stock are sold in the change of control.
Convertible Notes
The Company has issued several convertible notes. These notes are recorded as short-term or long-term liabilities according to their stated maturity dates (see Note 4).
The Company reviews the terms of convertible debt and equity instruments it issues to determine whether there are derivative financial instruments, including an embedded conversion option that is required to be bifurcated and accounted for separately as a derivative financial instrument. In circumstances where a host instrument contains more than one embedded derivative instrument, including a conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to the convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.
The Company has determined that the terms of the convertible notes do not require bifurcation as discussed above. The Company determined that these notes may contain a beneficial conversion feature contingent upon a future event due to the discounted conversion provisions. Following FASB ASC 470-20, the Company determined the intrinsic value of the conversion features on these convertible notes based on the issuance date fair value of the Company’s stock and the discounted conversion features. In accordance with FASB ASC 470-20, a contingent beneficial conversion feature in an instrument that becomes convertible only upon the occurrence of a future event outside the control of the holder is not recognized in earnings until the contingency is resolved. Therefore, these beneficial conversion features were not recorded as note discounts at the issuance dates of the notes, but rather will be recognized upon the occurrence of the contingent event (see Note 4). The convertible notes are recorded as long-term liabilities at their face value, which is equivalent to the proceeds received for issuance.
The Discount Rate is 20%, and the Pre-Money Valuation Cap is $2,000,000 for the convertible notes the Company has issued.
F-10
If the Company undergoes a change of control, defined as a majority of outstanding equity shares being sold to parties other than the current stockholders, while the convertible notes remain outstanding, each convertible noteholder will have the option of receiving his or her cash investment amount returned or receiving the number of shares of Common Stock purchased with his or her convertible note investment amount at the same price at which other shares of Common Stock are sold in the change of control.
Stock-Based Compensation
The Company has issued restricted stock units (“RSUs”) to key advisors and third-parties for services performed. The Company has accounted for these awards under ASC section 718 and Accounting Standards Update (“ASU”) 2018-07. During the periods ending December 31, 2020 and 2019, respectively, no RSUs met the criteria for vesting (see Note 8).
Revenue Recognition and Cost of Revenues
Creci will borrow money from individuals through the Company’s online platform. The Company must pay interest on the borrowings to its lenders. All such loans will be governed by signed contracts between the Company and individual lenders. The interest, which accrues according to the agreements governing terms of the loans from individual lenders, will constitute the major portion of the Company’s direct cost of revenues. Other direct costs of revenues include costs of operating the online platform, and customer support services.
Creci will use the money it borrows from individuals to loan money to small businesses. The Company earns interests on these loans, which will be the primary source of its revenues. All such loans to small businesses are governed by signed contracts between the Company and the small businesses. Interest income is recorded based on the terms of the loan agreement with each small business. Interest is accrued monthly. If ninety (90) days pass without the interest being paid in accordance with the amortization schedule or the terms of interest payment under each loan agreement, the Company will cease recording revenue until such time that the interest is collected.
Creci receives grants from foundations and other institutions. The company records grants received as revenue when all donor-imposed conditions on the grant have been satisfied.
Advertising and Promotion
The Company expenses the cost of advertising and promotions as incurred. Advertising costs expensed were $2,846 and $196 for the years ended December 31, 2020 and 2019, respectively.
General and Administrative
The Company expenses General and Administrative costs as incurred. These costs consist of payments made to outside contractors. General and Administrative expensed were $37,557 and $27,665 for the years ended December 31, 2020 and 2019, respectively.
F-11
Income Taxes
The Company accounts for income taxes in accordance with ASC Section 740, Accounting for Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws.
Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which they operate, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of Topic 740.
The Company accounts for uncertain tax position in accordance with ASC 740-10, Accounting for Uncertainty in Income Taxes. As required by the relevant guidance, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would, more likely than not, sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.
The Company is subject to tax in the United States (“U.S.”) and has filed tax returns in the U.S. Federal jurisdiction and Florida state jurisdiction. The Company has a subsidiary in Colombia that to date has not begun operations. Once it does, the subsidiary will be subject to income taxes in that country. At that time, the Company will evaluate the need to record valuation allowances against any deferred tax assets for that entity based on the “more likely than not” criteria of Topic 740.
Recent Accounting Pronouncements
ASU 2016-13, as amended by ASU 2019-10, changes the accounting for credit losses measurement on loans and debt securities. For loans and held-to-maturity securities, the Update requires a current expected credit loss (“CECL”) measurement to estimate the allowance for credit losses for the remaining estimated life of the financial asset. The CECL measurement must be developed using historical experience, current conditions, and reasonable and supportable forecasts. The standard will also expand disclosure requirements. Adoption of the new standards is required for the Company effective January 1, 2023. Early adoption is permitted. The Company is evaluating the impact of this standard, but the Company does not expect its adoption to materially affect the Company’s financial statements.
FASB issues ASU to amend the authoritative literature in ASC. There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.
F-12
Note 3. Risks and Uncertainties
Concentration of Credit Risk
During the early stages of the Company’s development, it is to be expected that the Company will extend loans to a relatively low number of small businesses. When the Company extends loans to a low number of borrowers, this results in a concentration of credit risk, wherein each borrower represents a relatively high risk, as compared with the relatively low risk that each individual borrower would constitute if the Company had many loans outstanding.
As of December 31, 2020 and 2019, the entire amount of loans receivables due to the Company are from one entity, a related party controlled by the Company’s CEO, that used the funds to originate loans in Colombia.
Foreign Credit
Creci intends to make loans to small businesses in the United States and in Latin America, beginning in Colombia. Loans made to Latin American small businesses involve risks including: (i) multiple, conflicting and changing laws and regulations such as tax laws, privacy laws, employment laws, regulatory requirements and other governmental approvals, permits and licenses; (ii) complexities associated with managing multiple payment processing methods; (iii) natural disasters, political and economic instability, including wars, terrorism, political unrest, outbreak of disease, protests, boycotts, curtailment of trade and other market restrictions; (iv) exchange-rate risk, and (iv) regulatory and compliance risks that relate to maintaining accurate information and control over activities subject to regulation under the United States Foreign Corrupt Practices Act of 1977 (“FCPA”) and comparable laws and regulations in other countries.
Loans made in the Company’s first market, Colombia, are subject to risks such as economic instability. Economic instability in Colombia, and in other Latin American and emerging market countries, has been caused by many different factors, including the following: high interest rates; changes in currency values; high levels of inflation; exchange controls; wage and price controls; changes in economic or tax policies; the imposition of trade barriers; and internal security issues. Emerging-market operations generally pose a greater degree of risk than operations in more mature market economies because the economies in the developing world are more susceptible to destabilization resulting from domestic and international developments.
A significant decline in the economic growth of any of Colombia’s major trading partners, such as the United States or the European Union, could have a material adverse impact on Colombia’s economic growth and on its small businesses. In addition, because international investors’ reactions to the events occurring in one emerging market country sometimes appear to demonstrate a “contagion” effect, in which an entire region or class of investments is disfavored by international investors, Colombia could be adversely affected by negative economic or financial developments occurring in other emerging market countries. There can be no assurance that any crises such as those described above or similar events will not negatively affect the principal countries in Latin America, including Colombia, and thus the Company’s operations.
F-13
COVID 19
In January 2020, the World Health Organization declared the coronavirus “COVID-19” outbreak a “Public Health Emergency of International Concern.” In March 2020, it declared it to be a pandemic. Actions taken around the world to help mitigate the spread of the COVID-19 include restrictions on travel, quarantines in certain areas, and forced closures for certain types of public places and businesses. COVID-19, and actions taken to mitigate it, have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates and plans to operate.
Other Risks and Uncertainties
The Company’s business could be impacted by continuing price pressure on its operating costs, acceptance of its products or services in the marketplace, new competitors, changing federal and/or state legislation, new technologies and other factors. Adverse changes in these areas could negatively impact the Company’s financial position, results of operations and cash flows.
Note 4. Long-Term Liabilities
During the year ended December 31, 2019, the Company issued two SAFEs in exchange for $250,000 cash financing and one convertible note in exchange for $15,000 cash financing. The Discount Rate is 20% and the Post-Money Valuation Cap is $2,000,000 for the two SAFEs.
During the year ended December 31, 2019, the Company issued one convertible note in exchange for $15,000 cash financing. During the year ended December 31, 2020, the Company issued various convertible notes in exchange for $207,000 cash financing. The Discount Rate is 20% and the Pre-Money Valuation Cap is $2,000,000 for the convertible notes.
As of December 31, 2020, there has not been any priced preferred stock round of financing that would trigger a conversion of the SAFE or convertible note funds to preferred stock.
F-14
The following tables provides a detail of the transactions for the periods:
| Date of Instrument | Type | Amount | Interest Rate (Accrued) | Valuation Cap | Discount | Converts to | ||||||||||||||
| 5/18/2019 | Post-Money SAFE | $ | 130,000 | 0 | % | 2,000,000 | 20 | % | Preferred | |||||||||||
| 6/24/2019 | Post-Money SAFE | 120,000 | 0 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| Total SAFEs | 250,000 | |||||||||||||||||||
| 12/13/2019 | Convertible Note | 15,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 2019 Total | 15,000 | |||||||||||||||||||
| 5/29/2020 | Convertible Note | 10,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 5/29/2020 | Convertible Note | 25,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 6/2/2020 | Convertible Note | 50,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 6/9/2020 | Convertible Note | 15,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 6/18/2020 | Convertible Note | 20,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 6/29/2020 | Convertible Note | 10,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 7/13/2020 | Convertible Note | 20,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 7/22/2020 | Convertible Note | 20,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 8/17/2020 | Convertible Note | 17,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 9/21/2020 | Convertible Note | 10,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 9/21/2020 | Convertible Note | 10,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 2020 Total | 207,000 | |||||||||||||||||||
| Total Convertible Notes | 222,000 | |||||||||||||||||||
| Total SAFEs and Convertible Notes | $ | 472,000 | ||||||||||||||||||
Note 5. Accrued Liabilities
Accrued liabilities represent expenses incurred, but not yet invoiced or paid. The Company’s accrued liabilities consists primarily of deferred interest due to convertible noteholders. The deferred amounts will be paid by the Company, in the future, upon certain conditions, as agreed upon by the Company and convertible noteholders.
Note 6. Commitments and Contingencies
Litigation
The Company is not currently involved with, and does not know of any pending or threatening litigation against the Company or any of its officers.
Note 7. Related Party Transactions
As of December 31, 2020, the Company issued $250,000 in SAFES to related parties controlled by the Company’s CEO and made a $150,000 loan to a related party controlled by the Company’s CEO to originate loans in Colombia (see Notes 4 and 10). Creci’s CEO initially developed the idea and business model described above through a pre-existing United States entity, Mentel LLC, and its wholly owned subsidiary in Colombia, Mentel Colombia SAS. Certain expenses and organizational costs were incurred by the Mentel LLC and Mentel Colombia SAS related parties for the formation of the Company, and such costs were then allocated and expensed to the Company after formation.
F-15
Note 8. Equity
Common Stock
The Company is authorized to issue 10,000,000 shares of Common Stock, each having a par value of $0.00001. Upon inception, 7,000,000 shares of Common Stock were issued to a Company co-founder. As of December 31, 2020, 7,000,000 shares of Common Stock are issued and outstanding, all of which are held by a Company co-founder.
Preferred Stock
The Company is authorized to issue 10,000,000 shares of Preferred Stock, each having a par value of $0.00001. As of December 31, 2020, the company has not issued any Preferred Stock.
Stock-Based Compensation
Creci may grant unrestricted and restricted stock awards (“RSAs”), restricted stock options (“RSOs”), or restricted stock units (“RSUs”) to employees, executives, directors, advisors, consultants, and third-parties who perform services for the company. The Company has issued only RSUs as of December 31, 2019 and December 31, 2020.
RSUs issued through December 31, 2020 and 2019 generally follow three time-based vesting schedules, as follows. In the first schedule, 10% of the award vests six months from the vesting commencement date, and 1.66% vests monthly thereafter. In the second schedule, 12.5% of the award vests six months from the vesting commencement date, and 2.08% vests monthly thereafter. In the third schedule, 12.5% of the award vests three months from the vesting commencement date, and 4.16% vests monthly thereafter. All vesting schedules are conditioned on the grantee continuing to provide services to Company through each vesting date.
The RSUs are also subject to performance-based vesting, and will only satisfy this requirement on the first of the following to occur: (i) a change in the ownership or effective control of the Company, or (ii) a change in the ownership of a substantial portion of the assets of the Company, all within the meaning of Section 409A and the rules and regulations promulgated thereunder.
As of December 31, 2020 and 2019, 3,000,000 were authorized to be issued. The company issued 535,000 and 1,500,000 for the years ended December 31, 2020 and 2019, respectively. There were 1,250,000 and 0 RSUs forfeited for the years ended December 31, 2020 and 2019, respectively. During the periods ending December 31, 2020 and 2019, respectively, no RSUs met the criteria for vesting.
A summary of RSUs as of December 31, 2020 and 2019, is as follows:
| December 31, 2020 | December 31, 2019 | |||||||
| Issued | 615,000 | 1,500,000 | ||||||
| Outstanding | 865,000 | 1,500,000 | ||||||
| Forfeited | 1,250,000 | - | ||||||
F-16
The estimated fair market value for the RSUs were determined by reference to valuations of the common stock conducted by unrelated, third parties on various dates. A summary of the value of unvested RSUs is as follows:
| Unvested Restricted Stock Units | ||||||||||||
| Number of Shares | Weighted- Average Grant-Date Fair Value | Deferred Tax Benefit | ||||||||||
| Unvested as of December 31, 2019 | 1,500,000 | $ | 8,720 | $ | 1,831 | |||||||
| Granted | 615,000 | 11,224 | 2,357 | |||||||||
| Vested | - | - | (2,788 | ) | ||||||||
| Forfeited | 1,250,000 | (13,277 | ) | - | ||||||||
| Unvested as of December 31, 2020 | 865,000 | $ | 6,667 | $ | 1,400 | |||||||
The company recognizes RSUs forfeitures as they occur, as there is insufficient historical data to accurately determine future forfeiture rates.
Note 9. Taxes
The components of the Company’s deferred tax assets (liabilities) for federal and state income taxes consisted of the following as of December 31, 2020 and 2019:
| December 31, 2020 | December 31, 2019 | |||||||
| Deferred Tax Assets: | ||||||||
| Net Operating Loss Carryover | $ | 167,743 | $ | 130,387 | ||||
| Temporary Differences | 1,400 | 1,831 | ||||||
| Valuation Allowances | (169,142 | ) | (132,218 | ) | ||||
| Net Deferred Tax Asset | $ | - | $ | - | ||||
Based on federal tax returns filed, or to be filed, through December 31, 2020, the Company had available approximately $167,743 in U.S. tax net operating loss carryforwards, pursuant to the Tax Reform Act of 1986, which assesses the utilization of a Company’s net operating loss carryforwards resulting from retaining continuity of its business operations and changes within its ownership structure. Net operating loss carryforwards start to expire in 2040 or 20 years for federal income and state tax reporting purposes.
The Company is subject to tax in the United States (“U.S.”) and has filed tax returns in the U.S. Federal jurisdiction and Florida state jurisdiction. The Company has a subsidiary in Colombia that has not begun operations. The subsidiary will be subject to income taxes in that country. The Company will evaluate the need to record valuation allowances against any deferred tax assets for that entity based on the “more likely than not” criteria of Topic 740.
Note 10. Subsequent Events
On March 1, 2021, Creci, Inc. entered into an agreement with Mentel, LLC, a company owned by one of co-founders, whereby Creci, Inc., receives from Mentel, LLC a loan portfolio in Colombia valued at $125,000; technology valued at $100,000; and $100,000 in cash. In turn, Mentel LLC receives a $175,000 convertible note and the cancellation of a $150,000 loan it previously received from Creci, Inc. On May 1, 2021, the Company issued two convertible notes, each one for $45,000, to each of the co-founders. The convertible notes dated March 1, 2021 and May 1, 2021, respectively, were issued with the same terms. They have a three-year maturity and convert to preferred stock upon the Company issuing of preferred stock during a future equity raise of at least $500,000 (a “qualified financing”) at a stock price to be determined relative to either a 20% discount to the valuation agreed to during that equity raise or a $4,000,000 pre-money valuation cap, or they may convert into either preferred stock or a right to receive payment, at the election of the holders, in the event the Company does not raise a qualified equity round prior to maturity or undergo a change of control transaction or initial public offering prior to an equity financing.
Management has evaluated events through October 12, 2021, the date the financial statements were available to be issued. Except for the above paragraph, no events have occurred subsequent to the date of the financial statements that would require adjustments to, or disclosure in, the financial statements.
F-17
Balance
Sheets
as of June 30, 2021 and December 31, 2020
(Unaudited)
| June 30, 2021 | December 31,
2020 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | $ | 133,006 | $ | 94,209 | ||||
| Other Receivable - Related Party | 67,500 | — | ||||||
| Prepaid Legal Expenses | 8,053 | 8,053 | ||||||
| Prepaid Expenses | 1,209 | |||||||
| Accrued Interest Receivable - Related Party | 1,500 | 8,500 | ||||||
| Grant Receivable | — | 35,000 | ||||||
| Total Current Assets | 211,268 | 145,762 | ||||||
| Fixed Assets | ||||||||
| Software Development Costs | 26,728 | 26,728 | ||||||
| Brand Development | 8,150 | |||||||
| Accumulated Amortization | (13,364 | ) | (10,691 | ) | ||||
| Total Fixed Assets | 21,514 | 16,037 | ||||||
| Other Assets | ||||||||
| Investment in Creci Finance Colombia SAS | 325,000 | — | ||||||
| Loans Receivable - Related Party | — | 150,000 | ||||||
| Total Other Assets | 325,000 | 150,000 | ||||||
| TOTAL ASSETS | $ | 557,782 | $ | 311,799 | ||||
| LIABILITIES AND SHAREHOLDER’S DEFICIT | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accrued Payable and Accrued Liabilities | $ | 17,498 | $ | 7,472 | ||||
| Total Current Liabilities | 17,498 | 7,472 | ||||||
| Long-Term Liabilities | ||||||||
| Convertible Notes | 222,000 | 222,000 | ||||||
| Convertible Notes - Related Parties | 265,000 | — | ||||||
| Contingent Obligations to Issue Future Equity (“SAFEs”) - Related Parties | 250,000 | 250,000 | ||||||
| Total Long-Term Liabilities | 737,000 | 472,000 | ||||||
| Total Liabilities | 754,498 | 479,472 | ||||||
| Shareholder’s Deficit | ||||||||
| Preferred Stock, par value $0.00001, 5,000,000 shares authorized, and 0 shares issued and outstanding as of June 30, 2021 and December 31, 2020. | ||||||||
| Common Stock, par value $0.00001, 10,000,000 shares authorized, and 7,000,000 shares issued and outstanding as of June 30, 2020 and December 31, 2020. | 70 | 70 | ||||||
| Accumulated Deficit | (196,786 | ) | (167,743 | ) | ||||
| Total Shareholder’s Deficit | (196,716 | ) | (167,673 | ) | ||||
| TOTAL LIABILITIES AND SHAREHOLDER’S DEFICIT | $ | 557,782 | $ | 311,799 | ||||
See accompanying notes to the financial statements
F-18
Statements
of Operations
for the Six-Month Periods Ended June 30, 2021 and June 30, 2020
(Unaudited)
| June 30, 2021 | June 30, 2020 | |||||||
| INCOME | ||||||||
| Grant Income | $ | - | $ | 72,000 | ||||
| Interest Income - Related Party | 9,000 | 3,840 | ||||||
| TOTAL INCOME | 9,000 | 75,840 | ||||||
| OPERATING EXPENSES | ||||||||
| Advertising and Promotion | 1,446 | 1,761 | ||||||
| Computer and Internet Expenses | 2,714 | 5,947 | ||||||
| Professional Fees | 15,525 | 4,474 | ||||||
| Software Development Expenses | - | 48,875 | ||||||
| Interest Expense | 9,217 | 766 | ||||||
| Other Expenses | 2,985 | 5,074 | ||||||
| General and Administrative Expenses | 3,600 | 23,457 | ||||||
| TOTAL OPERATING EXPENSES | 35,487 | 90,353 | ||||||
| OPERATING LOSS | (26,487 | ) | (14,513 | ) | ||||
| OTHER INCOME (EXPENSES) | ||||||||
| Other Income | 117 | 145 | ||||||
| Amortization | (2,673 | ) | (2,673 | ) | ||||
| TOTAL OTHER EXPENSES | (2,556 | ) | (2,528 | ) | ||||
| Less Provision for Income Taxes | - | - | ||||||
| NET LOSS | $ | (29,043 | ) | $ | (17,041 | ) | ||
| Weighted average common shares outstanding (basic and diluted) | 7,000,000 | 7,000,000 | ||||||
| Basic and diluted net loss per share | $ | (0.004149 | ) | $ | (0.005337 | ) | ||
See accompanying notes to the financial statements
F-19
Statements
of Stockholder’s Deficit
as of June 30, 2021 and December 31, 2020
(Unaudited)
| Common Stock | Total | |||||||||||||||
| Shares Issued | Cash Paid for Shares | Accumulated Deficit | Stockholder’s Deficit | |||||||||||||
| Balance at December 31, 2020 | 7,000,000 | $ | 70 | $ | (167,743 | ) | $ | (167,673 | ) | |||||||
| Net Loss | (29,043 | ) | (29,043 | ) | ||||||||||||
| Balance at June 30, 2021 | 7,000,000 | $ | 70 | $ | (196,786 | ) | $ | (196,716 | ) | |||||||
See accompanying notes to the financial statements
F-20
Statements
of Cash Flows
for the Six-Month Periods Ended June 30, 2021 and 2020
(Unaudited)
| June 30, 2021 | June 30, 2020 | |||||||
| CASH FLOW FROM OPERATING ACTIVITIES | ||||||||
| Net Loss | $ | (29,043 | ) | $ | (17,040 | ) | ||
| Adjustments to reconcile Net Loss to Net Cash used in Operating Activities | ||||||||
| Amortization | 2,673 | 2,673 | ||||||
| Other Receivable | (10,000 | ) | ||||||
| Other Receivable - Related Parties | (67,500 | ) | — | |||||
| Accrued Interest Receivable - Related Party | 7,000 | (1,700 | ) | |||||
| Grant Receivable | 35,000 | (70,000 | ) | |||||
| Accrued Receivable and Prepaid Expenses | (1,209 | ) | — | |||||
| Accrued Payable and Accrued Liabilities | 10,026 | (165 | ) | |||||
| Accrued Payable and Accrued Liability - Related Party | — | 57,500 | ||||||
| Total Adjustments to reconcile Net Income to Net Cash provided by operations: | (14,010 | ) | (21,692 | ) | ||||
| Net Cash Used in Operating Activities | (43,053 | ) | (38,732 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Investment in Creci Finance Colombia SAS | (325,000 | ) | — | |||||
| Loans Receivable - Related Party | 150,000 | (50,000 | ) | |||||
| Brand Development | (8,150 | ) | — | |||||
| Net Cash Used in Investing Activities | (183,150 | ) | (50,000 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Issuance of Convertible Notes | 265,000 | 130,000 | ||||||
| Net Cash Provided by Financing Activities | 265,000 | 130,000 | ||||||
| Increase or Decrease in Cash and Cash Equivalents | 38,797 | 41,268 | ||||||
| Cash and Cash Equivalents, beginning balance | 94,209 | 49,634 | ||||||
| Cash and Cash Equivalents, ending balance | $ | 133,006 | $ | 90,903 | ||||
| Supplemental Disclosures of Cash Flow Information | ||||||||
| Cash Paid for Income Taxes | $ | — | $ | — | ||||
| Cash Paid for Interest Expense | $ | — | $ | — | ||||
See accompanying notes to the financial statements
F-21
Notes to the Unaudited Financial Statements
Note 1. Organization and Nature of Operations
Creci, Inc., a Delaware corporation, (“Creci” or the “Company”) was founded on January 11, 2019. Creci is an early-stage company that is establishing an online platform to make loans and provide credit-based products to small businesses in the United States and Latin America that are furthering social impact goals. In November 2019, Creci Inc. formed a wholly owned subsidiary in Colombia, Creci Finance Colombia SAS. Colombia is the Company’s first market for its credit products.
For Creci, social impact small businesses are those that work to further at least one of the seventeen United Nations Sustainable Development Goals (“SDGs”), which include goals such as decent work and economic growth, good health, quality education, and affordable and clean energy. Creci will provide small businesses with financing solutions and investors with opportunities to support its portfolio of social impact small businesses by allowing investors to purchase Creci Notes that the Company will issue and that are the subject of this Offering Circular. Creci will pay a 5% annual interest rate on the Creci Notes it will issue and use the funds raised from the sale of the Creci Notes to offer term loans, lines of credit, credit cards, equipment financing, and accounts receivable financing to small businesses. The Company will earn revenues from the difference between the interest rate it pays to its noteholders and other lenders and the interest rate it charges on its credit products to small businesses. The difference, or spread, between the rates will constitute the primary component of the Company’s gross profits, before other direct costs of revenues, such as web site costs, customer support costs, and operating expenses.
Creci’s goal is to close the small business credit gap, using technology and the power of the crowd to provide fair, affordable, and transparent funding to underserved small businesses, including women- and minority-owned businesses, that are working to better their communities. The Company intends to offer the Creci Notes in $10.00 increments on a continuous basis directly through its Creci website. The Company intends to offer Creci Note investors higher rates of return on their Creci Note investments than are available to them through more traditional low-risk investment vehicles such as savings accounts, money market accounts, and certificates of deposit.
Creci is still in the very early stages of developing its business. Accordingly, risks associated with startup, early-stage companies apply to the Company. Such risks include, but are not limited to, the need to raise additional funding, the need to generate additional revenues, the need to develop ongoing relationships with additional lenders and borrowers, the need to hire skilled employees, the need to comply with regulatory requirements, and the need to achieve profitability and sustainability.
Management Plans and Going Concern
The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
To date, the Company has not generated significant revenues from principal operations and has not yet proved the viability of its business model. Because losses will continue until such time that profitable operations can be obtained, Creci is reliant on financing to support operations. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern within one year after the date that the financial statements are issued.
F-22
During the next 12 months, the Company intends to fund its operations through the sale of common stock and/or debt to third parties and related parties, as well as an increase in operating revenues. If Creci cannot raise additional short-term capital, the Company may consume all of its cash reserved for operations. There are no assurances that management will be able to raise capital on terms acceptable to the Company or increase revenues and margins enough to sustain operations. If Creci is unable to obtain sufficient amounts of additional capital, the Company may be required to reduce the scope of its planned operations, which could harm its business, financial condition and operating results. The financial statements do not include any adjustments that might result from these uncertainties.
Note 2. Summary of Significant Accounting Policies
Use of Estimates
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results, which may be material, could differ from those estimates. Estimates which are particularly significant to the financial statements include estimates relating to the valuation of Simple Agreements for Future Equity (“SAFEs”), convertible promissory notes (“convertible notes”), and startup and software development costs associated with establishing the Company.
In the opinion of management, all adjustments necessary in order to make the interim financial statements not misleading have been included.
Cash and Cash Equivalents
The Company maintains its cash on deposit with a well-established and widely known bank headquartered in California, which management considers to be financially stable and credit worthy. Deposited cash balances are insured by the Federal Deposit Insurance Corporation up to $250,000. At times, the Company may maintain balances in excess of the federally insured limits.
The Company considers short-term interest-bearing investments with initial maturities of three months or less to be cash equivalents. The Company has no cash equivalents as of June 30, 2021 and December 31, 2020.
Fair Value of Financial Instruments
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors that market participants would use in valuing the asset or liability. There are three levels of inputs that may be used to measure fair value:
Level 1 – Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 – Include other inputs that are directly or indirectly observable in the marketplace.
Level 3 – Unobservable inputs which are supported by little or no market activity.
F-23
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2021 and December 31, 2020. The respective carrying value of all financial instruments approximated their fair values. These financial instruments include SAFEs and convertible notes. Fair values of these items have been determined to approximate their carrying values because the instruments have been outstanding for a very short time, and market circumstances have not changed materially since the instruments were originated. SAFEs are considered Level 3 liabilities; however, during the current period there was no change in the carrying value of these liabilities based on management estimates.
Organizational Costs
In accordance with Accounting Standards Codification (“ASC”) 720, the Company expenses all costs incurred in connection with the startup and organization of the Company.
Internal Use Software
The Company incurs software development costs to develop software programs to be used solely to meet its internal needs and cloud-based applications used to deliver its services. In accordance with ASC 350-40, Internal-Use Software, Creci capitalizes development costs related to these software applications once the preliminary project stage is complete and it is probable that the project will be completed, the software will be used to perform the function intended, and the value will be recoverable. Reengineering costs, minor modifications and enhancements that do not significantly improve the overall functionality of the software are expensed as incurred. Capitalized development costs are amortized over the estimated useful life of the software, which is five years.
Simple Agreements for Future Equity (“SAFEs”)
The Company issued several Simple Agreements for Future Equity “SAFEs” in exchange for cash financing. These funds have been classified as long-term liabilities (see Note 4). The Company has accounted for its SAFE investments as liability derivatives under the Financial Accounting Standards Board (“FASB”) ASC 815-40 and ASC 815-10. If any changes in the fair value of the SAFEs occur, the Company will record such changes through earnings, under the guidance prescribed by ASC 825-10. As of June 30, 2021 and December 31, 2020, the fair values of the SAFEs are equal to their face amounts that are the amounts of initial investment, as evidenced by the terms of the SAFEs, which are with related parties, being similar to the terms of the convertible notes (discussed below) that were transacted in arm’s length transactions with unrelated parties.
F-24
Under the SAFEs, the funds contributed by the investors will convert to shares of preferred stock in a priced preferred stock financing round, at a conversion price per share equal to the lesser of:
| (iii) | the price per share of the newly issued preferred stock multiplied by the Discount Rate; or |
| (iv) | the Valuation Cap, as defined by the various agreements and described below, divided by the number of shares and potential shares of Common Stock, on a fully diluted basis, outstanding immediately prior to the preferred stock financing. |
The Discount Rate is 80%, and the Post-Money Valuation Cap is $2,000,000 for the SAFEs the Company has issued.
If the Company undergoes a change of control, defined as a majority of outstanding equity shares being sold to parties other than the current stockholders, while the SAFEs remain outstanding, each SAFE holder will have the option of receiving his or her cash investment amount returned or receiving the number of shares of Common Stock purchased with his or her SAFE investment amount at the same price at which other shares of Common Stock are sold in the change of control.
Convertible Notes
The Company has issued several convertible notes. These notes are recorded as short-term or long-term liabilities according to their stated maturity dates (see Note 4).
The Company reviews the terms of convertible debt and equity instruments it issues to determine whether there are derivative financial instruments, including an embedded conversion option that is required to be bifurcated and accounted for separately as a derivative financial instrument. In circumstances where a host instrument contains more than one embedded derivative instrument, including a conversion option, that is required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.
When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, the Company records, when necessary, discounts to the convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.
The Company has determined that the terms of the convertible notes do not require bifurcation as discussed above. The Company determined that these notes may contain a beneficial conversion feature contingent upon a future event due to the discounted conversion provisions. Following FASB ASC 470-20, the Company determined the intrinsic value of the conversion features on these convertible notes based on the issuance date fair value of the Company’s stock and the discounted conversion features. In accordance with FASB ASC 470-20, a contingent beneficial conversion feature in an instrument that becomes convertible only upon the occurrence of a future event outside the control of the holder is not recognized in earnings until the contingency is resolved. Therefore, these beneficial conversion features were not recorded as note discounts at the issuance dates of the notes, but rather will be recognized upon the occurrence of the contingent event (see Note 4). The convertible notes are recorded as long-term liabilities at their face value, which is equivalent to the proceeds received for issuance.
The Discount Rate is 20%, and the Pre-Money Valuation Cap is $2,000,000 for the convertible notes the Company issued as of December 31, 2020. The Discount Rate is 20%, and the Pre-Money Valuation Cap is 42,000,000 for the convertible notes the Company issued during the six-month period ended June 30, 2021.
F-25
If the Company undergoes a change of control, defined as a majority of outstanding equity shares being sold to parties other than the current stockholders, while the convertible notes remain outstanding, each convertible noteholder will have the option of receiving his or her cash investment amount returned or receiving the number of shares of Common Stock purchased with his or her convertible note investment amount at the same price at which other shares of Common Stock are sold in the change of control.
Stock-Based Compensation
The Company has issued restricted stock units (“RSUs”) to key advisors and third-parties for services performed. The Company has accounted for these awards under ASC section 718 and Accounting Standards Update (“ASU”) 2018-07. During the periods ending June 30, 2020 and a December 31, 2020, respectively, no RSUs met the criteria for vesting (see Note 8).
Revenue Recognition and Cost of Revenues
Creci will borrow money from individuals through the Company’s online platform. The Company must pay interest on the borrowings to its lenders. All such loans will be governed by signed contracts between the Company and individual lenders. The interest, which accrues according to the agreements governing terms of the loans from individual lenders, will constitute the major portion of the Company’s direct cost of revenues. Other direct costs of revenues include costs of operating the online platform, and customer support services.
Creci will use the money it borrows from individuals to loan money to small businesses. The Company earns interests on these loans, which will be the primary source of its revenues. All such loans to small businesses are governed by signed contracts between the Company and the small businesses. Interest income is recorded based on the terms of the loan agreement with each small business. Interest is accrued monthly. If ninety (90) days pass without the interest being paid in accordance with the amortization schedule or the terms of interest payment under each loan agreement, the Company will cease recording revenue until such time that the interest is collected.
Creci receives grants from foundations and other institutions. The company records grants received as revenue when all donor-imposed conditions on the grant have been satisfied.
Advertising and Promotion
The Company expenses the cost of advertising and promotions as incurred. Advertising costs expensed were $1,446 and $1,761 for the six-month periods ended June 31, 2021 and 2020, respectively.
General and Administrative
The Company expenses General and Administrative costs as incurred. These costs consist of payments made to outside contractors. General and Administrative expensed were $3,600 and $23,457 for the six-month periods ended June 31, 2021 and 2020, respectively.
F-26
Income Taxes
The Company accounts for income taxes in accordance with ASC Section 740, Accounting for Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws.
Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which they operate, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of Topic 740.
The Company accounts for uncertain tax position in accordance with ASC 740-10, Accounting for Uncertainty in Income Taxes. As required by the relevant guidance, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would, more likely than not, sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.
The Company is subject to tax in the United States (“U.S.”) and has filed tax returns in the U.S. Federal jurisdiction and Florida state jurisdiction. The Company has a subsidiary in Colombia that to date has not begun operations. Once it does, the subsidiary will be subject to income taxes in that country. At that time, the Company will evaluate the need to record valuation allowances against any deferred tax assets for that entity based on the “more likely than not” criteria of Topic 740.
Recent Accounting Pronouncements
ASU 2016-13, as amended by ASU 2019-10, changes the accounting for credit losses measurement on loans and debt securities. For loans and held-to-maturity securities, the Update requires a current expected credit loss (“CECL”) measurement to estimate the allowance for credit losses for the remaining estimated life of the financial asset. The CECL measurement must be developed using historical experience, current conditions, and reasonable and supportable forecasts. The standard will also expand disclosure requirements. Adoption of the new standards is required for the Company effective January 1, 2023. Early adoption is permitted. The Company is evaluating the impact of this standard, but the Company does not expect its adoption to materially affect the Company’s financial statements.
FASB issues ASU to amend the authoritative literature in ASC. There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.
F-27
Note 3. Risks and Uncertainties
Concentration of Credit Risk
During the early stages of the Company’s development, it is to be expected that the Company will extend loans to a relatively low number of small businesses. When the Company extends loans to a low number of borrowers, this results in a concentration of credit risk, wherein each borrower represents a relatively high risk, as compared with the relatively low risk that each individual borrower would constitute if the Company had many loans outstanding.
As of June 30, 2020 and December 31, 2020, the entire amount of loans receivables due to the Company are from one entity, a related party controlled by the Company’s CEO, that used the funds to originate loans in Colombia.
Foreign Credit
Creci intends to make loans to small businesses in the United States and in Latin America, beginning in Colombia. Loans made to Latin American small businesses involve risks including: (i) multiple, conflicting and changing laws and regulations such as tax laws, privacy laws, employment laws, regulatory requirements and other governmental approvals, permits and licenses; (ii) complexities associated with managing multiple payment processing methods; (iii) natural disasters, political and economic instability, including wars, terrorism, political unrest, outbreak of disease, protests, boycotts, curtailment of trade and other market restrictions; (iv) exchange-rate risk, and (iv) regulatory and compliance risks that relate to maintaining accurate information and control over activities subject to regulation under the United States Foreign Corrupt Practices Act of 1977 (“FCPA”) and comparable laws and regulations in other countries.
Loans made in the Company’s first market, Colombia, are subject to risks such as economic instability. Economic instability in Colombia, and in other Latin American and emerging market countries, has been caused by many different factors, including the following: high interest rates; changes in currency values; high levels of inflation; exchange controls; wage and price controls; changes in economic or tax policies; the imposition of trade barriers; and internal security issues. Emerging-market operations generally pose a greater degree of risk than operations in more mature market economies because the economies in the developing world are more susceptible to destabilization resulting from domestic and international developments.
A significant decline in the economic growth of any of Colombia’s major trading partners, such as the United States or the European Union, could have a material adverse impact on Colombia’s economic growth and on its small businesses. In addition, because international investors’ reactions to the events occurring in one emerging market country sometimes appear to demonstrate a “contagion” effect, in which an entire region or class of investments is disfavored by international investors, Colombia could be adversely affected by negative economic or financial developments occurring in other emerging market countries. There can be no assurance that any crises such as those described above or similar events will not negatively affect the principal countries in Latin America, including Colombia, and thus the Company’s operations.
F-28
COVID 19
In January 2020, the World Health Organization declared the coronavirus “COVID-19” outbreak a “Public Health Emergency of International Concern.” In March 2020, it declared it to be a pandemic. Actions taken around the world to help mitigate the spread of the COVID-19 include restrictions on travel, quarantines in certain areas, and forced closures for certain types of public places and businesses. COVID-19, and actions taken to mitigate it, have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates and plans to operate.
Other Risks and Uncertainties
The Company’s business could be impacted by continuing price pressure on its operating costs, acceptance of its products or services in the marketplace, new competitors, changing federal and/or state legislation, new technologies and other factors. Adverse changes in these areas could negatively impact the Company’s financial position, results of operations and cash flows.
Note 4. Long-Term Liabilities
During the year ended December 31, 2019, the Company issued two SAFEs in exchange for $250,000 cash financing and one convertible note in exchange for $15,000 cash financing. The Discount Rate is 20% and the Post-Money Valuation Cap is $2,000,000 for the two SAFEs.
During the year ended December 31, 2019, the Company issued one convertible note in exchange for $15,000 cash financing. During the year ended December 31, 2020, the Company issued various convertible notes in exchange for $207,000 cash financing. The Discount Rate is 20% and the Pre-Money Valuation Cap is $2,000,000 for the convertible notes. During the six-month period ended June 30, 2021, the Company issued various convertible notes in exchange for $265,000 cash financing. The Discount Rate is 20% and the Pre-Money Valuation Cap is $4,000,000 for the convertible notes.
As of June 30, 2021, there has not been any priced preferred stock round of financing that would trigger a conversion of the SAFE or convertible note funds to preferred stock.
F-29
The following tables provides a detail of the transactions for the periods:
| Date of Instrument | Type | Amount | Interest Rate (Accrued) | Valuation Cap | Discount | Converts to | ||||||||||||||
| 5/18/2019 | Post-Money SAFE | $ | 130,000 | 0 | % | 2,000,000 | 20 | % | Preferred | |||||||||||
| 6/24/2019 | Post-Money SAFE | 120,000 | 0 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| Total SAFEs | 250,000 | |||||||||||||||||||
| 12/13/2019 | Convertible Note | 15,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 2019 Total | 15,000 | |||||||||||||||||||
| 5/29/2020 | Convertible Note | 10,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 5/29/2020 | Convertible Note | 25,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 6/2/2020 | Convertible Note | 50,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 6/9/2020 | Convertible Note | 15,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 6/18/2020 | Convertible Note | 20,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 6/29/2020 | Convertible Note | 10,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 7/13/2020 | Convertible Note | 20,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 7/22/2020 | Convertible Note | 20,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 8/17/2020 | Convertible Note | 17,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 9/21/2020 | Convertible Note | 10,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 9/21/2020 | Convertible Note | 10,000 | 5 | % | 2,000,000 | 20 | % | Preferred | ||||||||||||
| 2020 Total | 207,000 | |||||||||||||||||||
| 3/1/2021 | Convertible Note | 175,000 | 5 | % | 4,000,000 | 20 | % | Preferred | ||||||||||||
| 5/1/2021 | Convertible Note | 45,000 | 5 | % | 4,000,000 | 20 | % | Preferred | ||||||||||||
| 5/1/2021 | Convertible Note | 45,000 | 5 | % | 4,000,000 | 20 | % | Preferred | ||||||||||||
| 2021 Total as of June 30, 2021 | 265,000 | |||||||||||||||||||
| Total Convertible Notes | 487,000 | |||||||||||||||||||
| Total SAFEs and Convertible Notes | $ | 737,000 | ||||||||||||||||||
Note 5. Accrued Liabilities
Accrued liabilities represent expenses incurred, but not yet invoiced or paid. The Company’s accrued liabilities consists primarily of deferred interest due to convertible noteholders. The deferred amounts will be paid by the Company, in the future, upon certain conditions, as agreed upon by the Company and convertible noteholders.
F-30
Note 6. Commitments and Contingencies
Litigation
The Company is not currently involved with, and does not know of any pending or threatening litigation against the Company or any of its officers.
Note 7. Related Party Transactions
As of June 30, 2021, the Company issued $250,000 in SAFES to related parties controlled by the Company’s CEO; issued $265,000 in convertible notes to related parties controlled by the Company’s co-founders; and made a $150,000 loan to a related party controlled by the Company’s CEO to originate loans in Colombia. Creci’s CEO initially developed the idea and business model described above through a pre-existing United States entity, Mentel LLC, and its wholly owned subsidiary in Colombia, Mentel Colombia SAS. Certain expenses and organizational costs were incurred by the Mentel LLC and Mentel Colombia SAS related parties for the formation of the Company, and such costs were then allocated and expensed to the Company after formation.
On March 1, 2021, Creci, Inc. entered into an agreement with Mentel, LLC, a company owned by one of co-founders, whereby Creci, Inc., receives from Mentel, LLC a loan portfolio in Colombia valued at $125,000; technology valued at $100,000; and $100,000 in cash. In turn, Mentel LLC receives a $175,000 convertible note and the cancellation of a $150,000 loan it previously received from Creci, Inc.
Note 8. Equity
Common Stock
The Company is authorized to issue 10,000,000 shares of Common Stock, each having a par value of $0.00001. Upon inception, 7,000,000 shares of Common Stock were issued to a Company co-founder. As of June 30, 2021, 7,000,000 shares of Common Stock are issued and outstanding, all of which are held by a Company co-founder.
Preferred Stock
The Company is authorized to issue 10,000,000 shares of Preferred Stock, each having a par value of $0.00001. As of December 31, 2020, the company has not issued any Preferred Stock.
Stock-Based Compensation
Creci may grant unrestricted and restricted stock awards (“RSAs”), restricted stock options (“RSOs”), or restricted stock units (“RSUs”) to employees, executives, directors, advisors, consultants, and third-parties who perform services for the company. The Company has issued only RSUs as of June 30, 2021.
RSUs issued through June 30, 2021 generally follow three time-based vesting schedules, as follows. In the first schedule, 10% of the award vests six months from the vesting commencement date, and 1.66% vests monthly thereafter. In the second schedule, 12.5% of the award vests six months from the vesting commencement date, and 2.08% vests monthly thereafter. In the third schedule, 12.5% of the award vests three months from the vesting commencement date, and 4.16% vests monthly thereafter. All vesting schedules are conditioned on the grantee continuing to provide services to Company through each vesting date.
F-31
The RSUs are also subject to performance-based vesting, and will only satisfy this requirement on the first of the following to occur: (i) a change in the ownership or effective control of the Company, or (ii) a change in the ownership of a substantial portion of the assets of the Company, all within the meaning of Section 409A and the rules and regulations promulgated thereunder.
As of June 30, 2021, 3,000,000 were authorized to be issued. In the six-month period ended June 30, 2021, the company issued 2,025,000 RSUs and 25,000 RSUs were forfeited. For the year ended December 31, 2020, the company issued 615,000 RSUs and 865,000 RSUs were forfeited.
A summary of RSUs as of June 30, 2021 and December 31, 2020, is as follows:
| June 30, 2021 | December 31, 2020 | |||||||
| Issued | 2,025,000 | 615,000 | ||||||
| Outstanding | 2,865,000 | 865,000 | ||||||
| Forfeited | 25,000 | 1,250,000 | ||||||
The estimated fair market value for the RSUs were determined by reference to valuations of the common stock conducted by unrelated, third parties on various dates. A summary of the value of unvested RSUs is as follows:
| Unvested Restricted Stock Units | ||||||||||||
| Number of Shares | Weighted- Average Grant-Date Fair Value | Deferred Tax Benefit | ||||||||||
| Unvested as of December 31, 2020 | 865,000 | $ | 6,666 | $ | 1,400 | |||||||
| Granted | 2,025,000 | 18,225 | 3,827 | |||||||||
| Vested | - | - | - | |||||||||
| Forfeited | 25,000 | (456 | ) | (96 | ) | |||||||
| Unvested as of June 30, 2021 | 2,865,000 | $ | 24,435 | $ | 5,131 | |||||||
The company recognizes RSUs forfeitures as they occur, as there is insufficient historical data to accurately determine future forfeiture rates.
Note 9. Taxes
The components of the Company’s deferred tax assets (liabilities) for federal and state income taxes consisted of the following as of June 30, 2021 and December 31, 2020:
| June 30, 2021 | December 31, 2020 | |||||||
| Deferred Tax Assets: | ||||||||
| Net Operating Loss Carryover | $ | 196,786 | $ | 167,743 | ||||
| Temporary Differences | 5,131 | 1,400 | ||||||
| Valuation Allowances | (201,917 | ) | (169,142 | ) | ||||
| Net Deferred Tax Asset | $ | - | $ | - | ||||
Based on federal tax returns filed, or to be filed, through June 30, 2021, the Company had available approximately $201,917 in U.S. tax net operating loss carryforwards, pursuant to the Tax Reform Act of 1986, which assesses the utilization of a Company’s net operating loss carryforwards resulting from retaining continuity of its business operations and changes within its ownership structure. Net operating loss carryforwards start to expire in 2040 or 20 years for federal income and state tax reporting purposes.
The Company is subject to tax in the United States (“U.S.”) and has filed tax returns in the U.S. Federal jurisdiction and Florida state jurisdiction. The Company has a subsidiary in Colombia that has not begun operations. The subsidiary will be subject to income taxes in that country. The Company will evaluate the need to record valuation allowances against any deferred tax assets for that entity based on the “more likely than not” criteria of Topic 740.
Note 10. Subsequent Events
On August 15, 2021, Creci, Inc.’s Colombian subsidiary, Creci Colombia Finance SAS, finalized the acquisition of the $125,000 loan book referenced in Note 7. The Colombian subsidiary began earning interest on these loans at that time and will pass on the interest earned to Creci, Inc.
Management has evaluated events through October 12, 2021, the date the financial statements were available to be issued. Except for the above paragraph, no events have occurred subsequent to the date of the financial statements that would require adjustments to, or disclosure in, the financial statements.
F-32
PART III - EXHIBITS
Index to Exhibits
Exhibit Number |
Description of Exhibit | |
| 2.1 | Bylaws of the Company | |
| 2.2 | Certificate of Incorporation | |
| 3.1 | Form of SAFEs | |
| 3.2 | Form of Convertible Notes | |
| 3.3 | Form of Restricted Stock Unit Agreement | |
| 4.1 | Form of Creci Note | |
| 4.2 | Form of Creci Investor Agreement | |
| 4.3 | Form of Creci Auto-Invest Program Authorization | |
| 6.1 | Agreement to Acquire Portfolio and Other Assets of Mentel Colombia SAS | |
| 11.1 | Consent of Cherry Bekaert LLP | |
| 12.1 | Legal Opinion of K&L Gates LLP | |
| 13.1 | Testing the Waters Webpage and Communications |
III-1
Signatures
Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this offering statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fort Lauderdale, State of Florida, on January 6, 2022.
| Creci Inc. | ||
| By: | /s/ Andres Idarraga | |
| Chief Executive Officer | ||
This offering statement has been signed by the following persons in the capacities listed and on the dates indicated:
| /s/ Andres Idarraga | |
| Director, Chief Executive Officer | |
| /s/ Pravin Rodrigues | |
| Director, Chief Operating Officer |
III-2
Exhibit 2.1
CRECI INC.
CERTIFICATE OF SECRETARY
I HEREBY CERTIFY THAT:
I am the duly elected and acting Secretary of CRECI INC., a Delaware corporation (the “Company”); and
Attached hereto is a complete and accurate copy of the Bylaws of the Company as duly adopted by the Board of Directors by Unanimous Written Consent dated January 11, 2019 and said Bylaws are presently in effect.
IN WITNESS WHEREOF, I have hereunto subscribed my name on January 11, 2019.
| /s/ Andres Idarraga | |
| ANDRES IDARRAGA | |
Secretary |
BYLAWS
OF
CRECI INC.
(A DELAWARE CORPORATION)
ARTICLE I
OFFICES
Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be 160 Greentree Drive, Suite 101, City of Dover, County of Kent, 19904 or in such other location as the Board of Directors may from time to time determine or the business of the corporation may require..
Section 2. Other Offices. The corporation shall also have and maintain an office or principal place of business at such place as may be fixed by the Board of Directors, and may also have offices at such other places, both within and without the State of Delaware, as the Board of Directors may from time to time determine or the business of the corporation may require.
ARTICLE II
CORPORATE SEAL
Section 3. Corporate Seal. The Board of Directors may adopt a corporate seal. Said seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise.
ARTICLE III
STOCKHOLDERS’ MEETINGS
Section 4. Place of Meetings. Meetings of the stockholders of the corporation may be held at such place, either within or without the State of Delaware, as may be determined from time to time by the Board of Directors. The Board of Directors may, in its sole discretion, determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided under the Delaware General Corporation Law (“DGCL”).
Section 5. Annual Meeting.
(a) The annual meeting of the stockholders of the corporation, for the purpose of election of directors and for such other business as may lawfully come before it, shall be held on such date and at such time as may be designated from time to time by the Board of Directors. Nominations of persons for election to the Board of Directors of the corporation and the proposal of business to be considered by the stockholders may be made at an annual meeting of stockholders: (i) pursuant to the corporation’s notice of meeting of stockholders; (ii) by or at the direction of the Board of Directors; or (iii) by any stockholder of the corporation who was a stockholder of record at the time of giving of notice provided for in the following paragraph, who is entitled to vote at the meeting and who complied with the notice procedures set forth in this Section.
1
(b) At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. For nominations or other business to be properly brought before an annual meeting by a stockholder pursuant to clause (iii) of paragraph (a) of this Section, (i) the stockholder must have given timely notice thereof in writing to the Secretary of the corporation, (ii) such other business must be a proper matter for stockholder action under the DGCL and applicable law, (iii) if the stockholder, or the beneficial owner on whose behalf any such proposal or nomination is made, has provided the corporation with a Solicitation Notice (as defined in this paragraph), such stockholder or beneficial owner must, in the case of a proposal, have delivered a proxy statement and form of proxy to holders of at least the percentage of the corporation’s voting shares required under applicable law to carry any such proposal, or, in the case of a nomination or nominations, have delivered a proxy statement and form of proxy to holders of a percentage of the corporation’s voting shares reasonably believed by such stockholder or beneficial owner to be sufficient to elect the nominee or nominees proposed to be nominated by such stockholder, and must, in either case, have included in such materials the Solicitation Notice, and (iv) if no Solicitation Notice relating thereto has been timely provided pursuant to this Section, the stockholder or beneficial owner proposing such business or nomination must not have solicited a number of proxies sufficient to have required the delivery of such a Solicitation Notice under this Section. To be timely, a stockholder’s notice shall be delivered to the Secretary at the principal executive offices of the corporation not later than the close of business on the ninetieth (90th) day nor earlier than the close of business on the one hundred twentieth (120th) day prior to the first anniversary of the preceding year’s annual meeting; provided, however, that in the event that the date of the annual meeting is advanced more than thirty (30) days prior to or delayed by more than thirty (30) days after the anniversary of the preceding year’s annual meeting, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the one hundred twentieth (120th) day prior to such annual meeting and not later than the close of business on the later of the ninetieth (90th) day prior to such annual meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first made. In no event shall the public announcement of an adjournment of an annual meeting commence a new time period for the giving of a stockholder’s notice as described above. Such stockholder’s notice shall set forth: (A) as to each person whom the stockholder proposed to nominate for election or reelection as a director all information relating to such person that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise required, in each case pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (the “1934 Act”), and Rule 14a-4(d) thereunder (including such person’s written consent to being named in the proxy statement as a nominee and to serving as a director if elected); (B) as to any other business that the stockholder proposes to bring before the meeting, a brief description of the business desired to be brought before the meeting, the reasons for conducting such business at the meeting and any material interest in such business of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made; and (C) as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (i) the name and address of such stockholder, as they appear on the corporation’s books, and of such beneficial owner, (ii) the class and number of shares of the corporation that are owned beneficially and of record by such stockholder and such beneficial owner, and (iii) whether either such stockholder or beneficial owner intends to deliver a proxy statement and form of proxy to holders of, in the case of the proposal, at least the percentage of the corporation’s voting shares required under applicable law to carry the proposal or, in the case of a nomination or nominations, a sufficient number of holders of the corporation’s voting shares to elect such nominee or nominees (an affirmative statement of such intent, a “Solicitation Notice”).
(c) Notwithstanding anything in the second sentence of paragraph (b) of this Section to the contrary, in the event that the number of directors to be elected to the Board of Directors of the corporation is increased and there is no public announcement naming all of the nominees for director or specifying the size of the increased Board of Directors made by the corporation at least one hundred (100) days prior to the first anniversary of the preceding year’s annual meeting, a stockholder’s notice required by this Section shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be delivered to the Secretary at the principal executive offices of the corporation not later than the close of business on the tenth (10th) day following the day on which such public announcement is first made by the corporation.
2
(d) Only such persons who are nominated in accordance with the procedures set forth in this Section (or elected or appointed pursuant to Article IV of these Bylaws) shall be eligible to serve as directors and only such business shall be conducted at a meeting of stockholders as shall have been brought before the meeting in accordance with the procedures set forth in this Section. Except as otherwise provided by law, the Chairman of the meeting shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made, or proposed, as the case may be, in accordance with the procedures set forth in these Bylaws and, if any proposed nomination or business is not in compliance with these Bylaws, to declare that such defective proposal or nomination shall not be presented for stockholder action at the meeting and shall be disregarded.
(e) Notwithstanding the foregoing provisions of this Section, in order to include information with respect to a stockholder proposal in the proxy statement and form of proxy for a stockholders’ meeting, stockholders must provide notice as required by the regulations promulgated under the 1934 Act. Nothing in these Bylaws shall be deemed to affect any rights of stockholders to request inclusion of proposals in the corporation proxy statement pursuant to Rule 14a-8 under the 1934 Act.
(f) For purposes of this Section, “public announcement” shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document publicly filed by the corporation with the Securities and Exchange Commission (the “SEC”) pursuant to Section 13, 14 or 15(d) of the 1934 Act.
Section 6. Special Meetings.
(a) Special meetings of the stockholders of the corporation may be called, for any purpose or purposes, by (i) the Chairman of the Board of Directors, (ii) the Chief Executive Officer,
(iii) the Board of Directors pursuant to a resolution adopted by directors representing a quorum of the Board of Directors or (iv) by the holders of shares entitled to cast not less than 50% of the votes at the meeting, and shall be held at such place, on such date, and at such time as the Board of Directors shall fix.
(b) If a special meeting is properly called by any person or persons other than the Board of Directors, the request shall be in writing, specifying the general nature of the business proposed to be transacted, and shall be delivered personally or sent by certified or registered mail, return receipt requested, or by telegraphic or other facsimile transmission to the Chairman of the Board of Directors, the Chief Executive Officer, or the Secretary of the corporation. No business may be transacted at such special meeting otherwise than specified in such notice. The Board of Directors shall determine the time and place of such special meeting, which shall be held not less than thirty-five (35) nor more than one hundred twenty (120) days after the date of the receipt of the request. Upon determination of the time and place of the meeting, the officer receiving the request shall cause notice to be given to the stockholders entitled to vote, in accordance with the provisions of Section 7 of these Bylaws. Nothing contained in this paragraph (b) shall be construed as limiting, fixing, or affecting the time when a meeting of stockholders called by action of the Board of Directors may be held.
Section 7. Notice of Meetings . Except as otherwise provided by law, notice, given in writing or by electronic transmission, of each meeting of stockholders shall be given not less than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to vote at such meeting, such notice to specify the place, if any, date and hour, in the case of special meetings, the purpose or purposes of the meeting, and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at any such meeting. If mailed, notice is given when deposited in the United States mail, postage prepaid, directed to the stockholder at such stockholder’s address as it appears on the records of the corporation. Notice of the time, place, if any, and purpose of any meeting of stockholders may be waived in writing, signed by the person entitled to notice thereof or by electronic transmission by such person, either before or after such meeting, and will be waived by any stockholder by his or her attendance thereat in person, by remote communication, if applicable, or by proxy, except when the stockholder attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Any stockholder so waiving notice of such meeting shall be bound by the proceedings of any such meeting in all respects as if due notice thereof had been given.
3
Section 8. Quorum. At all meetings of stockholders, except where otherwise provided by statute or by the Certificate of Incorporation, or by these Bylaws, the presence, in person, by remote communication, if applicable, or by proxy duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote shall constitute a quorum for the transaction of business. In the absence of a quorum, any meeting of stockholders may be adjourned, from time to time, either by the chairman of the meeting or by vote of the holders of a majority of the shares represented thereat, but no other business shall be transacted at such meeting. The stockholders present at a duly called or convened meeting, at which a quorum is present, may continue to transact business until adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum. Except as otherwise provided by statute, or by the Certificate of Incorporation or these Bylaws, in all matters other than the election of directors, the affirmative vote of a majority of shares present in person, by remote communication, if applicable, or represented by proxy duly authorized at the meeting and entitled to vote generally on the subject matter shall be the act of the stockholders. Except as otherwise provided by statute, the Certificate of Incorporation or these Bylaws, directors shall be elected by a plurality of the votes of the shares present in person, by remote communication, if applicable, or represented by proxy duly authorized at the meeting and entitled to vote generally on the election of directors. Where a separate vote by a class or classes or series is required, except where otherwise provided by the statute or by the Certificate of Incorporation or these Bylaws, a majority of the outstanding shares of such class or classes or series, present in person, by remote communication, if applicable, or represented by proxy duly authorized, shall constitute a quorum entitled to take action with respect to that vote on that matter. Except where otherwise provided by statute or by the Certificate of Incorporation or these Bylaws, the affirmative vote of the majority (plurality, in the case of the election of directors) of shares of such class or classes or series present in person, by remote communication, if applicable, or represented by proxy at the meeting shall be the act of such class or classes or series.
Section 9. Adjournment and Notice of Adjourned Meetings . Any meeting of stockholders, whether annual or special, may be adjourned from time to time either by the chairman of the meeting or by the vote of a majority of the shares present in person, by remote communication, if applicable, or represented by proxy. When a meeting is adjourned to another time or place, if any, notice need not be given of the adjourned meeting if the time and place, if any, thereof are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the corporation may transact any business which might have been transacted at the original meeting pursuant to the Certificate of Incorporation, these Bylaws or applicable law. If the adjournment is for more than thirty (30) days or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.
Section 10. Voting Rights. For the purpose of determining those stockholders entitled to vote at any meeting of the stockholders, except as otherwise provided by law, only persons in whose names shares stand on the stock records of the corporation on the record date, as provided in Section 12 of these Bylaws, shall be entitled to vote at any meeting of stockholders. Every person entitled to vote or execute consents shall have the right to do so either in person, by remote communication, if applicable, or by an agent or agents authorized by a proxy granted in accordance with Delaware law. An agent so appointed need not be a stockholder. No proxy shall be voted after three (3) years from its date of creation unless the proxy provides for a longer period.
4
Section 11. Joint Owners of Stock. If shares or other securities having voting power stand of record in the names of two (2) or more persons, whether fiduciaries, members of a partnership, joint tenants, tenants in common, tenants by the entirety, or otherwise, or if two (2) or more persons have the same fiduciary relationship respecting the same shares, unless the Secretary is given written notice to the contrary and is furnished with a copy of the instrument or order appointing them or creating the relationship wherein it is so provided, their acts with respect to voting (including giving consent pursuant to Section 13) shall have the following effect: (a) if only one (1) votes, his or her act binds all; (b) if more than one (1) votes, the act of the majority so voting binds all; (c) if more than one (1) votes, but the vote is evenly split on any particular matter, each faction may vote the securities in question proportionally, or may apply to the Delaware Court of Chancery for relief as provided in the DGCL, Section 217(b). If the instrument filed with the Secretary shows that any such tenancy is held in unequal interests, a majority or even-split for the purpose of subsection (c) shall be a majority or even-split in interest.
Section 12. List of Stockholders. The Secretary shall prepare and make, at least ten (10) days before every meeting of stockholders, a complete list of the stockholders entitled to vote at said meeting, arranged in alphabetical order, showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or during ordinary business hours, at the principal place of business of the corporation. In the event that the corporation determines to make the list available on an electronic network, the corporation may take reasonable steps to ensure that such information is available only to stockholders of the corporation. The list shall be open to examination of any stockholder during the time of the meeting as provided by law.
Section 13. Action Without Meeting.
(a) Unless otherwise provided in the Certificate of Incorporation, any action required by statute to be taken at any annual or special meeting of the stockholders, or any action which may be taken at any annual or special meeting of the stockholders, may be taken without a meeting, without prior notice and without a vote, if a consent in writing, or by electronic transmission setting forth the action so taken, shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.
(b) Every written consent or electronic transmission shall bear the date of signature of each stockholder who signs the consent, and no written consent or electronic transmission shall be effective to take the corporate action referred to therein unless, within sixty (60) days of the earliest dated consent delivered to the corporation in the manner herein required, written consents or electronic transmissions signed by a sufficient number of stockholders to take action are delivered to the corporation by delivery to its registered office in the State of Delaware, its principal place of business or an officer or agent of the corporation having custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to a corporation’s registered office shall be by hand or by certified or registered mail, return receipt requested.
(c) Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent shall be given to those stockholders who have not consented in writing or by electronic transmission and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if the record date for such meeting had been the date that written consents signed by a sufficient number of stockholders to take action were delivered to the corporation as provided in Section 228(c) of the DGCL. If the action to which the stockholders consent is such as would have required the filing of a certificate under any section of the DGCL if such action had been voted on by stockholders at a meeting thereof, then the certificate filed under such section shall state, in lieu of any statement required by such section concerning any vote of stockholders, that written consent has been given in accordance with Section 228 of the DGCL.
5
(d) An electronic mail, facsimile or other electronic transmission consenting to an action to be taken and transmitted by a stockholder or proxyholder, shall be deemed to be written, signed and dated for the purposes of this Section, provided that any such electronic mail, facsimile or other electronic transmission sets forth or is delivered with information from which the corporation can determine (i) that the electronic mail, facsimile or other electronic transmission was transmitted by the stockholder or proxyholder or by a person or persons authorized to act for the stockholder and (ii) the date on which such stockholder or proxyholder or authorized person or persons transmitted such electronic mail, facsimile or electronic transmission. The date on which such electronic mail, facsimile or electronic transmission is transmitted shall be deemed to be the date on which such consent was signed. No consent given by electronic mail, facsimile or other electronic transmission shall be deemed to have been delivered until such consent is reproduced in paper form and until such paper form shall be delivered to the corporation by delivery to its registered office in the state of Delaware, its principal place of business or an officer or agent of the corporation having custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to a corporation’s registered office shall be made by hand or by certified or registered mail, return receipt requested. Notwithstanding the foregoing limitations on delivery, consents given by electronic mail, facsimile or other electronic transmission may be otherwise delivered to the principal place of business of the corporation or to an officer or agent of the corporation having custody of the book in which proceedings of meetings of stockholders are recorded if, to the extent and in the manner provided by resolution of the board of directors of the corporation. Any copy, facsimile or other reliable reproduction of a consent in writing may be substituted or used in lieu of the original writing for any and all purposes for which the original writing could be used, provided that such copy, facsimile or other reproduction shall be a complete reproduction of the entire original writing.
Section 14. Organization.
(a) At every meeting of stockholders, the Chairman of the Board of Directors, or, if a Chairman has not been appointed or is absent, the Chief Executive Officer, or, if the Chief Executive Officer is absent, a chairman of the meeting chosen by a majority in interest of the stockholders entitled to vote, present in person or by proxy, shall act as chairman. The Secretary, or, in his or her absence, an Assistant Secretary directed to do so by the Chief Executive Officer, shall act as secretary of the meeting.
(b) The Board of Directors shall be entitled to make such rules or regulations for the conduct of meetings of stockholders as it shall deem necessary, appropriate or convenient. Subject to such rules and regulations of the Board of Directors, if any, the chairman of the meeting shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are necessary, appropriate or convenient for the proper conduct of the meeting, including, without limitation, establishing an agenda or order of business for the meeting, rules and procedures for maintaining order at the meeting and the safety of those present, limitations on participation in such meeting to stockholders of record of the corporation and their duly authorized and constituted proxies and such other persons as the chairman shall permit, restrictions on entry to the meeting after the time fixed for the commencement thereof, limitations on the time allotted to questions or comments by participants and regulation of the opening and closing of the polls for balloting on matters which are to be voted on by ballot. The date and time of the opening and closing of the polls for each matter upon which the stockholders will vote at the meeting shall be announced at the meeting. Unless and to the extent determined by the Board of Directors or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with rules of parliamentary procedure.
6
ARTICLE IV
DIRECTORS
Section 15. Number and Term of Office. The authorized number of directors of the corporation shall be fixed by the Board of Directors from time to time. Directors need not be stockholders unless so required by the Certificate of Incorporation. If for any cause, the directors shall not have been elected at an annual meeting, they may be elected as soon thereafter as convenient.
Section 16. Powers. The business and affairs of the corporation shall be managed by or under the direction of the Board of Directors, except as may be otherwise provided by statute or by the Certificate of Incorporation.
Section 17. Term of Directors. Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, directors shall be elected at each annual meeting of stockholders to serve until the next annual meeting of stockholders and his or her successor is duly elected and qualified or until his or her death, resignation or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.
Section 18. Vacancies. Unless otherwise provided in the Certificate of Incorporation, and subject to the rights of the holders of any series of Preferred Stock, any vacancies on the Board of Directors resulting from death, resignation, disqualification, removal or other causes and any newly created directorships resulting from any increase in the number of directors shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by stockholders, be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board of Directors, or by a sole remaining director; provided, however, that whenever the holders of any class or classes of stock or series thereof are entitled to elect one or more directors by the provisions of the Certificate of Incorporation, vacancies and newly created directorships of such class or classes or series shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by stockholders, be filled by a majority of the directors elected by such class or classes or series thereof then in office, or by a sole remaining director so elected. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director’s successor shall have been elected and qualified. A vacancy in the Board of Directors shall be deemed to exist under this Bylaw in the case of the death, removal or resignation of any director.
Section 19. Resignation. Any director may resign at any time by delivering his or her notice in writing or by electronic transmission to the Secretary, such resignation to specify whether it will be effective at a particular time, upon receipt by the Secretary or at the pleasure of the Board of Directors. If no such specification is made, it shall be deemed effective at the pleasure of the Board of Directors. When one or more directors shall resign from the Board of Directors, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each Director so chosen shall hold office for the unexpired portion of the term of the Director whose place shall be vacated and until his successor shall have been duly elected and qualified.
Section 20. Removal. Subject to any limitations imposed by applicable law, the Board of Directors or any director may be removed from office at any time (i) with cause by the affirmative vote of the holders of a majority of the voting power of all then-outstanding shares of capital stock of the corporation entitled to vote generally at an election of directors or (ii) without cause by the affirmative vote of the holders of a majority of the voting power of all then-outstanding shares of capital stock of the corporation, entitled to elect such director.
7
Section 21. Meetings
(a) Regular Meetings. Unless otherwise restricted by the Certificate of Incorporation, regular meetings of the Board of Directors may be held at any time or date and at any place within or without the State of Delaware which has been designated by the Board of Directors and publicized among all directors, either orally or in writing, including a voice-messaging system or other system designated to record and communicate messages, facsimile, or by electronic mail or other electronic means. No further notice shall be required for a regular meeting of the Board of Directors.
(b) Special Meetings. Unless otherwise restricted by the Certificate of Incorporation, special meetings of the Board of Directors may be held at any time and place within or without the State of Delaware whenever called by the Chairman of the Board, the Chief Executive Officer (if a director), the President (if a director) or any director.
(c) Meetings by Electronic Communications Equipment. Any member of the Board of Directors, or of any committee thereof, may participate in a meeting by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting by such means shall constitute presence in person at such meeting.
(d) Notice of Special Meetings. Notice of the time and place of all special meetings of the Board of Directors shall be orally or in writing, by telephone, including a voice messaging system or other system or technology designed to record and communicate messages, facsimile, telegraph or telex, or by electronic mail or other electronic means, during normal business hours, at least twenty-four (24) hours before the date and time of the meeting. If notice is sent by US mail, it shall be sent by first class mail, postage prepaid at least three (3) days before the date of the meeting. Notice of any meeting may be waived in writing or by electronic transmission at any time before or after the meeting and will be waived by any director by attendance thereat, except when the director attends the meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened.
(e) Waiver of Notice. The transaction of all business at any meeting of the Board of Directors, or any committee thereof, however called or noticed, or wherever held, shall be as valid as though had at a meeting duly held after regular call and notice, if a quorum be present and if, either before or after the meeting, each of the directors not present who did not receive notice shall sign a written waiver of notice or shall waive notice by electronic transmission. All such waivers shall be filed with the corporate records or made a part of the minutes of the meeting.
Section 22. Quorum and Voting.
(a) Unless the Certificate of Incorporation requires a greater number, a quorum of the Board of Directors shall consist of a majority of the total number of directors then serving; provided, however, that such number shall never be less than one-third (1/3) of the total number of directors except that when one director is authorized, then one director shall constitute a quorum. At any meeting, whether a quorum be present or otherwise, a majority of the directors present may adjourn from time to time until the time fixed for the next regular meeting of the Board of Directors, without notice other than by announcement at the meeting. If the Certificate of Incorporation provides that one or more directors shall have more or less than one vote per director on any matter, every reference in this Section to a majority or other proportion of the directors shall refer to a majority or other proportion of the votes of the directors.
8
(b) At each meeting of the Board of Directors at which a quorum is present, all questions and business shall be determined by the affirmative vote of a majority of the directors present, unless a different vote be required by law, the Certificate of Incorporation or these Bylaws.
Section 23. Action Without Meeting. Unless otherwise restricted by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the Board of Directors or committee, as the case may be, consent thereto in writing or by electronic transmission, and such writing or writings or transmission or transmissions are filed with the minutes of proceedings of the Board of Directors or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.
Section 24. Fees and Compensation. Directors shall be entitled to such compensation for their services as may be approved by the Board of Directors, including, if so approved, by resolution of the Board of Directors, a fixed sum and expenses of attendance, if any, for attendance at each regular or special meeting of the Board of Directors and at any meeting of a committee of the Board of Directors. Nothing herein contained shall be construed to preclude any director from serving the corporation in any other capacity as an officer, agent, employee, or otherwise and receiving compensation therefor.
Section 25. Committees.
(a) Executive Committee. The Board of Directors may appoint an Executive Committee to consist of one (1) or more members of the Board of Directors. The Executive Committee, to the extent permitted by law and provided in the resolution of the Board of Directors, shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the corporation, and may authorize the seal of the corporation to be affixed to all papers which may require it; but no such committee shall have the power or authority in reference to (i) approving or adopting, or recommending to the stockholders, any action or matter expressly required by the DGCL to be submitted to stockholders for approval, or (ii) adopting, amending or repealing any bylaw of the corporation.
(b) Other Committees. The Board of Directors may, from time to time, appoint such other committees as may be permitted by law. Such other committees appointed by the Board of Directors shall consist of one (1) or more members of the Board of Directors and shall have such powers and perform such duties as may be prescribed by the resolution or resolutions creating such committees, but in no event shall any such committee have the powers denied to the Executive Committee in these Bylaws.
(c) Term. The Board of Directors, subject to any requirements of any outstanding series of Preferred Stock and the provisions of paragraphs (a) or (b) of this Section may at any time increase or decrease the number of members of a committee or terminate the existence of a committee. The membership of a committee member shall terminate on the date of his or her death or voluntary resignation from the committee or from the Board of Directors. The Board of Directors may at any time for any reason remove any individual committee member and the Board of Directors may fill any committee vacancy created by death, resignation, removal or increase in the number of members of the committee. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee, and, in addition, in the absence or disqualification of any member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not he or they constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member.
9
(d) Meetings. Unless the Board of Directors shall otherwise provide, regular meetings of the Executive Committee or any other committee appointed pursuant to this Section shall be held at such times and places as are determined by the Board of Directors, or by any such committee, and when notice thereof has been given to each member of such committee, no further notice of such regular meetings need be given thereafter. Special meetings of any such committee may be held at any place which has been determined from time to time by such committee, and may be called by any director who is a member of such committee, upon notice to the members of such committee of the time and place of such special meeting given in the manner provided for the giving of notice to members of the Board of Directors of the time and place of special meetings of the Board of Directors. Notice of any special meeting of any committee may be waived in writing at any time before or after the meeting and will be waived by any director by attendance thereat, except when the director attends such special meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Unless otherwise provided by the Board of Directors in the resolutions authorizing the creation of the committee, a majority of the authorized number of members of any such committee shall constitute a quorum for the transaction of business, and the act of a majority of those present at any meeting at which a quorum is present shall be the act of such committee.
Section 26. Organization. At every meeting of the directors, the Chairman of the Board of Directors, or, if a Chairman has not been appointed or is absent, the Chief Executive Officer (if a director), or if the Chief Executive Officer is not a director or is absent, the President (if a director), or if the President is not a director or is absent, the most senior Vice President (if a director) or, in the absence of any such person, a chairman of the meeting chosen by a majority of the directors present, shall preside over the meeting. The Secretary, or in his or her absence, any Assistant Secretary directed to do so by the Chief Executive Officer or President, shall act as secretary of the meeting.
ARTICLE V
OFFICERS
Section 27. Officers Designated. The officers of the corporation shall include, if and when designated by the Board of Directors, the Chief Executive Officer, the President, one or more Vice Presidents, the Secretary, the Chief Financial Officer, the Treasurer and the Controller, all of whom shall be elected at the annual organizational meeting of the Board of Directors. The Board of Directors may also appoint one or more Assistant Secretaries, Assistant Treasurers, Assistant Controllers and such other officers and agents with such powers and duties as it shall deem necessary. The Board of Directors may assign such additional titles to one or more of the officers as it shall deem appropriate. Any one person may hold any number of offices of the corporation at any one time unless specifically prohibited therefrom by law. The salaries and other compensation of the officers of the corporation shall be fixed by or in the manner designated by the Board of Directors.
Section 28. Tenure and Duties of Officers.
(a) General. All officers shall hold office at the pleasure of the Board of Directors and until their successors shall have been duly elected and qualified, unless sooner removed. Any officer elected or appointed by the Board of Directors may be removed at any time by the Board of Directors. If the office of any officer becomes vacant for any reason, the vacancy may be filled by the Board of Directors, or by the Chief Executive Officer or other officer if so authorized by the Board of Directors.
10
(b) Duties of Chairman of the Board of Directors. The Chairman of the Board of Directors, when present, shall preside at all meetings of the stockholders and the Board of Directors. The Chairman of the Board of Directors shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors shall designate from time to time. If there is no Chief Executive Officer and no President, then the Chairman of the Board of Directors shall also serve as the Chief Executive Officer of the corporation and shall have the powers and duties prescribed in paragraph (c) of this Section.
(c) Duties of Chief Executive Officer. The Chief Executive Officer shall preside at all meetings of the stockholders and (if a director) at all meetings of the Board of Directors, unless the Chairman of the Board of Directors has been appointed and is present. The Chief Executive Officer shall be the chief executive officer of the corporation and shall, subject to the control of the Board of Directors, have general supervision, direction and control of the business and officers of the corporation. The Chief Executive Officer shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors shall designate from time to time.
(d) Duties of President. In the absence or disability of the Chief Executive Officer or if the office of Chief Executive Officer is vacant, the President shall preside at all meetings of the stockholders and (if a director) at all meetings of the Board of Directors, unless the Chairman of the Board of Directors has been appointed and is present. If the office of Chief Executive Officer is vacant, the President shall be the chief executive officer of the corporation and shall, subject to the control of the Board of Directors, have general supervision, direction and control of the business and officers of the corporation. The President shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors shall designate from time to time.
(e) Duties of Vice Presidents. The Vice Presidents may assume and perform the duties of the President in the absence or disability of the President or whenever the office of President is vacant. The Vice Presidents shall perform other duties commonly incident to their office and shall also perform such other duties and have such other powers as the Board of Directors or the President shall designate from time to time.
(f) Duties of Secretary. The Secretary shall attend all meetings of the stockholders and of the Board of Directors and shall record all acts and proceedings thereof in the minute book of the corporation. The Secretary shall give notice in conformity with these Bylaws of all meetings of the stockholders and of all meetings of the Board of Directors and any committee thereof requiring notice. The Secretary shall perform all other duties provided for in these Bylaws and other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors shall designate from time to time. The Chief Executive Officer may direct any Assistant Secretary to assume and perform the duties of the Secretary in the absence or disability of the Secretary, and each Assistant Secretary shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer shall designate from time to time.
11
(g) Duties of Chief Financial Officer. The Chief Financial Officer shall keep or cause to be kept the books of account of the corporation in a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required by the Board of Directors or the Chief Executive Officer. The Chief Financial Officer, subject to the order of the Board of Directors, shall have the custody of all funds and securities of the corporation. The Chief Financial Officer shall perform other duties commonly incident to his or her office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer shall designate from time to time. The Chief Executive Officer may direct the Treasurer or any Assistant Treasurer, or the Controller or any Assistant Controller to assume and perform the duties of the Chief Financial Officer in the absence or disability of the Chief Financial Officer, and each Treasurer and Assistant Treasurer and each Controller and Assistant Controller shall perform other duties commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive Officer shall designate from time to time.
Section 29. Delegation of Authority. The Board of Directors may from time to time delegate the powers or duties of any officer to any other officer or agent, notwithstanding any provision hereof.
Section 30. Resignations. Any officer may resign at any time by giving notice in writing or by electronic transmission notice to the Board of Directors or to the Chief Executive Officer or to the President or to the Secretary. Any such resignation shall be effective when received by the person or persons to whom such notice is given, unless a later time is specified therein, in which event the resignation shall become effective at such later time. Unless otherwise specified in such notice, the acceptance of any such resignation shall not be necessary to make it effective. Any resignation shall be without prejudice to the rights, if any, of the corporation under any contract with the resigning officer.
Section 31. Removal. Any officer may be removed from office at any time, either with or without cause, by the affirmative vote of a majority of the directors in office at the time, or by the unanimous written or electronic consent of the directors in office at the time, or by any committee or superior officers upon whom such power of removal may have been conferred by the Board of Directors.
ARTICLE VI
EXECUTION
OF CORPORATE INSTRUMENTS AND VOTING
OF SECURITIES OWNED BY THE CORPORATION
Section 32. Execution of Corporate Instruments . The Board of Directors may, in its discretion, determine the method and designate the signatory officer or officers, or other person or persons, to execute on behalf of the corporation any corporate instrument or document, or to sign on behalf of the corporation the corporate name, or to enter into contracts on behalf of the corporation, except where otherwise provided by law or these Bylaws, and such execution or signature shall be binding upon the corporation. All checks and drafts drawn on banks or other depositaries of funds to the credit of the corporation or on special accounts of the corporation shall be signed by such person or persons as the Board of Directors shall authorize so to do. Unless authorized or ratified by the Board of Directors or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.
Section 33. Voting of Securities Owned by the Corporation. All stock and other securities of other corporations owned or held by the corporation for itself, or for other parties in any capacity, shall be voted, and all proxies with respect thereto shall be executed, by the person authorized so to do by resolution of the Board of Directors, or, in the absence of such authorization, by the Chairman of the Board of Directors, the Chief Executive Officer, the President, or any Vice President.
12
ARTICLE VII
SHARES OF STOCK
Section 34. Form and Execution of Certificates. The shares of the corporation shall be represented by certificates, or shall be uncertificated. Certificates for the shares of stock, if any, of the corporation shall be in such form as is consistent with the Certificate of Incorporation and applicable law. Every holder of shares of stock in the corporation represented by certificate shall be entitled to have a certificate signed by or in the name of the corporation by any two authorized officers, including but not limited to the Chief Executive Officer, the President, the Chief Financial Officer, any Vice President, the Treasurer or Assistant Treasurer or the Secretary or Assistant Secretary, certifying the number of shares owned by him or her in the corporation. Any or all of the signatures on the certificate may be facsimiles. In case any officer, transfer agent, or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent, or registrar before such certificate is issued, it may be issued with the same effect as if he or she were such officer, transfer agent, or registrar at the date of issue.
Section 35. Lost Certificates. A new certificate or certificates shall be issued in place of any certificate or certificates theretofore issued by the corporation alleged to have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen, or destroyed. The corporation may require, as a condition precedent to the issuance of a new certificate or certificates, the owner of such lost, stolen, or destroyed certificate or certificates, or the owner’s legal representative, to agree to indemnify the corporation in such manner as it shall require or to give the corporation a surety bond in such form and amount as it may direct as indemnity against any claim that may be made against the corporation with respect to the certificate alleged to have been lost, stolen, or destroyed.
Section 36. Restrictions on Transfer.
(a) No holder of any of the shares of stock of the corporation may sell, transfer, assign, pledge, or otherwise dispose of or encumber any of the shares of stock of the corporation or any right or interest therein, whether voluntarily or by operation of law, or by gift or otherwise (each, a “Transfer”) if the corporation withholds its consent to such Transfer within five (5) business days following such holder providing the Board of Directors with notice thereof. The corporation may withhold consent for any legitimate corporate purpose, as determined by the Board of Directors. Examples of the basis for the corporation to withhold its consent include, without limitation, (i) if such Transfer to individuals, companies or any other form of entity identified by the corporation as a potential competitor or considered by the corporation to be unfriendly; or (ii) if such Transfer increases the risk of the corporation having a class of security held of record by two thousand (2,000) or more persons, or five hundred (500) or more persons who are not accredited investors (as such term is defined by the SEC), as described in Section 12(g) of the 1934 Act and any related regulations, or otherwise requiring the corporation to register any class of securities under the 1934 Act; or (iii) if such Transfer would result in the loss of any federal or state securities law exemption relied upon by the corporation in connection with the initial issuance of such shares or the issuance of any other securities; or (iv) if such Transfer is facilitated in any manner by any public posting, message board, trading portal, internet site, or similar method of communication, including without limitation any trading portal or internet site intended to facilitate secondary transfers of securities; or (v) if such Transfer is to be effected in a brokered transaction; or (vi) if such Transfer represents a Transfer of less than all of the shares then held by the stockholder and its affiliates or is to be made to more than a single transferee.
13
(b) If a stockholder desires to Transfer any shares, then the stockholder shall first give written notice thereof to the corporation. The notice shall name the proposed transferee and state the number of shares to be transferred, the proposed consideration, and all other terms and conditions of the proposed transfer. Any shares proposed to be transferred to which Transfer the corporation has consented pursuant to paragraph (a) of this Section will first be subject to the corporation’s right of first refusal located in Section 46 of these Bylaws.
(c) Any Transfer, or purported Transfer, of shares not made in strict compliance with this Section shall be null and void, shall not be recorded on the books of the corporation and shall not be recognized by the corporation.
(d) The foregoing restriction on Transfer shall terminate upon the date securities of the corporation are first offered to the public pursuant to a registration statement filed with, and declared effective by, the SEC under the Securities Act of 1933, as amended (the “1933 Act”).
(e) The certificates representing shares of stock of the corporation shall bear on their face the following legend so long as the foregoing Transfer restrictions are in effect:
“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A TRANSFER RESTRICTION, AS PROVIDED IN THE BYLAWS OF THE CORPORATION.”
Section 37. Fixing Record Dates.
(a) In order that the corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, the Board of Directors may fix, in advance, a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall, subject to applicable law, not be more than sixty (60) nor less than ten (10) days before the date of such meeting. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day immediately preceding the day on which notice is given, or if notice is waived, at the close of business on the day immediately preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.
(b) In order that the corporation may determine the stockholders entitled to consent to corporate action in writing without a meeting, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which date shall not be more than ten (10) days after the date upon which the resolution fixing the record date is adopted by the Board of Directors. Any stockholder of record seeking to have the stockholders authorize or take corporate action by written consent shall, by written notice to the Secretary, request the Board of Directors to fix a record date. The Board of Directors shall promptly, but in all events within ten (10) days after the date on which such a request is received, adopt a resolution fixing the record date. If no record date has been fixed by the Board of Directors within ten (10) days of the date on which such a request is received, the record date for determining stockholders entitled to consent to corporate action in writing without a meeting, when no prior action by the Board of Directors is required by applicable law, shall be the first date on which a signed written consent setting forth the action taken or proposed to be taken is delivered to the corporation by delivery to its registered office in the State of Delaware, its principal place of business or an officer or agent of the corporation having custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to the corporation’s registered office shall be by hand or by certified or registered mail, return receipt requested. If no record date has been fixed by the Board of Directors and prior action by the Board of Directors is required by law, the record date for determining stockholders entitled to consent to corporate action in writing without a meeting shall be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior action.
14
(c) In order that the corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board of Directors may fix, in advance, a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than sixty (60) days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.
Section 38. Registered Stockholders. The corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.
ARTICLE VIII
OTHER SECURITIES OF THE CORPORATION
Section 39. Execution of Other Securities. All bonds, debentures and other corporate securities of the corporation, other than stock certificates (covered in Section 34 of these Bylaws), may be signed by the Chairman of the Board of Directors, the Chief Executive Officer, the President or any Vice President, or such other person as may be authorized by the Board of Directors, and the corporate seal impressed thereon or a facsimile of such seal imprinted thereon and attested by the signature of the Secretary or an Assistant Secretary, or the Chief Financial Officer or Treasurer or an Assistant Treasurer; provided, however, that where any such bond, debenture or other corporate security shall be authenticated by the manual signature, or where permissible facsimile signature, of a trustee under an indenture pursuant to which such bond, debenture or other corporate security shall be issued, the signatures of the persons signing and attesting the corporate seal on such bond, debenture or other corporate security may be the imprinted facsimile of the signatures of such persons. Interest coupons appertaining to any such bond, debenture or other corporate security, authenticated by a trustee as aforesaid, shall be signed by the Treasurer or an Assistant Treasurer of the corporation or such other person as may be authorized by the Board of Directors, or bear imprinted thereon the facsimile signature of such person. In case any officer who shall have signed or attested any bond, debenture or other corporate security, or whose facsimile signature shall appear thereon or on any such interest coupon, shall have ceased to be such officer before the bond, debenture or other corporate security so signed or attested shall have been delivered, such bond, debenture or other corporate security nevertheless may be adopted by the corporation and issued and delivered as though the person who signed the same or whose facsimile signature shall have been used thereon had not ceased to be such officer of the corporation.
15
ARTICLE IX
DIVIDENDS
Section 40. Declaration of Dividends. Dividends upon the capital stock of the corporation, subject to the provisions of the Certificate of Incorporation and applicable law, if any, may be declared by the Board of Directors pursuant to law at any regular or special meeting. Dividends may be paid in cash, in property, or in shares of the capital stock, subject to the provisions of the Certificate of Incorporation and applicable law.
Section 41. Dividend Reserve. Before payment of any dividend, there may be set aside out of any funds of the corporation available for dividends such sum or sums as the Board of Directors from time to time, in their absolute discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the corporation, or for such other purpose as the Board of Directors shall think conducive to the interests of the corporation, and the Board of Directors may modify or abolish any such reserve in the manner in which it was created.
ARTICLE X
FISCAL YEAR
Section 42. Fiscal Year. The fiscal year of the corporation shall be fixed by resolution of the Board of Directors.
ARTICLE XI
INDEMNIFICATION
Section 43. Indemnification of Directors, Executive Officers, Employees and Other Agents.
(a) Directors and Executive Officers. The corporation shall indemnify its directors and executive officers (for the purposes of this Article, “executive officers” shall have the meaning defined in Rule 3b-7 promulgated under the 1934 Act) to the fullest extent not prohibited by the DGCL or any other applicable law; provided, however, that the corporation may modify the extent of such indemnification by individual contracts with its directors and executive officers; and, provided, further, that the corporation shall not be required to indemnify any director or executive officer in connection with any proceeding (or part thereof) initiated by such person unless (i) such indemnification is expressly required to be made by law, (ii) the proceeding was authorized by the Board of Directors of the corporation, (iii) such indemnification is provided by the corporation, in its sole discretion, pursuant to the powers vested in the corporation under the DGCL or any other applicable law or (iv) such indemnification is required to be made under paragraph (d) of this Section.
(b) Other Officers, Employees and Other Agents. The corporation shall have power to indemnify its other officers, employees and other agents as set forth in the DGCL or any other applicable law. The Board of Directors shall have the power to delegate the determination of whether indemnification shall be given to any such person except executive officers to such officers or other persons as the Board of Directors shall determine.
(c) Expenses. The corporation shall advance to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was a director or executive officer of the corporation, or is or was serving at the request of the corporation as a director or executive officer of another corporation, partnership, joint venture, trust or other enterprise, prior to the final disposition of the proceeding, promptly following request therefor, all expenses incurred by any director or executive officer in connection with such proceeding; provided, however, that, if the DGCL requires, an advancement of expenses incurred by a director or officer in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the corporation of an undertaking, by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal that such indemnitee is not entitled to be indemnified for such expenses under this Section or otherwise.
16
Notwithstanding the foregoing, unless otherwise determined pursuant to paragraph (e) of this Section, no advance shall be made by the corporation to an executive officer of the corporation (except by reason of the fact that such executive officer is or was a director of the corporation, in which event this paragraph shall not apply) in any action, suit or proceeding, whether civil, criminal, administrative or investigative, if a determination is reasonably and promptly made (i) by a majority vote of a quorum consisting of directors who were not parties to the proceeding, even if not a quorum, or (ii) by a committee of such directors designated by a majority of such directors, even though less than a quorum, or (iii) if there are no such directors, or such directors so direct, by independent legal counsel in a written opinion, that the facts known to the decision-making party at the time such determination is made demonstrate clearly and convincingly that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to the best interests of the corporation.
(d) Enforcement. Without the necessity of entering into an express contract, all rights to indemnification and advances to directors and executive officers under this Section shall be deemed to be contractual rights and be effective to the same extent and as if provided for in a contract between the corporation and the director or executive officer. Any right to indemnification or advances granted by this Section to a director or executive officer or officer shall be enforceable by or on behalf of the person holding such right in any court of competent jurisdiction if (i) the claim for indemnification or advances is denied, in whole or in part, or (ii) no disposition of such claim is made within ninety (90) days of request therefor. The claimant in such enforcement action, if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting the claim. In connection with any claim for indemnification, the corporation shall be entitled to raise as a defense to any such action that the claimant has not met the standards of conduct that make it permissible under the DGCL or any other applicable law for the corporation to indemnify the claimant for the amount claimed. In connection with any claim by an executive officer of the corporation (except in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such executive officer is or was a director of the corporation) for advances, the corporation shall be entitled to raise as a defense as to any such action clear and convincing evidence that such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to the best interests of the corporation, or with respect to any criminal action or proceeding that such person acted without reasonable cause to believe that his or her conduct was lawful. Neither the failure of the corporation (including its Board of Directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he has met the applicable standard of conduct set forth in the DGCL or any other applicable law, nor an actual determination by the corporation (including its Board of Directors, independent legal counsel or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that claimant has not met the applicable standard of conduct.
(e) Non-Exclusivity of Rights. The rights conferred on any person by this Section shall not be exclusive of any other right which such person may have or hereafter acquire under any applicable statute, provision of the Certificate of Incorporation, Bylaws, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his or her official capacity and as to action in another capacity while holding office. The corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers, employees or agents respecting indemnification and advances, to the fullest extent not prohibited by the DGCL or any other applicable law.
17
(f) Survival of Rights. The rights conferred on any person by this Section shall continue as to a person who has ceased to be a director or executive officer and shall inure to the benefit of the heirs, executors and administrators of such a person.
(g) Insurance. To the fullest extent permitted by the DGCL, or any other applicable law, the corporation, upon approval by the Board of Directors, may purchase insurance on behalf of any person required or permitted to be indemnified pursuant to this Section.
(h) Amendments. Any repeal or modification of this Section shall only be prospective and shall not affect the rights under this Bylaw in effect at the time of the alleged occurrence of any action or omission to act that is the cause of any proceeding against any agent of the corporation.
(i) Saving Clause. If this Section or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the corporation shall nevertheless indemnify each director and executive officer to the full extent not prohibited by any applicable portion of this Bylaw that shall not have been invalidated, or by any other applicable law. If this Section shall be invalid due to the application of the indemnification provisions of another jurisdiction, then the corporation shall indemnify each director and executive officer to the full extent under applicable law.
(j) Certain Definitions. For the purposes of this Section, the following definitions shall apply:
(1) The term “proceeding” shall be broadly construed and shall include, without limitation, the investigation, preparation, prosecution, defense, settlement, arbitration and appeal of, and the giving of testimony in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative.
(2) The term “expenses” shall be broadly construed and shall include, without limitation, court costs, attorneys’ fees, witness fees, fines, amounts paid in settlement or judgment and any other costs and expenses of any nature or kind incurred in connection with any proceeding.
(3) The term the “corporation” shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions of this Section with respect to the resulting or surviving corporation as he would have with respect to such constituent corporation if its separate existence had continued.
(4) References to a “director,” “executive officer,” “officer,” “employee,” or “agent” of the corporation shall include, without limitation, situations where such person is serving at the request of the corporation as, respectively, a director, executive officer, officer, employee, trustee or agent of another corporation, partnership, joint venture, trust or other enterprise.
(5) References to “other enterprises” shall include employee benefit plans; references to “fines” shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to “serving at the request of the corporation” shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee, or agent with respect to an employee benefit plan, its participants, or beneficiaries; and a person who acted in good faith and in a manner he reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the corporation” as referred to in this Section.
18
ARTICLE XII
NOTICES
Section 44. Notices.
(a) Notice to Stockholders. Written notice to stockholders of stockholder meetings shall be given as provided in Section 7 of these Bylaws. Without limiting the manner by which notice may otherwise be given effectively to stockholders under any agreement or contract with such stockholder, and except as otherwise required by law, written notice to stockholders for purposes other than stockholder meetings may be sent by United States mail or nationally recognized overnight courier, or by facsimile, telegraph or telex or by electronic mail or other electronic means.
(b) Notice to Directors. Any notice required to be given to any director may be given by the method stated in paragraph (a) of this Section, or as provided for in Section 21 of these Bylaws. If such notice is not delivered personally, it shall be sent to such address as such director shall have filed in writing with the Secretary, or, in the absence of such filing, to the last known post office address of such director.
(c) Affidavit of Mailing. An affidavit of mailing, executed by a duly authorized and competent employee of the corporation or its transfer agent appointed with respect to the class of stock affected or other agent, specifying the name and address or the names and addresses of the stockholder or stockholders, or director or directors, to whom any such notice or notices was or were given, and the time and method of giving the same, shall in the absence of fraud, be prima facie evidence of the facts therein contained.
(d) Methods of Notice. It shall not be necessary that the same method of giving notice be employed in respect of all recipients of notice, but one permissible method may be employed in respect of any one or more, and any other permissible method or methods may be employed in respect of any other or others.
(e) Notice to Person with Whom Communication Is Unlawful. Whenever notice is required to be given, under any provision of law or of the Certificate of Incorporation or Bylaws of the corporation, to any person with whom communication is unlawful, the giving of such notice to such person shall not be required and there shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice to such person. Any action or meeting which shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had been duly given. In the event that the action taken by the corporation is such as to require the filing of a certificate under any provision of the DGCL, the certificate shall state, if such is the fact and if notice is required, that notice was given to all persons entitled to receive notice except such persons with whom communication is unlawful.
(f) Notice to Stockholders Sharing an Address. Except as otherwise prohibited under DGCL, any notice given under the provisions of DGCL, the Certificate of Incorporation or the Bylaws shall be effective if given by a single written notice to stockholders who share an address if consented to by the stockholders at that address to whom such notice is given. Such consent shall have been deemed to have been given if such stockholder fails to object in writing to the corporation within 60 days of having been given notice by the corporation of its intention to send the single notice. Any consent shall be revocable by the stockholder by written notice to the corporation.
19
ARTICLE XIII
AMENDMENTS
Section 45. Amendments. The Board of Directors is expressly empowered to adopt, amend or repeal Bylaws of the corporation. The stockholders shall also have power to adopt, amend or repeal the Bylaws of the corporation; provided, however, that, in addition to any vote of the holders of any class or series of stock of the corporation required by law or by the Certificate of Incorporation, such action by stockholders shall require the affirmative vote of the holders of a majority of the voting power of all of the then-outstanding shares of the capital stock of the corporation entitled to vote generally in the election of directors, voting together as a single class.
ARTICLE XIV
RIGHT OF FIRST REFUSAL
Section 46. Right of First Refusal. No stockholder shall Transfer any of the shares of Common Stock of the corporation, except by a Transfer which meets the requirements set forth in Section
36 and below:
(a) If the stockholder desires to Transfer any of his shares of Common Stock, then the stockholder shall first give the notice specified in Section 36(b) of these Bylaws and comply with the provisions therein.
(b) For thirty (30) days following receipt of such notice, the corporation shall have the option to purchase of the shares of Common Stock specified in the notice at the price and upon the terms set forth in such notice; provided, however, that, with the consent of the stockholder, the corporation shall have the option to purchase a lesser portion of the shares specified in said notice at the price and upon the terms set forth therein. In the event of a gift, property settlement or other Transfer in which the proposed transferee is not paying the full price for the shares, and that is not otherwise exempted from the provisions of this Section, the price shall be deemed to be the fair market value of the stock at such time as determined in good faith by the Board of Directors. In the event the corporation elects to purchase all of the shares or, with consent of the stockholder, a lesser portion of such shares, it shall give written notice to the transferring stockholder of its election and settlement for said shares shall be made as provided below in paragraph (d) of this Section.
(c) The corporation may assign its rights hereunder.
(d) In the event the corporation and/or its assignee(s) elect to acquire any of the shares of Common Stock of the transferring stockholder as specified in said transferring stockholder’s notice, the Secretary of the corporation shall so notify the transferring stockholder and settlement thereof shall be made in cash within thirty (30) days after the Secretary of the corporation receives said transferring stockholder’s notice; provided that if the terms of payment set forth in said transferring stockholder’s notice were other than cash against delivery, the corporation and/or its assignee(s) shall pay for said shares on the same terms and conditions set forth in said transferring stockholder’s notice.
20
(e) In the event the corporation and/or its assignees(s) do not elect to acquire all of the shares specified in the transferring stockholder’s notice, said transferring stockholder may, subject to the corporation’s approval and all other restrictions on Transfer located in Section 36 of these Bylaws, within the sixty-day period following the expiration or waiver of the option rights granted to the corporation and/or its assignees(s) herein, Transfer the shares specified in said transferring stockholder’s notice which were not acquired by the corporation and/or its assignees(s) as specified in said transferring stockholder’s notice. All shares so sold by said transferring stockholder shall continue to be subject to the provisions of this bylaw in the same manner as before said Transfer.
(f) Anything to the contrary contained herein notwithstanding, the following transactions shall be exempt from the right of first refusal in paragraph (a) of this Section:
(1) A stockholder’s Transfer of any or all shares held either during such stockholder’s lifetime or on death by will or intestacy to such stockholder’s immediate family or to any custodian or trustee for the account of such stockholder or such stockholder’s immediate family or to any limited partnership of which the stockholder, members of such stockholder’s immediate family or any trust for the account of such stockholder or such stockholder’s immediate family will be the general or limited partner(s) of such partnership. “Immediate family” as used herein shall mean spouse, lineal descendant, father, mother, brother, or sister of the stockholder making such Transfer, and shall include adoptive relationships;
(2) A stockholder’s bona fide pledge or mortgage of any shares with a commercial lending institution, provided that any subsequent Transfer of said shares by said institution shall be conducted in the manner set forth in this bylaw;
(3) A stockholder’s Transfer of any or all of such stockholder’s shares to the corporation or to any other stockholder of the corporation;
(4) A stockholder’s Transfer of any or all of such stockholder’s shares to a person who, at the time of such Transfer, is an officer or director of the corporation;
(5) A corporate stockholder’s Transfer of any or all of its shares pursuant to and in accordance with the terms of any merger, consolidation, reclassification of shares or capital reorganization of the corporate stockholder, or pursuant to a sale of all or substantially all of the stock or assets of a corporate stockholder;
(6) A corporate stockholder’s Transfer of any or all of its shares to any or all of its stockholders; or
(7) A Transfer by a stockholder which is a limited or general partnership to any or all of its partners or former partners in accordance with partnership interests.
In any such case, the transferee, assignee, or other recipient shall receive and hold such stock subject to the provisions of this Section and the transfer restrictions in Section 36, and there shall be no further Transfer of such stock except in accord with this Section and the transfer restrictions in Section 36.
21
(g) The provisions of this bylaw may be waived with respect to any Transfer either by the corporation, upon duly authorized action of its Board of Directors, or by the stockholders, upon the express written consent of the owners of a majority of the voting power of the corporation (excluding the votes represented by those shares to be transferred by the transferring stockholder). This bylaw may be amended or repealed either by a duly authorized action of the Board of Directors or by the stockholders, upon the express written consent of the owners of a majority of the voting power of the corporation.
(h) Any Transfer, or purported Transfer, of securities of the corporation shall be null and void unless the terms, conditions, and provisions of this bylaw are strictly observed and followed.
(i) The foregoing right of first refusal shall terminate upon the date securities of the corporation are first offered to the public pursuant to a registration statement filed with, and declared effective by, the SEC under the Securities Act of 1933, as amended.
(j) The certificates representing shares of stock of the corporation shall bear on their face the following legend so long as the foregoing right of first refusal remains in effect:
“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL OPTION IN FAVOR OF THE CORPORATION AND/OR ITS ASSIGNEE(S), AS PROVIDED IN THE BYLAWS OF THE CORPORATION.”
(k) To the extent this Section conflicts with any written agreements between the Company and the stockholder attempting to Transfer shares, such agreement shall control.
ARTICLE XV
LOANS TO OFFICERS
Section 47. Loans to Officers. Except as otherwise prohibited under applicable law, the corporation may lend money to, or guarantee any obligation of, or otherwise assist any officer or other employee of the corporation or of its subsidiaries, including any officer or employee who is a Director of the corporation or its subsidiaries, whenever, in the judgment of the Board of Directors, such loan, guarantee or assistance may reasonably be expected to benefit the corporation. The loan, guarantee or other assistance may be with or without interest and may be unsecured, or secured in such manner as the Board of Directors shall approve, including, without limitation, a pledge of shares of stock of the corporation. Nothing in these Bylaws shall be deemed to deny, limit or restrict the powers of guaranty or warranty of the corporation at common law or under any statute.
ARTICLE XVI
MISCELLANEOUS
Section 48. Forum. Unless the corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the corporation; (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the corporation to the corporation or the corporation’s stockholders; (iii) any action asserting a claim against the corporation or any director or officer or other employee of the corporation arising pursuant to any provision of the DGCL, the certificate of incorporation or the Bylaws of the corporation; or (iv) any action asserting a claim against the corporation or any director or officer or other employee of the corporation governed by the internal affairs doctrine.
22
Exhibit 2.2
CERTIFICATE OF INCORPORATION OF
Creci Inc. |
State of Delaware Secretary of State Division of Corporations Delivered 01:55 PM 01/11/2019 FILED 01:55 PM 10/11/2019 SR 20190218535 - File Number 7233418 |
| FIRST: | The name of the corporation is: Creci Inc. |
| SECOND: | The address of the registered office of the corporation in the State of Delaware is located at: 108 West 13th Street, Wilmington, Delaware 19801 Located in the County of New Castle The name of the registered agent at that address is: Business Filings Incorporated |
| THIRD: | The purpose of the corporation is to engage in any lawful act or activity for which corporations may be organized under the Delaware General Corporation Law. |
| FOURTH: | The total number of shares of stock which the corporation is authorized to issue is 15,000,000 shares, of which 10,000,000 are common stock having a ($0.00001) par value and 5,000,000 are preferred stock having a ($0.00001) par value. |
| FIFTH: | No director of the corporation shall be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director; provided, however, that the foregoing clause shall not apply to any liability of a director (i) for any breach of the director's duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good. faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the General Corporation Law of the State of Delaware, or (iv) for any transaction from which the director derived an improper personal benefit. This Article shall not eliminate or limit the liability of a director for any act or omission occurring prior to the time this Article became effective. |
| SIXTH: | The name and address of the incorporator is Business Filings Incorporated, 8020 Excelsior Dr., Suite 200, Madison, WI 53717. |
| SEVENTH: | The name and address of the director of the corporation is: |
| Andres Idarraga, 4936 Sw 33rd Terrace, Fort Lauderdale, Florida 33312 |
I, the undersigned, being the incorporator, for the purpose of forming a corporation under the laws of the State of Delaware do make, file, and record this Certificate of Incorporation and do certify that the facts herein are true.
| /s/ Mark Williams | ||
| Business Filings Incorporated, Incorporator | Dated: January 11, 2019 | |
| Mark Williams, A.V.P. |
Page 1
Delaware
The First State
I , JEFFREY JI. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF INCORPORATION OF “CRECI INC.” , FILED IN THIS OFFICE ON THE ELEVENTH DAY OF JANUARY, A.D. 2019, AT 1:55 O'CLOCK P.M.
A FILED COPY OF THIS CERTIFICATE HAS BEEN FORWARDED TO THE NEW CASTLE COUNTY RECORDER OF DEEDS .
| ||
7233418 8100 SR# 20190218535 |
Authentication: 202071672 Date: 01-14-19 |
You may verify this certificate online at corp.delaware.gov/authver.shtml
Exhibit 3.1
POST-MONEY VALUATION CAP WITH DISCOUNT
THIS INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED IN THIS SAFE AND UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.
CRECI INC.
SAFE
(Simple Agreement for Future Equity)
THIS CERTIFIES THAT in exchange for the payment by [NAME] (the “Investor”) of [AMOUNT] ($__________) (the “Purchase Amount”) on or about [DATE], CRECI INC., a Delaware corporation (the “Company”), issues to the Investor the right to certain shares of the Company’s Capital Stock, subject to the terms described below.
This Safe is based on one of the forms available at http://ycombinator.com/documents, modified as agreed by Investor and the Company.
The “Post-Money Valuation Cap” is Two Million U.S. Dollars ($2,000,000).
The “Discount Rate” is Eighty Percent (80%).
See Section 2 for certain additional defined terms.
1. Events
(a) Equity Financing. If there is an Equity Financing before the termination of this Safe, on the initial closing of such Equity Financing, this Safe will automatically convert into the number of shares of Safe Preferred Stock equal to the Purchase Amount divided by the Conversion Price.
In connection with the automatic conversion of this Safe into shares of Safe Preferred Stock, the Investor will execute and deliver to the Company all of the transaction documents related to the Equity Financing; provided, that such documents are the same documents to be entered into with the purchasers of Standard Preferred Stock, with appropriate variations for the Safe Preferred Stock if applicable, and provided further, that such documents have customary exceptions to any drag-along applicable to the Investor, including, without limitation, limited representations and warranties and limited liability and indemnification obligations on the part of the Investor.
(b) Liquidity Event. If there is a Liquidity Event before the termination of this Safe, this Safe will automatically be entitled to receive a portion of Proceeds, due and payable to the Investor immediately prior to, or concurrent with, the consummation of such Liquidity Event, equal to the greater of (i) the Purchase Amount, plus an additional 1.25% of the Purchase Amount per full 90-day period elapsed during the time period beginning on the date of this Safe and ending on the date of the Liquidity Event (the “Cash-Out Amount”) or (ii) the amount payable on the number of shares of Common Stock equal to the Purchase Amount divided by the Liquidity Price (the “Conversion Amount”). If any of the Company’s securityholders are given a choice as to the form and amount of Proceeds to be received in a Liquidity Event, the Investor will be given the same choice, provided that the Investor may not choose to receive a form of consideration that the Investor would be ineligible to receive as a result of the Investor’s failure to satisfy any requirement or limitation generally applicable to the Company’s securityholders, or under any applicable laws.
Notwithstanding the foregoing, in connection with a Change of Control intended to qualify as a tax-free reorganization, the Company may reduce the cash portion of Proceeds payable to the Investor by the amount determined by its board of directors in good faith for such Change of Control to qualify as a tax-free reorganization for U.S. federal income tax purposes, provided that such reduction (A) does not reduce the total Proceeds payable to such Investor and (B) is applied in the same manner and on a pro rata basis to all securityholders who have equal priority to the Investor under Section 1(d).
POST-MONEY VALUATION CAP WITH DISCOUNT
(c) Dissolution Event. If there is a Dissolution Event before the termination of this Safe, the Investor will automatically be entitled to receive a portion of Proceeds equal to the Cash-Out Amount, due and payable to the Investor immediately prior to the consummation of the Dissolution Event.
(d) Liquidation Priority. In a Liquidity Event or Dissolution Event, this Safe is intended to operate like standard non-participating Preferred Stock. The Investor’s right to receive its Cash-Out Amount is:
(i) Junior to payment of outstanding indebtedness and creditor claims, including contractual claims for payment and convertible promissory notes (to the extent such convertible promissory notes are not actually or notionally converted into Capital Stock);
(ii) On par with payments for other Safes and/or Preferred Stock, and if the applicable Proceeds are insufficient to permit full payments to the Investor and such other Safes and/or Preferred Stock, the applicable Proceeds will be distributed pro rata to the Investor and such other Safes and/or Preferred Stock in proportion to the full payments that would otherwise be due; and
(iii) Senior to payments for Common Stock.
The Investor’s right to receive its Conversion Amount is (A) on par with payments for Common Stock and other Safes and/or Preferred Stock who are also receiving Conversion Amounts or Proceeds on a similar as-converted to Common Stock basis, and (B) junior to payments described in clauses (i) and (ii) above (in the latter case, to the extent such payments are Cash-Out Amounts or similar liquidation preferences).
(e) Termination. This Safe will automatically terminate (without relieving the Company of any obligations arising from a prior breach of or non-compliance with this Safe) immediately following the earliest to occur of: (i) the issuance of Capital Stock to the Investor pursuant to the automatic conversion of this Safe under Section 1(a); or (ii) the payment, or setting aside for payment, of amounts due the Investor pursuant to Section 1(b) or Section 1(c).
2. Definitions
“Capital Stock” means the capital stock of the Company, including, without limitation, the “Common Stock” and the “Preferred Stock.”
“Change of Control” means (i) a transaction or series of related transactions in which any “person” or “group” (within the meaning of Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of more than 50% of the outstanding voting securities of the Company having the right to vote for the election of members of the Company’s board of directors, (ii) any reorganization, merger or consolidation of the Company, other than a transaction or series of related transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after such transaction or series of related transactions, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity or (iii) a sale, lease or other disposition of all or substantially all of the assets of the Company.
“Company Capitalization” is calculated as of immediately prior to the Equity Financing and (without double-counting):
| ● | Includes all shares of Capital Stock issued and outstanding; |
| ● | Includes all Converting Securities; |
| ● | Includes all (i) issued and outstanding Options and (ii) Promised Options; |
| ● | Includes the Unissued Option Pool; and |
-2-
POST-MONEY VALUATION CAP WITH DISCOUNT
“Conversion Price” means either: (1) the Safe Price or (2) the Discount Price, whichever calculation results in a greater number of shares of Safe Preferred Stock.
“Converting Securities” includes this Safe and other convertible securities issued by the Company, including but not limited to: (i) other Safes; (ii) convertible promissory notes and other convertible debt instruments; and (iii) convertible securities that have the right to convert into shares of Capital Stock.
“Discount Price” means the price per share of the Standard Preferred Stock sold in the Equity Financing multiplied by the Discount Rate.
“Dissolution Event” means (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company’s creditors or (iii) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event), whether voluntary or involuntary.
“Dividend Amount” means, with respect to any date on which the Company pays a dividend on its outstanding Common Stock, the amount of such dividend that is paid per share of Common Stock multiplied by (x) the Purchase Amount divided by (y) the Liquidity Price (treating the dividend date as a Liquidity Event solely for purposes of calculating such Liquidity Price).
“Equity Financing” means a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company issues and sells Preferred Stock at a fixed valuation, including but not limited to, a pre-money or post-money valuation.
“Initial Public Offering” means the closing of the Company’s first firm commitment underwritten initial public offering of Common Stock pursuant to a registration statement filed under the Securities Act.
“Liquidity Capitalization” is calculated as of immediately prior to the Liquidity Event, and (without double- counting):
| ● | Includes all shares of Capital Stock issued and outstanding; |
| ● | Includes all (i) issued and outstanding Options and (ii) to the extent receiving Proceeds, Promised Options; |
| ● | Includes all Converting Securities, other than any Safes and other convertible securities (including without limitation shares of Preferred Stock) where the holders of such securities are receiving Cash-Out Amounts or similar liquidation preference payments in lieu of Conversion Amounts or similar “as-converted” payments; and |
| ● | Excludes the Unissued Option Pool. |
“Liquidity Event” means a Change of Control or an Initial Public Offering.
“Liquidity Price” means the price per share equal to the Post-Money Valuation Cap divided by the Liquidity Capitalization.
“Options” includes options, restricted stock awards or purchases, RSUs, SARs, warrants or similar securities, vested or unvested.
“Proceeds” means cash and other assets (including without limitation stock consideration) that are proceeds from the Liquidity Event or the Dissolution Event, as applicable, and legally available for distribution.
“Promised Options” means promised but ungranted
-3-
POST-MONEY VALUATION CAP WITH DISCOUNT
“Safe” means an instrument containing a future right to shares of Capital Stock, similar in form and content to this instrument, purchased by investors for the purpose of funding the Company’s business operations. References to “this Safe” mean this specific instrument.
“Safe Preferred Stock” means the shares of the series of Preferred Stock issued to the Investor in an Equity Financing, having the identical rights, privileges, preferences and restrictions as the shares of Standard Preferred Stock, other than with respect to: (i) the per share liquidation preference and the initial conversion price for purposes of price-based anti-dilution protection, which will equal the Conversion Price; and (ii) the basis for any dividend rights, which will be based on the Conversion Price.
“Safe Price” means the price per share equal to the Post-Money Valuation Cap divided by the Company Capitalization.
“Standard Preferred Stock” means the shares of the series of Preferred Stock issued to the investors investing new money in the Company in connection with the initial closing of the Equity Financing.
“Unissued Option Pool” means all shares of Capital Stock that are reserved, available for future grant and not subject to any outstanding Options or Promised Options (but in the case of a Liquidity Event, only to the extent Proceeds are payable on such Promised Options) under any equity incentive or similar Company plan.
3. Company Representations
(a) The Company is a corporation duly organized, validly existing and in good standing under the laws of its state of incorporation, and has the power and authority to own, lease and operate its properties and carry on its business as now conducted.
(b) The execution, delivery and performance by the Company of this Safe is within the power of the Company and has been duly authorized by all necessary actions on the part of the Company (subject to section 3(d)). This Safe constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity. To its knowledge, the Company is not in violation of (i) its current certificate of incorporation or bylaws, (ii) any material statute, rule or regulation applicable to the Company or (iii) any material debt or contract to which the Company is a party or by which it is bound, where, in each case, such violation or default, individually, or together with all such violations or defaults, could reasonably be expected to have a material adverse effect on the Company.
(c) The performance and consummation of the transactions contemplated by this Safe do not and will not: (i) violate any material judgment, statute, rule or regulation applicable to the Company; (ii) result in the acceleration of any material debt or contract to which the Company is a party or by which it is bound; or (iii) result in the creation or imposition of any lien on any property, asset or revenue of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license or authorization applicable to the Company, its business or operations.
(d) No consents or approvals are required in connection with the performance of this Safe, other than: (i) the Company’s corporate approvals; (ii) any qualifications or filings under applicable securities laws; and (iii) necessary corporate approvals for the authorization of Capital Stock issuable pursuant to Section 1.
(e) To its knowledge, the Company owns or possesses (or can obtain on commercially reasonable terms) sufficient legal rights to all patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, processes and other intellectual property rights necessary for its business as now conducted and as currently proposed to be conducted, without any conflict with, or infringement of the rights of, others.
-4-
POST-MONEY VALUATION CAP WITH DISCOUNT
4. Investor Representations
(a) The Investor has full legal capacity, power and authority to execute and deliver this Safe and to perform its obligations hereunder. This Safe constitutes valid and binding obligation of the Investor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.
(b) The Investor is an accredited investor as such term is defined in Rule 501 of Regulation D under the Securities Act, and acknowledges and agrees that if not an accredited investor at the time of an Equity Financing, the Company may void this Safe and return the Purchase Amount. The Investor has been advised that this Safe and the underlying securities have not been registered under the Securities Act, or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an exemption from such registration requirements is available. The Investor is purchasing this Safe and the securities to be acquired by the Investor hereunder for its own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and the Investor has no present intention of selling, granting any participation in, or otherwise distributing the same. The Investor has such knowledge and experience in financial and business matters that the Investor is capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment without impairing the Investor’s financial condition and is able to bear the economic risk of such investment for an indefinite period of time.
5. Miscellaneous
(a) Any provision of this Safe may be amended, waived or modified by written consent of the Company and either (i) the Investor or (ii) the majority-in-interest of all then-outstanding Safes with the same “Post-Money Valuation Cap” and “Discount Rate” as this Safe (and Safes lacking one or both of such terms will be considered to be the same with respect to such term(s)), provided that with respect to clause (ii): (A) the Purchase Amount may not be amended, waived or modified in this manner, (B) the consent of the Investor and each holder of such Safes must be solicited (even if not obtained), and (C) such amendment, waiver or modification treats all such holders in the same manner. “Majority-in-interest” refers to the holders of the applicable group of Safes whose Safes have a total Purchase Amount greater than 50% of the total Purchase Amount of all of such applicable group of Safes.
(b) Any notice required or permitted by this Safe will be deemed sufficient when delivered personally or by overnight courier or sent by email to the relevant address listed on the signature page, or 48 hours after being deposited in the U.S. mail as certified or registered mail with postage prepaid, addressed to the party to be notified at such party’s address listed on the signature page, as subsequently modified by written notice.
(c) The Investor is not entitled, as a holder of this Safe, to vote or be deemed a holder of Capital Stock for any purpose other than tax purposes, nor will anything in this Safe be construed to confer on the Investor, as such, any rights of a Company stockholder or rights to vote for the election of directors or on any matter submitted to Company stockholders, or to give or withhold consent to any corporate action or to receive notice of meetings, until shares have been issued on the terms described in Section 1. However, if the Company pays a dividend on outstanding shares of Common Stock (that is not payable in shares of Common Stock) while this Safe is outstanding, the Company will pay the Dividend Amount to the Investor at the same time.
(d) Neither this Safe nor the rights in this Safe are transferable or assignable, by operation of law or otherwise, by either party without the prior written consent of the other; provided, however, that this Safe and/or its rights may be assigned without the Company’s consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor; and provided, further, that the Company may assign this Safe in whole, without the consent of the Investor, in connection with a reincorporation to change the Company’s domicile.
(e) In the event any one or more of the provisions of this Safe is for any reason held to be invalid, illegal or unenforceable, in whole or in part or in any respect, or in the event that any one or more of the provisions of this Safe operate or would prospectively operate to invalidate this Safe, then and in any such event, such provision(s) only will be deemed null and void and will not affect any other provision of this Safe and the remaining provisions of this Safe will remain operative and in full force and effect and will not be affected, prejudiced, or disturbed thereby.
-5-
POST-MONEY VALUATION CAP WITH DISCOUNT
(f) All rights and obligations hereunder will be governed by the laws of the State of Delaware, without regard to the conflicts of law provisions of such jurisdiction.
(g) The parties acknowledge and agree that for United States federal and state income tax purposes this Safe is, and at all times has been, intended to be characterized as stock, and more particularly as common stock for purposes of Sections 304, 305, 306, 354, 368, 1036 and 1202 of the Internal Revenue Code of 1986, as amended. Accordingly, the parties agree to treat this Safe consistent with the foregoing intent for all United States federal and state income tax purposes (including, without limitation, on their respective tax returns or other informational statements).
(h) The Company will use commercially reasonable efforts to implement best practices for corporations of similar size and in a similar industry, with respect to the Company’s governance, noting that, prior to the Equity Financing, the Company may only have one director on its Board of Directors.
(Signature page follows)
-6-
IN WITNESS WHEREOF, the undersigned have caused this Safe to be duly executed and delivered.
| CRECI INC. | ||
| By: | ||
| Andres Idarraga | ||
| Chief Executive Officer | ||
| Address: | ||
| Email: | andres.idarraga@creci.co | |
| INVESTOR: | ||
| By: | ||
| Name: | ||
| Address: | ||
| Email: | ||
Exhibit 3.2
THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES IN THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
CONVERTIBLE PROMISSORY NOTE
| Note Series: | Pre-Seed | |
| Date of Note: | ||
| Principal Amount of Note: | $ |
For value received Creci, Inc., a Delaware corporation (the “Company”), promises to pay to the undersigned holder or such party’s assigns (the “Holder”) the principal amount set forth above with simple interest on the outstanding principal amount at the rate of 5% per annum. Interest shall commence with the date hereof and shall continue on the outstanding principal amount until paid in full or converted. Interest shall be computed on the basis of a year of 365 days for the actual number of days elapsed. All unpaid interest and principal shall be due and payable upon request of the Majority Holders on or after ___________________ (the “Maturity Date”).
1. Basic Terms.
(a) Series of Notes. This convertible promissory note (the “Note”) is issued as part of a series of notes designated by the Note Series above (collectively, the “Notes”) and issued in a series of multiple closings to certain persons and entities (collectively, the “Holders”). The Company shall maintain a ledger of all Holders.
(b) Payments. All payments of interest and principal shall be in lawful money of the United States of America and shall be made pro rata among all Holders. All payments shall be applied first to accrued interest, and thereafter to principal.
(c) Prepayment. The Company may not prepay this Note prior to the Maturity Date without the consent of the Holders of a majority of the outstanding principal amount of the Notes (the “Majority Holders”).
2. Conversion and Repayment.
(a) Conversion upon a Qualified Financing. In the event that the Company issues and sells shares of its equity securities ( “Equity Securities”) to investors (the “Investors”) while this Note remains outstanding in an equity financing with total proceeds to the Company of not less than $500,000 (excluding the conversion of the Notes or other convertible securities issued for capital raising purposes (e.g., Simple Agreements for Future Equity)) (a “Qualified Financing”), then the outstanding principal amount of this Note and any unpaid accrued interest shall automatically convert in whole without any further action by the Holder into Equity Securities sold in the Qualified Financing at a conversion price equal to the lesser of (i) the cash price paid per share for Equity Securities by the Investors in the Qualified Financing multiplied by 0.80, and (ii) the quotient resulting from dividing $2,000,000 by the number of outstanding shares of the Capital Stock of the Company immediately prior to the Qualified Financing (assuming conversion of all securities convertible into Preferred or Common Stock and exercise of all outstanding options and warrants, including all shares of Preferred or Common Stock reserved and available for future grant under any equity incentive or similar plan of the Company, and/or any equity incentive or similar plan to be created or increased in connection with the Qualified Financing, but excluding the shares of equity securities of the Company issuable upon the conversion of Notes or other convertible securities issued for capital raising purposes (e.g., Simple Agreements for Future Equity)). The issuance of Equity Securities pursuant to the conversion of this Note shall be upon and subject to the same terms and conditions applicable to Equity Securities sold in the Qualified Financing. Notwithstanding this paragraph, if the conversion price of the Notes as determined pursuant to this paragraph (the “Conversion Price”) is less than the price per share at which Equity Securities are issued in the Qualified Financing, the Company may, solely at its option, elect to convert this Note into shares of Preferred Stock having the identical rights, privileges, preferences and restrictions as the Equity Securities issued in the Qualified Financing, and otherwise on the same terms and conditions, other than with respect to (if applicable): (i) the per share liquidation preference and the conversion price for purposes of price-based anti-dilution protection, which will equal the Conversion Price; and (ii) the per share dividend, which will be the same percentage of the Conversion Price as applied to determine the per share dividends of the Investors in the Qualified Financing relative to the purchase price paid by the Investors.
(b) Optional Conversion at non-Qualified Financing. In the event the Company consummates, while this Note remains outstanding, an equity financing pursuant to which it sells shares of Preferred Stock in a transaction that does not constitute a Qualified Financing, then the Majority Holders shall have the option to treat such equity financing as a Qualified Financing on the same terms set forth herein.
(c) Change of Control. If the Company consummates a Change of Control (as defined below) while this Note remains outstanding, the Holder of this Note shall have the option to (i) convert this Note into Preferred Stock under the same conversion terms applicable pursuant to a Qualified Financing (so that note holders can share in any sale proceeds as Preferred Stockholders) or (ii) immediately make all principal and unpaid accrued interest due and payable. For purposes of this Note, a “Change of Control” means (i) a consolidation or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization, other than any such consolidation, merger or reorganization in which the shares of capital stock of the Company immediately prior to such consolidation, merger or reorganization continue to represent a majority of the voting power of the surviving entity immediately after such consolidation, merger or reorganization; (ii) any transaction or series of related transactions to which the Company is a party in which in excess of 50% of the Company’s voting power is transferred; or (iii) the sale or transfer of all or substantially all of the Company’s assets, or the exclusive license of all or substantially all of the Company’s material intellectual property; provided that a Change of Control shall not include any transaction or series of transactions principally for bona fide equity financing purposes in which cash is received by the Company or any successor, indebtedness of the Company is cancelled or converted or a combination thereof. The Company shall give the Holder notice of a Change of Control not less than 10 days prior to the anticipated date of consummation of the Change of Control. Any repayment pursuant to this paragraph in connection with a Change of Control shall be subject to any required tax withholdings, and may be made by the Company (or any party to such Change of Control or its agent) following the Change of Control in connection with payment procedures established in connection with such Change of Control.
2
(d) Procedure for Conversion. In connection with any conversion of this Note into capital stock, the Holder shall surrender this Note to the Company and deliver to the Company any documentation reasonably required by the Company (including, in the case of a Qualified Financing, all financing documents executed by the Investors in connection with such Qualified Financing). The Company shall not be required to issue or deliver the capital stock into which this Note may convert until the Holder has surrendered this Note to the Company and delivered to the Company any such documentation. Upon the conversion of this Note into capital stock pursuant to the terms hereof, in lieu of any fractional shares to which the Holder would otherwise be entitled, the Company shall pay the Holder cash equal to such fraction multiplied by the price at which this Note converts.
(e) Interest Accrual. If a Change of Control or Qualified Financing is consummated, all interest on this Note shall be deemed to have stopped accruing as of a date selected by the Company that is up to 10 days prior to the signing of the definitive agreement for the Change of Control or Qualified Financing.
3. Representations and Warranties.
(a) Representations and Warranties of the Company. The Company hereby represents and warrants to the Holder as of the date the first Note was issued as follows:
(i) Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. The Company has the requisite corporate power to own and operate its properties and assets and to carry on its business as now conducted and as proposed to be conducted. The Company is duly qualified and is authorized to do business and is in good standing as a foreign corporation in all jurisdictions in which the nature of its activities and of its properties (both owned and leased) makes such qualification necessary, except for those jurisdictions in which failure to do so would not have a material adverse effect on the Company or its business (a “Material Adverse Effect”).
(ii) Corporate Power. The Company has all requisite corporate power to issue this Note and to carry out and perform its obligations under this Note. The Company’s Board of Directors (the “Board”) has approved the issuance of this Note based upon a reasonable belief that the issuance of this Note is appropriate for the Company after reasonable inquiry concerning the Company’s financing objectives and financial situation.
(iii) Authorization. All corporate action on the part of the Company, the Board and the Company’s stockholders necessary for the issuance and delivery of this Note has been taken. This Note constitutes a valid and binding obligation of the Company enforceable in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency, the relief of debtors and, with respect to rights to indemnity, subject to federal and state securities laws. Any securities issued upon conversion of this Note (the “Conversion Securities”), when issued in compliance with the provisions of this Note, will be validly issued, fully paid, nonassessable, free of any liens or encumbrances and issued in compliance with all applicable federal and securities laws.
(iv) Governmental Consents. All consents, approvals, orders or authorizations of, or registrations, qualifications, designations, declarations or filings with, any governmental authority required on the part of the Company in connection with issuance of this Note has been obtained.
(v) Compliance with Laws. To its knowledge, the Company is not in violation of any applicable statute, rule, regulation, order or restriction of any domestic or foreign government or any instrumentality or agency thereof in respect of the conduct of its business or the ownership of its properties, which violation of which would have a Material Adverse Effect.
3
(vi) Compliance with Other Instruments. The Company is not in violation or default of any term of its certificate of incorporation or bylaws, or of any provision of any mortgage, indenture or contract to which it is a party and by which it is bound or of any judgment, decree, order or writ, other than such violation(s) that would not have a Material Adverse Effect. The execution, delivery and performance of this Note will not result in any such violation or be in conflict with, or constitute, with or without the passage of time and giving of notice, either a default under any such provision, instrument, judgment, decree, order or writ or an event that results in the creation of any lien, charge or encumbrance upon any assets of the Company or the suspension, revocation, impairment, forfeiture, or nonrenewal of any material permit, license, authorization or approval applicable to the Company, its business or operations or any of its assets or properties. Without limiting the foregoing, the Company has obtained all waivers reasonably necessary with respect to any preemptive rights, rights of first refusal or similar rights, including any notice or offering periods provided for as part of any such rights, in order for the Company to consummate the transactions contemplated hereunder without any third party obtaining any rights to cause the Company to offer or issue any securities of the Company as a result of the consummation of the transactions contemplated hereunder.
(vii) No “Bad Actor” Disqualification. The Company has exercised reasonable care to determine whether any Company Covered Person (as defined below) is subject to any of the “bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii), as modified by Rules 506(d)(2) and (d)(3), under the Act (“Disqualification Events”). To the Company’s knowledge, no Company Covered Person is subject to a Disqualification Event. The Company has complied, to the extent required, with any disclosure obligations under Rule 506(e) under the Act. For purposes of this Note, “Company Covered Persons” are those persons specified in Rule 506(d)(1) under the Act; provided, however, that Company Covered Persons do not include (a) any Holder, or (b) any person or entity that is deemed to be an affiliated issuer of the Company solely as a result of the relationship between the Company and any Holder.
(viii) Offering. Assuming the accuracy of the representations and warranties of the Holder contained in subsection (b) below, the offer, issue, and sale of this Note and the Conversion Securities (collectively, the “Securities”) are and will be exempt from the registration and prospectus delivery requirements of the Act, and have been registered or qualified (or are exempt from registration and qualification) under the registration, permit or qualification requirements of all applicable state securities laws.
(ix) Use of Proceeds. The Company shall use the proceeds of this Note solely for the operations of its business, and not for any personal, family or household purpose.
(b) Representations and Warranties of the Holder. The Holder hereby represents and warrants to the Company as of the date hereof as follows:
(i) Purchase for Own Account. The Holder is acquiring the Securities solely for the Holder’s own account and beneficial interest for investment and not for sale or with a view to distribution of the Securities or any part thereof, has no present intention of selling (in connection with a distribution or otherwise), granting any participation in, or otherwise distributing the same, and does not presently have reason to anticipate a change in such intention.
(ii) Information and Sophistication. Without lessening or obviating the representations and warranties of the Company set forth in subsection (a) above, the Holder hereby: (A) acknowledges that the Holder has received all the information the Holder has requested from the Company and the Holder considers necessary or appropriate for deciding whether to acquire the Securities, (B) represents that the Holder has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of the Securities and to obtain any additional information necessary to verify the accuracy of the information given the Holder and (C) further represents that the Holder has such knowledge and experience in financial and business matters that the Holder is capable of evaluating the merits and risk of this investment.
4
(iii) Ability to Bear Economic Risk. The Holder acknowledges that investment in the Securities involves a high degree of risk, and represents that the Holder is able, without materially impairing the Holder’s financial condition, to hold the Securities for an indefinite period of time and to suffer a complete loss of the Holder’s investment.
(iv) Further Limitations on Disposition. Without in any way limiting the representations set forth above, the Holder further agrees not to make any disposition of all or any portion of the Securities unless and until:
(1) There is then in effect a registration statement under the Act covering such proposed disposition and such disposition is made in accordance with such registration statement; or
(2) The Holder shall have notified the Company of the proposed disposition and furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration under the Act or any applicable state securities laws; provided that no such opinion shall be required for dispositions in compliance with Rule 144 under the Act, except in unusual circumstances.
(3) Notwithstanding the provisions of paragraphs (1) and (2) above, no such registration statement or opinion of counsel shall be necessary for a transfer by the Holder to a partner (or retired partner) or member (or retired member) of the Holder in accordance with partnership or limited liability company interests, or transfers by gift, will or intestate succession to any spouse or lineal descendants or ancestors, if all transferees agree in writing to be subject to the terms hereof to the same extent as if they were the Holders hereunder.
(v) Accredited Investor Status. The Holder is an “accredited investor” as such term is defined in Rule 501 under the Act.
(vi) No “Bad Actor” Disqualification. The Holder represents and warrants that neither (A) the Holder nor (B) any entity that controls the Holder or is under the control of, or under common control with, the Holder, is subject to any Disqualification Event, except for Disqualification Events covered by Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Act and disclosed in writing in reasonable detail to the Company. The Holder represents that the Holder has exercised reasonable care to determine the accuracy of the representation made by the Holder in this paragraph, and agrees to notify the Company if the Holder becomes aware of any fact that makes the representation given by the Holder hereunder inaccurate.
(vii) Foreign Investors. If the Holder is not a United States person (as defined by Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended (the “Code”)), the Holder hereby represents that he, she or it has satisfied itself as to the full observance of the laws of the Holder’s jurisdiction in connection with any invitation to subscribe for the Securities or any use of this Note, including (A) the legal requirements within the Holder’s jurisdiction for the purchase of the Securities, (B) any foreign exchange restrictions applicable to such purchase, (C) any governmental or other consents that may need to be obtained, and (D) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale or transfer of the Securities. The Holder’s subscription, payment for and continued beneficial ownership of the Securities will not violate any applicable securities or other laws of the Holder’s jurisdiction.
5
(viii) Forward-Looking Statements. With respect to any forecasts, projections of results and other forward-looking statements and information provided to the Holder, the Holder acknowledges that such statements were prepared based upon assumptions deemed reasonable by the Company at the time of preparation. There is no assurance that such statements will prove accurate, and the Company has no obligation to update such statements.
4. Events of Default.
(a) If there shall be any Event of Default (as defined below) hereunder, at the option and upon the declaration of the Majority Holders and upon written notice to the Company (which election and notice shall not be required in the case of an Event of Default under subsection (ii) or (iii) below), this Note shall accelerate and all principal and unpaid accrued interest shall become due and payable. The occurrence of any one or more of the following shall constitute an “Event of Default”:
(i) The Company fails to pay timely any of the principal amount due under this Note on the date the same becomes due and payable or any unpaid accrued interest or other amounts due under this Note on the date the same becomes due and payable;
(ii) The Company files any petition or action for relief under any bankruptcy, reorganization, insolvency or moratorium law or any other law for the relief of, or relating to, debtors, now or hereafter in effect, or makes any assignment for the benefit of creditors or takes any corporate action in furtherance of any of the foregoing; or
(iii) An involuntary petition is filed against the Company (unless such petition is dismissed or discharged within 60 days under any bankruptcy statute now or hereafter in effect, or a custodian, receiver, trustee or assignee for the benefit of creditors (or other similar official) is appointed to take possession, custody or control of any property of the Company).
(b) In the event of any Event of Default hereunder, the Company shall pay all reasonable attorneys’ fees and court costs incurred by the Holder in enforcing and collecting this Note.
5. Miscellaneous Provisions.
(a) Waivers. The Company hereby waives demand, notice, presentment, protest and notice of dishonor.
(b) Further Assurances. The Holder agrees and covenants that at any time and from time to time the Holder will promptly execute and deliver to the Company such further instruments and documents and take such further action as the Company may reasonably require in order to carry out the full intent and purpose of this Note and to comply with state or federal securities laws or other regulatory approvals.
6
(c) Transfers of Notes. This Note may be transferred only upon its surrender to the Company for registration of transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer in form satisfactory to the Company. Thereupon, this Note shall be reissued to, and registered in the name of, the transferee, or a new Note for like principal amount and interest shall be issued to, and registered in the name of, the transferee. Interest and principal shall be paid solely to the registered holder of this Note. Such payment shall constitute full discharge of the Company’s obligation to pay such interest and principal.
(d) Market Standoff. To the extent requested by the Company or an underwriter of securities of the Company, the Holder and any permitted transferee thereof shall not, without the prior written consent of the managing underwriters in the IPO (as hereafter defined), offer, sell, make any short sale of, grant or sell any option for the purchase of, lend, pledge, otherwise transfer or dispose of (directly or indirectly), enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership (whether any such transaction is described above or is to be settled by delivery of Securities or other securities, in cash, or otherwise), any Securities or other shares of stock of the Company then owned by the Holder or any transferee thereof, or enter into an agreement to do any of the foregoing, for up to 180 days following the effective date of the registration statement of the initial public offering of the Company (the “IPO”) filed under the Securities Act. For purposes of this paragraph, “Company” includes any wholly owned subsidiary of the Company into which the Company merges or consolidates. The Company may place restrictive legends on the certificates representing the shares subject to this paragraph and may impose stop transfer instructions with respect to the Securities and such other shares of stock of the Holder and any transferee thereof (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period. The Holder and any transferee thereof shall enter into any agreement reasonably required by the underwriters to the IPO to implement the foregoing within any reasonable timeframe so requested. The underwriters for any IPO are intended third party beneficiaries of this paragraph and shall have the right, power and authority to enforce the provisions of this paragraph as though they were parties hereto.
(e) Amendment and Waiver. Any term of this Note may be amended or waived with the written consent of the Company and the Holder. In addition, any term of this Note may be amended or waived with the written consent of the Company and the Majority Holders. Upon the effectuation of such waiver or amendment with the consent of the Majority Holders in conformance with this paragraph, such amendment or waiver shall be effective as to, and binding against the holders of, all of the Notes and the Company shall promptly give written notice thereof to the Holder if the Holder has not previously consented to such amendment or waiver in writing; provided that the failure to give such notice shall not affect the validity of such amendment or waiver.
(f) Governing Law; Jurisdiction and Venue. This Note shall be governed by and construed under the laws of the State of Delaware, as applied to agreements among Delaware residents, made and to be performed entirely within the State of Delaware, without giving effect to conflicts of laws principles. Any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this First Amendment will be brought exclusively in the Delaware Chancery Court, or, if the Delaware Chancery Court does not have subject matter jurisdiction, in the federal courts located in the State of Delaware. Each of the parties hereby consents to personal jurisdiction in any such action, suit or proceeding brought in any such court (and of the appropriate appellate courts therefrom) and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court.
7
(g) Binding Agreement. The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Note, expressed or implied, is intended to confer upon any third party any rights, remedies, obligations or liabilities under or by reason of this Note, except as expressly provided in this Note.
(h) Counterparts; Manner of Delivery. This Note may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
(i) Titles and Subtitles. The titles and subtitles used in this Note are used for convenience only and are not to be considered in construing or interpreting this Note.
(j) Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (iii) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications to a party shall be sent to the party’s address set forth on the signature page hereto or at such other address(es) as such party may designate by 10 days’ advance written notice to the other party hereto.
(k) Expenses. The Company and the Holder shall each bear its respective expenses and legal fees incurred with respect to the negotiation, execution and delivery of this Note and the transactions contemplated herein.
(l) Delays or Omissions. It is agreed that no delay or omission to exercise any right, power or remedy accruing to the Holder, upon any breach or default of the Company under this Note shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach or default, or any acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character by the Holder of any breach or default under this Note, or any waiver by the Holder of any provisions or conditions of this Note, must be in writing and shall be effective only to the extent specifically set forth in writing and that all remedies, either under this Note, or by law or otherwise afforded to the Holder, shall be cumulative and not alternative. This Note shall be void and of no force or effect in the event that the Holder fails to remit the full principal amount to the Company within five calendar days of the date of this Note.
(m) Entire Agreement. This Note constitutes the full and entire understanding and agreement between the parties with regard to the subjects hereof, and no party shall be liable or bound to any other party in any manner by any representations, warranties, covenants and agreements except as specifically set forth herein.
(n) Exculpation among Holders. The Holder acknowledges that the Holder is not relying on any person, firm or corporation, other than the Company and its officers and Board members, in making its investment or decision to invest in the Company.
8
(o) Senior Indebtedness. The indebtedness evidenced by this Note is subordinated in right of payment to the prior payment in full of any Senior Indebtedness in existence on the date of this Note or hereafter incurred. “Senior Indebtedness” shall mean, unless expressly subordinated to or made on a parity with the amounts due under this Note, all amounts due in connection with (i) indebtedness of the Company to banks or other lending institutions regularly engaged in the business of lending money (excluding venture capital, investment banking or similar institutions and their affiliates, which sometimes engage in lending activities but which are primarily engaged in investments in equity securities), and (ii) any such indebtedness or any debentures, notes or other evidence of indebtedness issued in exchange for such Senior Indebtedness, or any indebtedness arising from the satisfaction of such Senior Indebtedness by a guarantor.
(p) Broker’s Fees. Each party hereto represents and warrants that no agent, broker, investment banker, person or firm acting on behalf of or under the authority of such party hereto is or will be entitled to any broker’s or finder’s fee or any other commission directly or indirectly in connection with the transactions contemplated herein. Each party hereto further agrees to indemnify each other party for any claims, losses or expenses incurred by such other party as a result of the representation in this subsection being untrue.
(q) Florida Corporate Securities Law. THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS NOTE HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF FLORIDA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION OR IN THE ABSENCE OF AN EXEMPTION FROM SUCH QUALIFICATION IS UNLAWFUL. PRIOR TO ACCEPTANCE OF SUCH CONSIDERATION BY THE COMPANY, THE RIGHTS OF ALL PARTIES TO THIS NOTE ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED OR AN EXEMPTION FROM SUCH QUALIFICATION BEING AVAILABLE.
[Signature pages follow]
9
The parties have executed this Convertible Promissory Note as of the date first noted above.
| COMPANY: | |||
| Creci, Inc. | |||
| By: | |||
| Name: | Andres Idarraga | ||
| Title: | Chief Executive Officer | ||
| E-mail: | andres.idarraga@creci.co | ||
| Address: |
2001 Hollywood Blvd., Suite 211 | ||
| Hollywood, Florida 33020 | |||
SIGNATURE PAGE TO
CRECI, INC.
CONVERTIBLE PROMISSORY NOTE
The parties have executed this Convertible Promissory Note as of the date first noted above.
| HOLDER (if an entity): | |||
| Name of Holder: | |||
| Signature: | |||
| Name: | |||
| Title: | |||
| E-mail: | |||
| Address: | |||
| HOLDER (if an individual): | ||
| Name of Holder: | ||
| Signature: | ||
| E-mail: | ||
| Address: | ||
SIGNATURE PAGE TO
CRECI, INC.
CONVERTIBLE PROMISSORY NOTE
Exhibit 3.3
RESTRICTED STOCK UNIT AGREEMENT
THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), is made as of ________ ___, 2021 (the “Grant Date”) by and between Creci Inc., a Delaware corporation (the “Company”), and _________________ (the “Recipient”).
STATEMENT OF PURPOSE
Effective as of the date hereof, and in connection with certain services provided or to be provided by the Recipient to the Company, the Company is making an award to Recipient of a number of “Restricted Stock Units” in accordance with, and subject to, the terms and conditions of this Agreement.
NOW, THEREFORE, in consideration of the Statement of Purpose set forth above and of the mutual covenants and agreements herein set forth and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Recipient do hereby agree as follows:
1. Definitions. As used in this Agreement, unless the context expressly indicates otherwise, the following terms have the following meanings:
“Board” shall mean the Board of Directors of the Company.
“Change in Control” shall mean a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the assets of the Company, all within the meaning of Section 409A and the rules and regulations promulgated thereunder.
“Code” means the Internal Revenue Code of 1986, as amended.
“Common Stock” means the Common Stock of the Company or any security of the Company issued in substitution, exchange or lieu thereof pursuant to Section 5 hereof.
“Fair Market Value” with respect to a share of the Common Stock at a particular time, shall be that value as reasonably determined by the Board, which shall be (i) if such Common Stock is listed on a national securities exchange or traded on the NASDAQ Stock Market, Inc., the mean between the highest price and the lowest price at which the Common Stock shall have been sold regular way on a national securities exchange or the NASDAQ Stock Market, Inc. on said date, or, if no sales occur on said date, then on the next preceding date on which there were such sales of Common Stock, (ii) if the Common Stock shall not be listed on a national securities exchange or traded on the NASDAQ Stock Market, Inc., the mean between the bid and asked prices last reported by the National Association of Securities Dealers, Inc. for the over-the-counter market on said date or, if no bid and asked prices are reported on said date, then on the next preceding date on which there were such quotations, or (iii) if at any time quotations for the Common Stock shall not be reported by the National Association of Securities Dealers, Inc. for the over-the-counter market and the Common Stock shall not be listed on any national securities exchange or traded on the NASDAQ Stock Market, Inc., the fair market value determined by the Board in such manner as it reasonably determines.
“Restricted Stock Unit” means a right to receive one share of Common Stock (subject to adjustment as described herein), at such time, and in accordance with such terms and conditions, as set forth in this Agreement. Restricted Stock Units include Dividend Units.
“Section 409A” means Section 409A of the Code.
“Termination” means the termination of the Recipient’s service relationship with the Company, whether by the Company or by the Recipient.
“Vesting Commencement Date” means __________, 20__.
2. Award of Restricted Stock Units; Expiration. Effective as of the Grant Date, Recipient is awarded _____________ Restricted Stock Units. If a Change in Control has not occurred on or prior to the date that is ten (10) years after the Grant Date, this Agreement shall terminate and all the Restricted Stock Units granted hereby, whether then vested or unvested, shall expire in their entirety on such date (the “Expiration”).
3. Dividend Equivalents; No Voting Rights.
(a) Dividend Equivalents. If a cash dividend is paid with respect to the Common Stock, Recipient shall be credited as of the applicable dividend payment date with an additional number of whole and fractional Restricted Stock Units (the “Dividend Units”) equal to (A) the total cash dividend Recipient would have received had the Restricted Stock Units (and any previously credited Dividend Units with respect thereto) been actual shares of Common Stock divided by (B) the Fair Market Value of a share of Common Stock as of the applicable dividend payment date. All Dividend Units shall be become part of the aggregate Restricted Stock Units award hereunder when credited to Recipient, and therefore shall be subject to all of the terms and conditions of this Agreement, including without limitation the vesting and payment provisions set forth in Sections 4 and 5 below.
(b) No Voting Rights. Recipient shall have no voting rights with respect to the Restricted Stock Units.
4. Vesting. None of the Restricted Stock Units shall initially be vested, and they shall become vested on the following schedule: (i) 1.667% of the total number of Restricted Stock Units shall become vested on the 1st day of the first calendar month after the Vesting Commencement Date, provided that the Termination has not occurred prior to such date, and (ii) an additional 1.667% of the total number of Restricted Stock Units shall become vested on the 1st day of each of the fifty-nine (59) calendar months therafter, provided that the Termination has not occurred prior to such date. The foregoing provisions shall be interpreted such that 100% of the Restricted Stock Units shall _________ 1, 202__ if the Termination has not occurred prior to such date. Upon the occurance of the Termination for any reason, all Restricted Stock Units then unvested shall automatically be forfeited, and therafter no additional Restricted Stock Units shall become vested.
2
5. Payment of Restricted Stock Units.
(a) Time of Payment. If the Company consummates a Change in Control prior to the Expiration, then the Restricted Stock Units, to the extent vested, shall be payable immediately prior to the consummation of such Change in Control (provided that in no event shall payment occur more than 30 days prior to the consummation of such Change in Control). For the avoidance of doubt, no payment of any Restricted Stock Units shall be due unless a Change in Control occurs.
(b) Form of Payment. As of the applicable payment date, vested Restricted Stock Units shall be payable by delivery of one share of Common Stock for each such vested Restricted Stock Unit (subject to adjustment as described in Section 6).
(c) Compliance With Securities Laws. The shares of Common Stock shall be delivered to Recipient, pursuant to subparagraphs 5(a) and 5(b) above, unless counsel for the Company reasonably determines that such issuance will violate applicable federal or state securities laws and the Company has taken all reasonable steps necessary to avoid any such violation. The Company agrees to use commercially reasonable efforts to ensure that such shares are issued to Recipient on a timely basis as provided herein. The certificates for shares of Common Stock delivered under this Agreement may be subject to such stop-transfer orders and other restrictions as the Board may reasonably determine are required under the rules, regulations, and other requirements of the Securities and Exchange Commission, any stock exchange upon which the Common Stock is then listed, and any applicable federal or state securities law. The Board may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. It is intended that this Agreement shall constitute a written compensation contract within the meaning of Rule 701 of the Securities Act of 1933, as amended (“Rule 701”), and that the Restricted Stock Units and any securities issuable upon payment thereof shall be issued in compliance with the requirements of Rule 701.
6. Adjustments Upon Changes in Capitalization.
(a) No Limitation on Company Rights. The existence of the Agreement shall not affect or restrict in any way the right or power of the Board or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business, any merger or consolidation of the Company, any issue of bonds, other debentures, preferred or prior preference stocks, the dissolution or liquidation of the Company or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding.
(b) Adjustments. The Board shall make appropriate adjustments in the number and class of shares issuable upon payment of the Restricted Stock Units in the event of a stock dividend, stock split, reverse stock split, combination, reclassification or similar change in the capital structure of the Company.
3
7. Assignment of This Agreement or Benefits Hereunder.
(a) Successors. The Company will require any successor (whether via a Change in Control, direct or indirect, by purchase, merger, consolidation, or otherwise) of the Company to expressly assume and agree to perform the obligations under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.
(b) Assignment by Recipient. This Agreement shall inure to the benefit of and be enforceable by Recipient’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees, and legatees. If Recipient should die while any amount is still payable to Recipient hereunder had the Recipient continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to Recipient’s estate. Recipient’s rights hereunder shall not otherwise be assignable. In that regard, no part of any amounts granted or payable hereunder shall, prior to actual payment, (i) be subject to seizure, attachment, garnishment or sequestration for the payment of debts, judgments, alimony or separate maintenance owed by Recipient or any other person, (ii) be transferable by operation of law in the event of Recipient’s or any person’s bankruptcy or insolvency or (iii) be transferable to a spouse as a result of a property settlement or otherwise.
8. Contractual Rights to Benefits. This Agreement establishes in Recipient a right to the benefits to which Recipient is entitled hereunder. However, except as expressly stated herein, nothing herein contained shall require or be deemed to require, or prohibit or be deemed to prohibit, the Company to segregate, earmark or otherwise set aside any funds or other assets, in trust or otherwise, to provide for any payments to be made or required hereunder. This Agreement is intended to be an unfunded general asset promise for a select, highly compensated member of the Company’s management and, therefore, is intended to be exempt from the substantive provisions of the Employee Retirement Income Security Act of 1974, as amended.
9. Entire Agreement. This Agreement represents the entire agreement between the parties with respect to the subject matter hereof, and supersedes all prior discussions, negotiations, and agreements concerning the subject matter hereof. The Board may amend or modify this Agreement; provided, however, that no amendment or modification authorized hereby may materially adversely affect the rights of the Recipient, as determined in the discretion of the Board, without the consent of the Recipient.
4
10. Tax Matters.
(a) Recipient’s Responsibility for Taxes. Regardless of any action the Company takes with respect to any or all income tax, payroll tax or other tax-related withholding (“Tax-Related Items”), Recipient acknowledges that the ultimate liability for all Tax-Related Items owed by Recipient is and remains Recipient’s responsibility and that the Company (i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the grant of Restricted Stock Units, including the grant and vesting the Restricted Stock Units, the subsequent sale of shares of Common Stock acquired upon the vesting of the Restricted Stock Units and the receipt of any dividends; and (ii) does not commit to structure the terms of the grant or any aspect of the Restricted Stock Units to reduce or eliminate Recipient’s liability for Tax-Related Items.
(b) Tax Withholding. In the event the Company reasonably determines that it must withhold any Tax-Related Items as a result of the award hereunder, Recipient agrees as a condition of the grant of the Restricted Stock Units to make arrangements reasonably satisfactory to the Company to enable it to satisfy all withholding requirements, including, but not limited to, withholding any applicable Tax-Related Items from the payment of the Restricted Stock Units. If Recipient does not make such arrangements, Recipient authorizes the Company to fulfill its withholding obligations by all legal means, including, but not limited to: withholding Tax-Related Items from Recipient’s wages, salary or other cash compensation; withholding Tax-Related Items from the cash proceeds, if any, received upon sale of any shares received in payment for the Restricted Stock Units; and at the time of payment, withholding shares of Common Stock sufficient to meet minimum withholding obligations for Tax-Related Items. The Company may refuse to issue and deliver shares of Common Stock in payment of any vested Restricted Stock Units if Recipient fails to comply with his withholding obligations hereunder.
(c) Compliance With Section 409A. To the extent applicable, this Agreement is intended to comply with the requirements of Section 409A. Notwithstanding any provision of this Agreement to the contrary, this Agreement shall be interpreted, operated and administered consistent with this intent.
11. Severability. In the event any provision of this Agreement shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Agreement, and this Agreement shall be construed and enforced as if the illegal or invalid provision had not been included.
5
12. Applicable Law. To the extent not preempted by the laws of the United States, the laws of the State of Delaware shall be the controlling law in all matters relating to this Agreement. Each party (i) consents to the personal jurisdiction of any state or federal court located in Wilmington, Delaware (and any corresponding appellate court) in any proceeding arising out of or relating to this Agreement, (ii) waives any venue or inconvenient forum defense to any proceeding maintained in such courts and (iii) except as otherwise provided in this Agreement, agrees not to bring any proceeding arising out of or relating to this Agreement in any other court.
13. Execution. This Agreement is hereby executed in duplicate originals, one of which is being retained by each of the parties hereto.
IN WITNESS WHEREOF, Creci Inc. has caused this Agreement to be signed by its duly authorized officer, and Recipient has hereunto set his hand, all as of the day and year first above written.
| COMPANY: | ||
| Creci Inc. | ||
| By: | ||
| Andres Idarraga | ||
| Chief Executive Officer | ||
| RECIPIENT: | ||
| [_________] | ||
6
Exhibit 4.1
Exhibit A
CRECI NOTE
Principal: $ ________________________
Effective Date: _____________________
Borrower: Creci, Inc., a Delaware corporation (the “Borrower” or “Creci”)
Lender: ____________________________ (the “Lender”)
| 1. | Principal and Term. |
FOR VALUE RECEIVED, Creci hereby promises to pay to the Lender in U.S. dollars an amount equal to the principal sum shown above (the “Principal”) and the interest, as set forth and defined in Section 2 and subject to the conditions and limitations on payment described herein.
The term “Outstanding Principal Balance” means, as of any date of determination, the principal amount of this Note that remains unpaid.
| 2. | Calculation and Payment of Interest. |
(a) Interest shall accrue on this Note at the fixed interest rate of 5% per annum (the “Interest Rate”) from the date that the purchase funds have cleared (the “Accrual Date”). Interest shall be computed on the basis of a year consisting of 360 days, with interest credited monthly to Lender’s account.
(b) Any accrued and unpaid interest (together with any Outstanding Principal Balance, the “Amount Owed”) shall be compounded monthly.
| 3. | Payment of Outstanding Principal Balance and Accrued Interest. |
Unless prepaid pursuant to Section 4, accelerated pursuant to Section 5, or withdrawn previously pursuant to Section 6, the Amount Owed shall be due and payable within ten business days of a written demand from the Lender, to be made at any time thirty-six (36) months after the Accrual Date (the “Maturity Date”).
| 4. | Prepayment. |
The Borrower shall have the right, in its sole discretion, at any time from time to time, to prepay the Amount Owed, in whole in part, without the need to provide advance notice; provided, however, that the Borrower shall not make any prepayments under this Section 4 if it has received any Withdrawal Requests in a given fiscal quarter, unless it has made adequate provision for the satisfaction of all such Withdrawal Requests prior to making such prepayments. There shall be no premium or penalty for prepayment pursuant to this section. If the Lender has submitted a Withdrawal Request pursuant to Section 6 of this Note, any subsequent prepayment by Borrower (which, for the sake of clarity, shall be made subject to the restriction set forth above) shall be considered to be in full or partial (as applicable, based on the amount of prepayment) satisfaction of such Withdrawal Request.
1
| 5. | Acceleration of Note |
The Lender may declare this Note immediately due and payable upon the occurrence of any of the following events: the insolvency of the Borrower; the commission of any act of bankruptcy by the Borrower; the execution by the Borrower of a general assignment for the benefit of creditors; the filing by or against the Borrower of any petition in bankruptcy or any petition for relief under bankruptcy laws for the relief of debtors and the continuation of such petition without dismissal of a period of thirty (30) days or more; or the appointment of a receiver or trustee to take possession of any property or assets of the Borrower.
| 6. | Withdrawals by Lender |
No more than once in any given fiscal quarter, and provided that this Note has not been prepaid, the Lender may submit a request to Borrower to withdraw any amount less than or equal to the Amount Owed, up to the greater of: (i) five-hundred dollars ($500); or (ii) ten percent (10%) of the Amount Owed, in each case subject to the terms of this section (each, a “Withdrawal Request”).
(a) A Withdrawal Request for any given fiscal quarter must be submitted at least thirty (30) calendar days prior to the last day of the fiscal quarter, either via the Lender’s Creci Note account page available at www.crecinotes.com, by email to investor-services@crecinotes.com, or through such other means as Borrower may make available to Lender with written notice. Any Withdrawal Request submitted fewer than thirty (30) calendar days prior to the last day of the fiscal quarter shall be applied to the following quarter. The Withdrawal Request must clearly identify the Lender and the requested withdrawal amount.
(b) The Borrower shall, subject to subsection (d) of this Section 6, honor any Withdrawal Request timely submitted pursuant to Section 6(a) by transferring the requested amount to the bank account designated by the Lender no later than ten (10) business days after the end of the fiscal quarter.
(c) For the avoidance of doubt, it is agreed that fiscal quarters shall end on March 31, June 30, September 30, and December 31 of that respective year.
(d) Withdrawal Requests are subject to the funds received from small business loans made and other available cash to the Borrower. In the event that in any given fiscal quarter the Borrower determines that it does not have sufficient available cash to honor all requested withdrawals from Notes made pursuant to the Offering Circular of which this Note forms a part while maintaining sufficient operating capital, the Withdrawal Requests made in such fiscal quarter shall be subject to partial or complete reduction on a pro rata basis among all such requested withdrawals.
| 7. | Compliance With Securities Laws. |
The Lender represents and warrants to the Borrower that the Lender: (i) has sufficient knowledge an experience in financial or business matters that it is capable of evaluating the merits and risks of its investment in this Note; (ii) is able to protect its interests and fend for itself in the transaction contemplated by this Note; (iii) has the ability to bear the economic risks of its investment; and (iv) is acquiring this Note for the Lender’s own account for investment and not with a view to, or for sale in connection with, any distribution thereof, nor with any present intention of distributing or selling the same.
2
| 8. | Dispute Resolution. |
The Borrower and Lender agree to resolve any dispute related to or arising out of this Note according to the dispute resolution procedures set forth in Section 6 of the Creci Note Investor Agreement.
| 9. | Governing Law; Venue. |
This Note shall be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to principles of conflict of laws. In the event that the dispute resolution procedures in Section 8 are found not to apply to a given claim, any judicial proceeding will be brought in the state courts of New Castle County, Delaware. Both parties hereto consent to venue and personal jurisdiction in such location.
| 10. | Miscellaneous. |
(a) Both the Outstanding Principal Balance and interest are payable in lawful money of the United States of America. If any payment due hereunder falls on a Saturday, a Sunday or any other day on which commercial banks in New York City are authorized or required to close under applicable law, such payment shall be payable on the next succeeding business day, with interest accruing thereon until the date of payment thereof.
(b) No terms in this Note may be changed except by an amendment or separate agreement executed in writing by an authorized representative of the Borrower and the Lender. Failure by either Borrower or Lender to enforce its rights under this Note shall not be deemed to constitute a waiver of its rights to enforce the same or any other provision under this Note. No waiver shall be effective unless made in writing and signed by an authorized representative of the waiving parties hereto. If one or more provisions of this Note are held to be unenforceable under applicable law, such provision shall be excluded from this Note, and the balance of the Note shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.
3
IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed as of the date first above written.
| Creci, Inc. | ||
| Name: | ||
| Signature: | ||
| Title: |
4
Exhibit 4.2
CRECI NOTE INVESTOR AGREEMENT
The following terms constitute a binding agreement (“Agreement”) between you, as an Investor (“Investor,” “you”) and Creci, Inc., a Delaware corporation (“Creci,” “we,” or “us”). This Agreement will govern all purchases of Creci Notes (the “Creci Notes”) that you may, from time to time, make from Creci. Prior to completing your purchase of Creci Notes, by executing this Agreement, you acknowledge you have reviewed the Creci Terms of Use (“Terms of Use”), the Privacy Policy (“Privacy Policy”), and the Frequently Asked Questions (“FAQs”) on the Creci web site at www.crecinotes.com and any subdomain thereof (collectively, the “Creci Site”). By signing electronically below, you agree that you have read these documents and agree to the following terms (together with the Terms of Use), consent to our Privacy Policy, agree to transact business with us and receive communications relating to the Creci Notes electronically, and agree to have any dispute with us resolved by binding arbitration. All terms not otherwise defined herein shall have the same meaning as in the Creci Note.
In consideration of the covenants, agreements, representations, and warranties hereinafter set forth, and for other good and valuable consideration, receipt of which is hereby acknowledged, it is agreed as follows:
1. Purchase of Creci Notes. Subject to the terms and conditions of this Agreement, we will provide you with the opportunity to purchase Creci Notes with minimum denominations of $10 through the Creci Site. At the time you commit to purchase a Creci Note, you must have sufficient funds to complete the purchase, and you will not have access to those funds after you make a purchase commitment. Your commitment to purchase Creci Notes pursuant to the terms and conditions of this Agreement will be made by you through an acceptance of this Agreement on the Creci Site at www.crecinotes.com. Such acceptance is binding upon you.
2. Issuance. Each time you purchase a Creci Note, it will be issued immediately. Upon our receipt of your payment of the purchase price, your Creci Note will begin bearing interest on the average daily balance at the interest rate stated on the Creci Note. We will not issue Creci Notes in physical or paper form. The Creci Notes shall be issued electronically, and recorded and maintained on an internal register.
3. Terms of the Creci Notes. Each Creci Note shall have the terms and conditions described in the Creci Note issued by Creci, a copy of which is attached to this Agreement as Exhibit A and incorporated herein by such reference.
(a) The Creci Notes shall be issued by Creci. Creci Notes are unsecured, general obligations of Creci. You understand that you are NOT investing in, nor taking on direct financial risk of, any particular Creci borrower(s). The payments made by Creci on your Creci Notes will be made to you regardless of whether any particular Creci borrower(s) makes timely or consistent loan payments.
(b) Creci Notes may be purchased by both accredited investors (as that term is defined in the Securities Act of 1933, as amended (the “Securities Act”) and non-accredited investors. Generally, we place no limit on the amount of Creci Notes which may be purchased by an accredited investor. Pursuant to Rule 251(d)(2)(C) of the Securities Act, however, non-accredited investors who are natural persons may only invest the greater of 10% of their annual income or net worth and non-natural, non-accredited persons may invest up to 10% of the greater of their net assets or revenues for the most recently completed fiscal year.
(c) The Creci Notes have not been registered under the Securities Act, or under the securities act of any other jurisdiction, nor is any such registration contemplated. The Creci Notes will be offered and sold under the exemption provided by Section 3(b)(2) of the Securities Act and Regulation A promulgated thereunder pursuant to an offering statement on Form 1-A including the offering circular which forms a part thereof and the supplements and post-qualification amendments thereto (collectively, the “Offering Circular”) filed with the U.S. Securities and Exchange Commission (“SEC”) available at: www.sec.gov and other exemptions of similar import in the laws of the states and other jurisdictions where the offering will be made. You have received and have had the opportunity to review the Offering Circular provided to you.
(d) No entity or person has been authorized to give any information or to make any representation not contained in this agreement or the Offering Circular and, if given or made, such information or representation must not be relied upon as having been authorized by Creci.
4. Investor acknowledgements, representations, warranties, and covenants. Investor hereby acknowledges, represents, and warrants as follows:
(a) Investor has reviewed the risk disclosures and other terms in the Offering Circular, available on the SEC’s Edgar filings database at www.sec.gov. Investor has not relied on any information or representations with respect to Creci or the Creci Notes, other than as expressly set forth in the Offering Circular.
(b) Investor represents and warrant (i) at the time of the purchase of Creci Notes that Investor is an accredited investor (as that term is defined in the Securities Act), or if Investor is not an accredited investor, Investor will not invest more than the greater of 10% of Investor’s annual income or net worth (for natural persons) or revenue or net assets for most recently completed fiscal year end (if a non-natural person), (ii) that Investor satisfies any additional minimum financial suitability standards applicable to the state in which Investor resides, and (iii) that Investor covenants that Investor will abide by the investment limits set forth above or as may be set forth on the Creci Site. Investor agrees to provide any additional documentation reasonably requested by us, as may be required by the securities administrators or regulators of the federal government or of any state, to confirm that Investor meets such minimum financial suitability standards and have satisfied any maximum investment limits.
(c) Investor further represents and warrants, as of the date of this Agreement and as of any date that Investor commits to purchasing Creci Notes that: (i) Investor has the power to enter into and perform his, her, or its obligations under this Agreement; (ii) this Agreement has been duly authorized, executed and delivered by Investor and (iii) in connection with this Agreement, Investor have complied in all material respects with application federal, state and local laws.
2
(d) Investor acknowledges that an investment in the Creci Notes is speculative and involves a high degree of risk and no assurance or guarantee has or can be given that an investor in the Creci Notes will receive a return of his, her, or its capital or realize a profit on such investor’s investment. Investor should purchase these securities only if the Investor can afford a complete loss of his, her, or its investment.
(e) Investor has determined that he, she, or it can afford to bear the risk of the investment in the Creci Notes, including the loss of the entire investment, without experiencing personal hardship if such a loss occurs.
(f) Investor acknowledges that there is no public market for the Creci Notes, that no market may ever develop for them, and that they have not been approved or disapproved by the SEC or any governmental agency. Creci Notes may be subject to transfer restrictions, and Investor should be prepared to hold the Creci Notes the Investor purchases until the Creci Notes are repurchased by us at the Investor’s demand or upon our redemption of the Creci Notes.
(g) Investor understands that the Creci Notes are unsecured general obligations of Creci only and not of any Creci borrower. The Creci Notes do not represent an ownership interest in any specific Creci loans, their proceeds, or their assets. Investor has no right, and shall not, make any attempt, directly or through any third-party, to collect from borrowers. All agreements and obligations relating to an investor’s Creci Notes are between the Investor and Creci and not with Creci’s third-party borrowers.
(h) Investor is purchasing the Creci Notes solely for his, her, or its own account for investment, not for the account of any other person or entity, and not with a view to, of for, any resale, distribution, or other transfer thereof.
(i) Investor acknowledges and agrees that the purchase and sale of the Creci Notes pursuant to this agreement is an arms-length transaction between Investor and Creci. Creci is not an investment adviser or broker dealer. In connection with the purchase and sale of the Creci Notes, Creci is not acting as the Investor’s agent or fiduciary. Creci assumes no advisory or fiduciary responsibility in the Investor’s favor in connection with the purchase and sale of the Creci Notes. Creci has not provided the Investor with any legal, accounting, regulatory, investment or tax advice with respect to the Creci Notes. Investor has consulted his, her, or its own legal, accounting, regulatory, investment and/or tax advisors to the extent you have deemed appropriate.
(j) Investor will not sell, transfer, donate, assign, mortgage, hypothecate, or otherwise encumber (each a “Transfer”) the Creci Notes unless (i) Creci consents in writing to any such Transfer, and (ii) any buyer, transferee, pledgee, done, or assignee, respectively, shall agree in writing to be bound by the terms hereof prior to any such Transfer. Creci reserves the right to charge investors up to a 1% servicing fee on the transfer of Creci Notes.
(k) Investor acknowledges that Creci will issue the Creci Notes only in electronic form. Investors will be required to hold their Creci Notes through Creci’s electronic bond register.
(l) Investor acknowledges that the Creci Notes will not restrict Creci’s ability to incur additional indebtedness, including indebtedness secured by our assets.
3
(m) Investor also acknowledges that no more than once each fiscal quarter an investor may withdraw up to $500 or 10% of the investor’s principal and accrued interest each quarter, whichever is greater, generally upon 30 days’ notice and subject to available funds from loans made and other cash available to the Company. Management retains discretion to allow investors to withdraw additional amounts, subject to the availability of additional funds. The Company also retains the discretion to limit withdrawal requests prior to maturity and reserves the right to wait until the maturity date to pay all accrued interest.
(n) Investor represent that the amounts invested by he, she, or it in the Creci Notes were not and are not directly or indirectly derived from activities that contravene federal, state or international laws and regulations, including anti-money laundering laws and regulations. Federal regulations and Executive Orders administered by OFAC prohibit, among other things, the engagement in transactions with, and the provision of services to, certain foreign countries, territories, entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found on the OFAC website at www.treas.gov/ofac. In addition, the programs administered by OFAC (the “OFAC Programs”) prohibit dealing with individuals1 or entities in certain countries regardless of whether such individuals or entities appear on the OFAC lists.
5. Creci representations and warranties. Creci represents and warrants to you, as of the date of this Agreement and as of any date that you commit to purchase Creci Notes, that:
(a) Creci is duly organized and validly existing as a corporation in good standing under the laws of the State of Delaware and has the requisite corporate power to enter into and perform its obligations under this Agreement.
(b) This Agreement and the Creci Notes have been duly authorized and, following payment of the purchase price by you and electronic execution, authentication, and delivery to you, will constitute valid and binding obligations of Creci enforceable in accordance with their terms, except as the enforcement thereof may be limited by applicable bankruptcy, insolvency, or other laws.
(c) Creci has complied in all material respects with applicable federal, state, and local laws in connection with the offer and sale of the Creci Notes.
(d) All consents, approvals, orders or authorizations of, or registrations, qualifications, designations, declarations, or filings with, any governmental authority or any other person, required on the part of the Creci in connection with the valid execution and delivery of this Agreement, sale and issuance of the Creci Notes, and the consummation of any other transaction contemplated hereby, shall have been obtained.
6. Notice of dispute resolution by binding arbitration and class action/class arbitration waiver.
(a) The following provision (the “arbitration provision”) constitutes a binding agreement that limits certain rights, including your right to obtain relief or damages through court action or as a member of a class. That means that, in the event that you have a complaint against Creci that Creci is unable to resolve to your satisfaction, you and Creci agree to resolve your dispute through binding arbitration or small claims court, instead of through courts of general jurisdiction or through a class action. By entering into this agreement, you and Creci are each waiving the right to a trial by jury and to participate in any class action, except in cases that involve personal injury. The arbitration provision and the waiver of the right to a jury trial and class action is not intended to be deemed a waiver by you of our compliance with the Exchange Act and Securities Act and the rules and regulations promulgated thereunder. The arbitration, class action waiver and jury waiver provisions do not apply to claims brought under the Exchange Act and Securities Act.
| 1 | These individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs. |
4
(b) “Claim” shall mean any dispute or controversy arising out of or relating to this Agreement, your use of the Creci Site, and/or the transactions, activities, or relationships that involve, lead to, or result from any of the foregoing, (except for cases pending in Small Claims Court as provided in Section 6(h) below, or claims for personal injury). Claims include, but not limited to breach of contract, fraud, misrepresentation, express or implied warranty, and equitable, injunctive, or declaratory relief, as well as claims relating to loan servicing, credit/collections, and securities matters, regardless of the originating source (common law, statute, constitution, regulation, etc.). Claims include matters arising as initial claims, counter-claims, cross-claims, third-party claims, or otherwise and include those brought by or against your assigns, heirs, or beneficiaries.
(c) Either party to this Agreement has the right to require binding arbitration as the sole and exclusive forum and remedy for resolution of a claim between you and Creci. The party initiating arbitration shall do so with the American Arbitration Association (the “AAA”). The procedure shall be governed by the AAA Commercial Rules, and the parties stipulate that the laws of the State of Delaware apply, without regard to conflict-of-law principles. In the case of a conflict between the rules and policies of the administrator and this Arbitration Provision, this Arbitration Provision shall control, subject to controlling law, unless all parties to the arbitration consent to have the rules and policies of the administrator apply. Arbitration shall take place in New Castle County, Delaware, within the United States District Court sitting in Wilmington, Delaware, or in such location as agreed upon by the parties.
(d) Absent agreement among the parties, the presiding arbitrator shall determine how to allocate the fees and costs of arbitration among the parties according to the administrator’s rules or in accordance with controlling law if contrary to those rules. Each party shall bear the expense of that party’s attorneys, experts, and witnesses, regardless of which party prevails in the arbitration, unless controlling law provides a right for the prevailing party to recover fees and costs from the other party. Notwithstanding the foregoing, if the arbitrator determines that your claim is frivolous or brought for an improper purpose (as measured by the standards set forth in Federal Rule of Civil Procedure 11(b)), we shall not be required to pay any fees or costs of the arbitration proceeding, and any previously paid fees or costs shall be reimbursed by you.
(e) If the amount in controversy exceeds $50,000, any party may appeal the arbitrator’s award to a three-arbitrator panel within thirty (30) days of the final award. Additionally, in the event of such an appeal, any opposing party may cross-appeal within thirty (30) days after notice of the appeal. The three-arbitrator panel may consider all of the evidence and issue a new award, and the panel does not have to adopt or give any weight to the first arbitrator’s findings of fact or conclusion. This is called “de novo” review. Costs and conduct of any appeal shall be governed by this Arbitration Provision and the administrator’s rules, in the same way as the initial arbitration proceeding. Any award by the individual arbitrator that is not subject to appeal, and any panel award on appeal, shall be final and binding, except for any appeal right under the Federal Arbitration Act (the “FAA”), and may be entered as a judgment in any court of competent jurisdiction.
(f) The parties agree that this Arbitration Provision is made pursuant to a transaction between you and Creci that involves and affects interstate commerce and therefore shall be governed by and enforceable under the FAA. The arbitrator will apply substantive law consistent with the FAA and applicable statutes of limitations. The arbitrator may award damages or other types of relief permitted by the law of the State of Delaware, subject to the limitations set forth in this Agreement. The arbitrator will not be bound by judicial rules of procedure and evidence that would apply in a court. The parties also agree that the proceedings shall be confidential to protect intellectual property rights.
5
(g) If you do not agree to the terms of this arbitration agreement, you may opt out of this arbitration provision by sending an arbitration opt-out notice to Creci, Inc., 1201 North Market Street, Suite 111, Wilmington, Delaware 19801, that is received at this address within thirty (30) days of your first electronic acceptance of this form. Your opt-out notice must clearly state that you are rejecting arbitration; identify the agreement to which it applies by date; provide your name and address; and be signed by you. You may convey the opt-out notice by U.S. mail or any private mail carrier (e.g., Federal Express, United Parcel Service, DHL Express, etc.), so long as it is received at the above mailing address within thirty (30) days of your first electronic acceptance of the terms of this agreement. If the notice is sent by a third party, such third party must include evidence of his or her legal authority to submit the opt-out notice on your behalf. If your opt-out notice is not received within thirty (30) days, you will be deemed to have accepted all terms of this arbitration agreement.
(h) Creci agrees not to invoke our right to arbitrate an individual Claim you may bring in Small Claims Court or an equivalent court, if any, so long as the Claim is pending only in that court. No arbitration shall proceed on a class, representative, or collective basis (including as private attorney general on behalf of others), even if the claim or claims that are the subject of the arbitration had previously been asserted (or could have been asserted) in a court as class representative, or collective actions in a court. Unless consented to in writing by all parties to the arbitration, no party to the arbitration may join, consolidate, or otherwise bring claims for or on behalf of two or more individuals or unrelated corporate entities in the same arbitration.
(i) This Arbitration Provision shall survive (i) suspension, termination, revocation, closure, or amendments to this Agreement and the relationship of the parties; (ii) the bankruptcy or insolvency of any party or other person; and (iii) any transfer of any Creci Note which you own, or any amounts owed on such Creci Notes, to any other person or entity. If any portion of this Arbitration Provision other than the prohibitions on class arbitration in Sections 6(a) and 6(h) is deemed invalid or unenforceable under any law or statute consistent with the FAA, it shall not invalidate the other provisions of this Arbitration Provision or this Agreement; if the prohibition on class arbitration is deemed invalid, however, then this entire Arbitration Provision shall be null and void.
(j) The parties acknowledge that they have a right to litigate claims through a court before a judge, but will not have that right if any party elects arbitration pursuant to this arbitration provision. The parties hereby knowingly and voluntarily waive their rights to litigate such claims in a court upon election of arbitration by any party. The parties hereto waive a trial by jury in any litigation relating to this agreement, or any other agreements related thereto.
7. Governing Law; Venue. This Agreement is to be construed in accordance with the internal laws of the State of Delaware, without giving effect to principles of conflict of laws. In the event that the dispute resolution procedures in Section 6 are found not to apply to a given claim, any judicial proceeding will be brought in the state courts of New Castle County, Delaware. Both parties hereto consent to venue and personal jurisdiction in such location.
8. Entire Agreement. This Agreement and the Creci Note constitute the entire agreement between the parties regarding the subject matter contained herein and supersedes all prior or contemporaneous agreements, representations, and understanding of the parties.
6
IN WITNESS WHEREOF, the Investor has executed this Note Investor Agreement on ___________________.
| HOLDER (if an individual): | ||
| Name of Holder: | ||
| Signature: | ||
| E-mail: | ||
| Address: | ||
| HOLDER (if an entity): | |||
| Name of Holder: | |||
| Signature: | |||
| Name: | |||
| Title: | |||
| E-mail: | |||
| Address: | |||
7
Exhibit 4.3

Creci, Inc. Auto-Invest Program
1. As a Creci Note holder, you may elect to participate in our auto-invest program (the “Auto-Invest Program”) in which you may automatically place orders for additional Creci Notes in minimum denominations of ten dollars ($10) on a monthly or quarterly basis.
2. If you wish to participate in the Auto-Invest Program, please complete the Auto-Invest Program Authorization (on page 2). By completing the Auto-Invest Program Authorization you are affirmatively agreeing to and reconfirming the terms and conditions of the Creci Note Investor Agreement, including the form of Creci Note which is an exhibit to the Creci Note Investor Agreement. Capitalized terms not otherwise defined herein shall have the meaning given to them in the Creci Note Investor Agreement.
3. You may affirmatively elect to participate in or cancel your participation in the Auto-Invest Program by selecting “active” or “pause” on the Creci Auto-Invest Program Authorization. If you do not complete a form, you will be deemed to have selected “pause.” Currently, the Auto-Invest Program allows for recurring new investments on a daily, weekly or monthly basis. Funds will be drawn from the bank account designated by you on the Creci Site.
4. Upon affirmatively electing to participate in the Auto-Invest Program, you will be asked to agree to the terms and conditions of the Creci Note Investor Agreement. Upon each “auto investment” being made, Creci will send a confirmatory email to you denoting the amount invested.
5. You can adjust the Auto-Invest Program at any time by completing an updated Auto-Invest Program Authorization and delivering it to investor-services@crecinotes.com. Each purchase of a Creci Note in the Auto-Invest Program is a considered a new investment and will be subject to the terms and conditions of the Creci Note Investor Agreement. If you are no longer able to make the representations and warranties in the Creci Note Investor Agreement, you are not eligible to participate in the Auto-Invest Program. All terms not otherwise defined herein shall have the same meaning as in the Creci Note Investor Agreement.
6. Once Creci has qualified with the Securities and Exchange Commission (“SEC”) for a Regulation A offering of Creci Notes, the only offering to sell securities is found in the Company’s Form 1-A and amendments and supplements thereto, including the offering circular which forms a part thereof (collectively, the “Offering Statement”), which can be obtained from the SEC’s website: www.sec.gov.
7. No decision to invest in Creci Notes should be made without reading the Offering Statement. Neither the SEC nor any state securities regulator has passed upon or endorsed the merits of any investment decision in Creci. We do not give investment, legal, or tax advice. You are urged to consult your investment, legal, and tax professional before making any investment decision.

Creci Note Auto-Invest Program Authorization
| 1. | Auto-Invest Program (Select One): |
Active [ ] Adjust [ ] Pause [ ] Cancel [ ]
| 2. | Investor Name, exactly as it appears in your Creci account: |
____________________________________________
| 3. | Auto-Invest Frequency and Amount in Minimum Denominations of $10 (Select One) |
[ ] Monthly. Amount $ ____________.
You are electing to automatically purchase Creci Notes on a monthly basis in this amount and authorizing Creci to automatically deduct this amount from the bank account designated in your Creci account beginning the first business day of each month beginning the month following this authorization and continuing until you cancel this automatic investment at least three (3) business days in advance.
[ ] Quarterly. Amount $ ____________.
You are electing to automatically purchase Creci Notes on a quarterly basis in this amount and authorizing Creci to automatically deduct this amount from the bank account designated in your Creci account beginning the first business day of each quarter beginning the quarter following this authorization and continuing until you cancel this automatic investment at least three (3) business days in advance.
I hereby represent and warrant that by executing this Creci Note Auto-Invest Program Authorization, I agree to be bound by and reconfirm the representations and warranties and the terms and conditions of the Auto-Invest Agreement and the Creci Note Investor Agreement. This authority is to remain in full force and effect until Creci has received notification from me of its termination. I understand that Creci can take up to three (3) business days to process the cancellation.
| Name of Investor | _______________________________ |
| Signature: | _______________________________ |
| Title: | _______________________________ |
Exhibit 6.1
|
|
|
Memorandum
| Date: | March 1, 2021 |
| From: | Andres Idarraga, Mentel LLC and Creci Inc. |
| To: | VaroTeam and Phylo Legal |
| Subject: | Sale of Mentel Colombia SAS’s Lending Operations to Creci Finance Colombia SAS |
| I. | Introduction and Background |
This memo sets forth the background and the terms for the tranfer and sale of Mentel Colombia SAS’s lending operations to Creci Finance Colombia SAS. Mentel Colombia SAS is wholly-owned by Mentel LLC and Creci Finance Colombia SAS is wholly-owned by Creci, Inc.
I began the “Creci” social impact lending operations under Mentel Colombia SAS in mid-2018 to research the fintech industry; begin to map a strategy to establish a company that would make loans to social impact entrepreneurs; build a team; and set up an MVP. In early 2019, after seeing that Creci had potential to be an independent entity, I set up Creci Inc., a Delaware C-Corp. In late 2019, I set up Creci Finance Colombia SAS.
We now need to transfer the social impact lending operations from Mentel Colombia SAS to Creci Finance Colombia SAS as soon as possible.
| II. | History Up to This Point |
Financial history between the two organizations include:
| ● | Mentel LLC invested $120,000 in Creci Inc. |
| ● | In July 2020, Creci Inc. paid Mentel LLC $57,500 in development costs for the Creci social impact line of business. |
| ● | Creci owes Mentel an additional $79,451 in development costs that have not been paid. |
| ● | Creci Inc. loaned Mentel $150,000 at 12% to make social impact loans in Colombia. |
| III. | Fair Market Value |
The net fair market value of the transaction is $175,000 based on the following:
| ● | The value of Mentel’s social impact loan book in Colombia as of 2/28/21, which total approximately $160,000 in value; plus |
| ● | $79,451 in expenses that Mentel has absorbed for Creci in Colombia that has not been paid; plus |
| ● | $35,000 value of infrastructure and IP development; plus |
| ● | $100,000 that Mentel will transfer to Creci in Colombia for operating capital; minus |
| ● | the value of Creci’s $150,000 loan to Mentel (which almost equals the value of the current loan book); minus |
| ● | $50,000 in income Mentel has earned that should properly be credited to the Creci operations in 2019 and 2020. |
Creci will pay Mentel for the sale and transfer by issuing Mentel a convertible note for $175,000 that pays 5% annual interest, has a three-year maturity, a 20% discount rate, and a valuation cap of $4 million. These terms are benchmarked against the most recent convertible notes Creci issued, which were issued at a $2 million valuation cap with all the other terms being identical.
| IV. | Execution and Results of the Transaction |
These are the steps for executing the transaction:
| 1. | Execute the legal paperwork in Colombia between Creci Finance Colombia SAS and Mentel Colombia SAS for the transfer. |
| a. | Phylo Legal to handle the Colombian side of the transaction. |
| b. | Creci Inc. to issue the $175,000 convertible note. |
| 2. | Transfer workforce from Mentel Colombia SAS to Creci Finance Colombia SAS. |
| 3. | Transfer all needed service provider contracts. |
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S.
Entre los suscritos, por una parte, ANDRES FELIPE IDARRAGA GIRALDO, mayor de edad, domiciliado en la ciudad de Hollywood, Florida, identificado civilmente con número de Cédula de Ciudadanía 98.668.570, actuando en calidad de Representante Legal de MENTEL COLOMBIA S.A.S., sociedad comercial legalmente constituida bajo las normas de la República de Colombia, con domicilio principal en la ciudad de Medellín, identificada tributariamente con el número de identificación tributaria 901.165.106-9 (quienes en adelante y para efectos del presente contrato se denominará “ENAJENANTE”) y, por otra parte, ANDRES FELIPE IDARRAGA GIRALDO, mayor de edad, domiciliado en la ciudad de Hollywood, Florida, identificado civilmente con número de Cédula de Ciudadanía 98.668.570, actuando en calidad de Representante Legal de CRECI FINANCE COLOMBIA S.A.S., sociedad comercial legalmente constituida bajo las normas de la República de Colombia, con domicilio principal en la ciudad de Medellín, identificada con el número de identificación tributaria 901.344.753-2 (quienes en adelante y para efectos del presente contrato se denominará el “ADQUIRENTE”, y conjuntamente (“LAS PARTES”), hemos acordado celebrar el presente contrato de enajenación global de activos (el “Contrato”), de conformidad con las siguientes:
I. CONSIDERACIONES
| 1. | Que el ENAJENANTE en el contexto de la realización de sus activos, inició un proceso de enajenación global de activos (el “Proceso de Aporte”). |
| 2. | Que en el Proceso de Aporte, el ADQUIRENTE se encontró interesado en adquirir los Activos del ENAJNANTE, de forma tal que, por medio de oferta comercial las Partes establecieron los principales elementos que serán determinantes para la ejecución del Contrato de enajenación Global de Activos. |
| 3. | Que aceptada la oferta comercial que fue elaborada por las Partes, ambas deciden suscribir un contrato de enajenación global de activos que establezca las condiciones particulares, adicionales a las establecidas por la legislación colombiana, para el desarrollo de las obligaciones que les corresponden. |
Página 1 de 11
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | |
En virtud de las consideraciones anteriormente expuestas, las Partes mutuamente y de forma voluntaria, convienen que el presente acuerdo se regulará bajo los siguientes términos:
II. CLÁUSULAS
PRIMERA. DEFINICIONES.
Los siguientes términos tendrán el significado que se les asigna a continuación:
| ● | “Activo Intangible”, es el activo identificable, de carácter no monetario y sin presencia física, sobre el cual se espera la obtención de beneficios económicos futuros. |
| ● | “Activo”, es el activo fijo -mismo que permanece por un período de más de dos (2) años en el patrimonio-, de carácter monetario o no monetario, con o sin presencia física, sobre cual se espera la obtención de beneficios económicos futuros. |
| ● | “Autoridad gubernamental”, significa cualquier entidad pública, del orden nacional, departamental, regional, municipal, distrital, o de cualquier otro orden, de las ramas legislativa, ejecutiva, judicial, entidad autónoma u órgano de control, colombiana o extranjera. |
| ● | “COP” o “Pesos”, significa Pesos Colombianos (moneda de curso legal de la República de Colombia). |
| ● | “Cuarto de Datos” significa el cuarto de datos dispuesto por el enajenante en el transcurso del Proceso de Aporte para la identificación de los Activos. |
| ● | “Funcionario Público” significará toda persona que ostente en cualquier jurisdicción un cargo público o sea contratista en cualquiera de las ramas del poder público, ente o dependencia de dicho país, en cualquiera de los niveles nacional, departamental, municipal, regional, federal, estatal, etc., e incluyendo a cualquier negocio perteneciente al gobierno o a un organismo público internacional; se consideran también funcionarios públicos los miembros de la fuerza pública, los particulares que ejerzan funciones públicas en forma permanente o transitoria y trabajadores de órganos autónomos así como cualquier persona que actué con un carácter oficial para o por un gobierno. |
| ● | “Ley”, significa la Constitución, todas las leyes, decretos, resoluciones, circulares, ordenanzas, acuerdos municipales y distritales, y en general cualquier norma de cualquier nivel emanada de cualquier Autoridad Gubernamental. |
| ● | “Tributo”, significa, todos los impuestos, contribuciones, aranceles, tasas, tarifas, sin importar su denominación, incluyendo cualesquiera intereses, sanciones u otras adicionales al tributo que pudieran volverse pagaderas sobre tales tributos, exigidos por cualquier Autoridad Gubernamental, y tales tributos incluirán, sin perjuicio de la generalidad de lo anterior, todos los impuestos sobre renta o a las utilidades, impuestos a los ingresos brutos y/o netos, impuestos a las ventas, impuestos ad valorem, impuestos a la propiedad, impuestos al valor agregado, impuesto complementario de ganancia ocasional, retenciones en la fuente, contribuciones parafiscales, cualquier otro tributario, y demás obligaciones tributarias o fiscales formales o sustanciales. |
Página 2 de 11
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | ![]() |
CLÁUSULA SEGUNDA. INTERPRETACIÓN.
Las referencias que se hagan en el texto a artículos o secciones harán únicamente referencia a los artículos del presente Contrato. Los títulos de las cláusulas se incluyen con fines de referencia y de conveniencia, pero de ninguna manera limitan, definen o describen el alcance y la intención del presente Contrato y no se consideran como parte de este. Cuando se usen las palabras “incluyendo” o “incluidas”, se entenderán que son seguidas por las expresiones “sin limitación”, aunque no se encuentre dicha expresión escrita textualmente en este contrato. Las palabras técnicas o científicas que no se encuentren definidas expresamente en este Contrato tendrán los significados que les corresponda según la técnica o ciencia respectiva y las demás palabras se entenderán en su sentido natural y obvio, según el uso general de las mismas. Para efectos de este Contrato, los términos definidos podrán ser usados tanto en singular como en plural.
CLÁUSULA TERCERA. ENAJENACIÓN DE ACTIVOS.
Con sujeción a los términos y condiciones establecidos en este Contrato, el ENAJENANTE se obliga, en la presente fecha, a ceder al ADQUIRENTE a título oneroso el Activo que es propiedad de la persona jurídica a la que representa y, el ADQUIRENTE se obliga a recibir dicho Activo en la presente fecha a un precio de MIL CIENTO SESENTA Y NUEVE MILLONES NUEVECIENTOS NOVENTA Y OCHO MIL TRESCIENTOS TREINTA Y OCHO PESOS M/CTE (COP$1.169.998.338), a título de un aporte en capital y especie que será pagado en la forma y plazos establecidos en la cláusula cuarta del presente acuerdo, así como en el correspondiente reglamento de emisión y colocación (en adelante y para efectos del presente acuerdo el “Precio de Cesión”), y en contraprestación del cual se emitirá el número de acciones del ADQUIRIENTE que se detallan más adelante.
El valor anteriormente indicado corresponde al siguiente Activo, Activo intangible y efectivo:
| ● | Aporte en capital - Efectivo o equivalentes de efectivo: COP$360.000.000. |
| ● | Aporte en especie - Derechos contractuales en calidad de acreedor: COP$543.969.138. |
| ● | Aporte en especie - Intagibles (i.e., software, propiedad intelectual, entre otros): COP$266.029.200 |
Página 3 de 11
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | ![]() |
CLÁUSULA CUARTA. FORMA DE PAGO.
El ADQUIRENTE pagará al ENAJENANTE el Precio de Cesión de la siguiente manera dentro de los quince (15) días calendario siguientes a la fecha de celebración del presente Contrato y en los términos que se definan en el reglamento de emisión y suscripción correspondiente:
| A. | A través de la emisión de dieciséis punto veinticinco por ciento (16.25%) de acciones ordinarias de la sociedad del ADQUIRENTE en favor del ENAJENANTE, a valor nominal y con XX valor por concepto de prima de colocación en acciones. |
PARÁGRAFO ÚNICO. En caso de mora total o parcial en el pago de estas sumas, EL ADQUIRENTE liquidará y pagará al ENAJENANTE intereses moratorios a la tasa más alta permitida por la ley.
CLÁUSULA QUINTA. TRADICIÓN.
Las Partes ejecutarán todos los actos y adoptarán todas las medidas necesarias para que se produzca el traspaso del Activo y el Activo Intangible, así:
| ● | Efectivo o equivalentes de efectivo: Mediante transferencia electrónica a la cuenta bancaria que indique el ADQUIRIENTE dentro de los 3 días hábiles contado desde la fecha de firma del presente Contrato. |
| ● | Derechos contractuales en calidad de acreedor: Mediante la suscripción entre las Partes de un contrato de cesión de posición contractual de acreedor, sobre todos los contratos de mutuo del portafolio del ENAJENANTE, dentro de los 3 días hábiles contados desde la fecha de firma del presente Contrato. |
| ● | Intagibles (i.e., software, propiedad intelectual, entre otros): Mediante la suscripción entre las Partes de un contrato de transferencia de derechos patrimoniales de autor sobre el software y de mandato para el registro ante las autoridades competentes, así de un contrato de transferencia de marca, dentro de los 3 días hábiles contados desde la fecha de firma del presente Contrato. | |
| ● | Recursos humanos: Mediante la suscripción entre las Partes de un contrato de cesión de posición contractual de empleador, sobre todos los contratos laborales del ENAJENANTE, dentro de los 3 días hábiles contados desde la fecha de firma del presente Contrato. |
CLÁUSULA SEXTA. OBLIGACIÓN DE COOPERACIÓN Y ASISTENCIA.
Las Partes se obligan hacer todos sus esfuerzos para tomar, o hacer que sean tomadas todas las medidas, y para hacer, o hacer que se hagan, todas aquellas cosas necesarias, apropiadas o razonablemente conveniente para perfeccionar y hacer efectivo, en cuanto sea posible, el traspaso del Activo.
Las Partes aceptan que aún después de la fecha del presente Contrato, y previa solicitud de la otra Parte, llevarán a cabo todas las acciones necesarias, y suscribirán y entregarán en la debida forma y sin costo adicional aquellos documentos que sean razonablemente necesarios o convenientes, para llevar a cabo el traspaso del Activo o para dar cumplimiento a cualquier requerimiento de Autoridad Gubernamental relacionado con dicha transferencia.
Página 4 de 11
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | ![]() |
CLÁUSULA SÉPTIMA. ALCANCE LAS OBLIGACIONES DEL ENAJENANTE.
Las obligaciones del ENAJENANTE en relación con la cesión del Activo se limitan a:
| A. | La obligación del ENAJENANTE de ceder no otorga ninguna declaración o garantía, ni asume ninguna responsabilidad por los Activos que se encuentran en su posición desde el momento en que efectúe la enajenación, de forma tal que, una vez se efectúe la enajenación, la responsabilidad en relación con los activos del ENAJENANTE será única y exclusiva del ADQUIRENTE. |
| B. | La obligación del ENAJENANTE en relación con la inscripción de los documentos se limita a adelantar los trámites necesarios ante las Autoridades Gubernamentales competentes para que en un término no mayor a los treinta (30) días siguientes de la suscripción del contrato inicie cada uno de los mismos. |
CLÁUSULA OCTAVA. ASUNCIÓN DE PASIVOS.
Las Partes se comprometen a ejecutar todos los actos y a suscribir todos los documentos necesarios para que se perfeccione la enajenación global de los activos del ENAJENANTE, de forma tal que, el ENAJENANTE queda liberado de toda responsabilidad frente a los pasivos cedidos al ADQUIRENTE.
CLÁUSULA NOVENA. RESPONSABILIDADES LABORALES DE LA ENAJENACIÓN GLOBAL DE ACTIVOS.
Por medio de la enajenación global de Activos del ENAJENANTE, las Partes reconocen y aceptan que se dará continuidad para los efectos laborales del personal contratado por parte del ENAJENANTE, que este no sufre variaciones esenciales en el giro ordinario de las actividades o negocio que desarrolla, razón por la cual, la ejecución del presente Contrato no extingue, suspende, ni modifica los contratos de trabajo vigentes de los empleados del ENAJENANTE. A partir de la fecha del presente contrato, las Partes reconocen y aceptan que, respecto de los empleados del ENAJENANTE, operará una sustitución de empleador en los términos del artículo 27 del Código Sustantivo del Trabajo, razón por la cual continuarán ejecutando sus contratos de trabajo con la compañía del ADQUIRENTE en las condiciones en que fueron pactados con el ENAJENANTE, sin solución de continuidad.
Si en virtud de la ley laboral resulta necesario documentar la cesión de uno o algunos de los contratos de trabajo de los empleados del ENAJENANTE al ADQUIRENTE mediante documentos adicionales, las Partes se obligan a suscribir en el menor tiempo posible todos los documentos necesarios para documentar el asunto, dándole los efectos de una sustitución de empleador, es decir que se mantendrán las condiciones laborales que fueron pactadas en los contratos de trabajo suscritos entre el ENAJENANTE y los trabajadores sin solución de continuidad.
Salvo por lo expresamente mencionado en los contratos laborales en cuestión o en contratos de prestación de servicios, a partir de la presente fecha, EL ADQUIRENTE asume toda la responsabilidad por el pago de todas las acreencias laborales o comerciales que a la presente fecha sean exigibles, y de todas las que nazcan a partir de dicha fecha. EL ADQUIRENTE renuncia al derecho de repetición en contra del ENAJENANTE, descrito en el artículo 69 del Código Sustantivo del Trabajo. EL ENAJENANTE no tendrá la obligación descrita en el artículo 69 numeral 5º del Código Sustantivo del Trabajo.
Página 5 de 11
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | ![]() |
CLÁUSULA DÉCIMA. PLAZO DE DESARROLLO, VIGENCIA Y DURACIÓN DEL CONTRATO.
El desarrollo del contrato tendrá una duración de tres (3) meses para la ejecución de las obligaciones específicas que permitan perfeccionar la enajenación global de los activos y de la suscripción de las acciones que tendrá lugar como consecuencia de la operación económica que pretenden las Partes. El término de duración contará desde el momento de suscripción del presente acuerdo.
CLÁUSULA DÉCIMO PRIMERA. SUSCRIPCIÓN DE LAS ACCIONES EN FAVOR DEL ENAJENANTE.
EL ADQUIRENTE se obligará a suscribir el número de acciones que correspondan al Precio de Cesión de acuerdo con la Cláusula Tercera del presente acuerdo una vez efectuada la entrega de los Activos por parte del ENAJENANTE en favor de este último. Al tratarse de un aporte en capital y en especie, el mismo no se encuentra gravado de acuerdo con el artículo 319 Estatuto Tributario nacional. De esa forma, EL ADQUIRENTE tendrá la obligación de emitir las acciones a las que haya lugar, entregar los certificados accionarios y hacer la inscripción en el libro de accionistas de su sociedad en un término no mayor a los treinta (30) días siguientes a la fecha de firma de este Contrato. En esos términos, EL ADQUIRENTE estará obligado a realizar todos los trámites necesarios ante la Cámara de Comercio de Medellín y garantizará al ENAJENANTE el perfeccionamiento en la suscripción en la oferta de sucripción, siendo esta una de las obligaciones principales derivadas de la suscripción del presente acuerdo.
CLÁUSULA DÉCIMA SEGUNDA. GARANTÍA DE ACEPTACIÓN POR PARTE DE LA ASAMBLEA DE ACCIONISTAS DEL ADQUIRENTE.
EL ADQUIRENTE garantizará al ENAJENANTE que, previa a la suscripción del presente acuerdo, los accionistas que ostenten tal calidad de acuerdo con los libros de accionistas han aceptado por medio de Asamblea General de Accionistas, la emisión del número de acciones que corresponde al valor total de la enajenación global de activos en los términos aquí pactados. De esa forma, EL ADQUIRENTE garantiza que la decisión de liberar un número determinado de acciones y la ejecución de las operaciones comerciales se encuentra perfeccionada y aceptada por unanimidad y con observancia al derecho de preferencia; así mismo, garantiza que a la fecha de la suscripción del acuerdo la Compañía del ADQUIRENTE ya cuenta con un reglamento de emisión y suscripción de acciones que faculte al cumplimiento a cabalidad de la operación societaria que se pretende por medio del presente Contrato.
Página 6 de 11
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | ![]() |
CLÁUSULA DÉCIMO TERCERA: OBLIGACIONES GENERALES DEL ADQUIRENTE.
Además de las obligaciones señaladas en el presente documento o aquellas que sean asumidas con posterioridad en documentos adicionales, EL ADQUIRENTE se obliga a:
| 1. | Adoptar las medidas que considere adecuadas para la realización de las obligaciones especiales contenidas en el contrato, establecidas en el presente documento. |
| 2. | Realizar todas las actividades que sean necesarias para la realización de las obligaciones especiales señaladas en el contrato. |
| 3. | Actuar de buena fe y de conformidad con los principios señalados en el Código Civil, Código de Comercio y en las disposiciones expuestas por la Corte Suprema de Justicia para este tipo de contratos. |
| 4. | Poner a disposición del CONTRATANTE su capacidad, experiencia y conocimientos para cumplir con el desarrollo del objeto contractual. |
| 5. | Guardar absoluta reserva sobre los hechos, documentos, informaciones y en general, sobre todos los asuntos y materias que lleguen a su conocimiento por causa o con ocasión de su contrato de prestación de servicios. |
| 6. | Cumplir en forma eficiente y oportuna los requerimientos que le sean asignados y aquellas obligaciones que se generen de acuerdo con la naturaleza del servicio con plena autonomía técnica y administrativa, y bajo su propia responsabilidad. |
| 7. | Obrar de buena fe en la ejecución de este contrato. |
| 8. | Entregar, elaborar y suscribir todos los documentos que sean necesarios para el perfeccionamiento de la enajenación global de activos en favor del ADQUIRENTE. |
Página 7 de 11
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | |
| 9. | Propender por una conducta respetuosa y profesional que permita el máximo rendimiento tanto individual como colectivo de las Partes. |
| 10. | Suscribir el número de acciones que corresponda de conformidad con las estipulaciones contractuales señaladas en virtud del presente acuerdo. |
| 11. | Todas las demás que se deriven de la ejecución del presente contrato. |
CLÁUSULA DÉCIMO CUARTA: OBLIGACIONES GENERALES DEL ENAJENANTE.
Además de las obligaciones señaladas en el presente documento o aquellas que sean asumidas con posterioridad en documentos adicionales, EL ENAJENANTE se obliga a:
| 1. | Obligar al ADQUIRENTE al cumplimiento de sus obligaciones, de forma tal que pueda responder en todas las cuestiones del negocio jurídico que se pretende y frente a terceros, en los aspectos que estén relacionados con el desarrollo de la prestación del servicio. |
| 2. | Cumplir con cada una de las obligaciones especiales que han sido consagradas en virtud del presente acuerdo. |
| 3. | Poner a disposición de la ejecución adecuada del contrato su talento humano o recursos de capital que se ha comprometido aportar de conformidad con el presente contrato. |
| 4. | Realizar todas las actividades que sean necesarias para permitir al ADQUIERNTE la ejecución de sus obligaciones. |
| 5. | Adelantar los trámites para obtener los permisos, autorizaciones y licencias necesarias para la ejecución de las obligaciones contenidas en este acuerdo. |
| 6. | Actuar de buena fe y de conformidad con los principios señalados en el Código Civil, Código de Comercio y en las disposiciones expuestas por la Corte Suprema de Justicia para este tipo de contratos. |
| 7. | Emitir el número de acciones que corresponda de conformidad con las estipulaciones contractuales señaladas en virtud del presente acuerdo. |
| 8. | Informar oportunamente al ADQUIRENTE de cualquier decisión que afecte de forma directa o indirecta el desarrollo del contrato o su continuidad. |
Página 8 de 11
|
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | |
CLÁUSULA DÉCIMO QUINTA: CLÁUSULA PENAL.
El incumplimiento grave por parte de cualquiera de las Partes le dará a la otra la posibilidad de dar por terminado el contrato, y la posibilidad de exigirle a la otra, a título de pena, la fracción del valor del contrato que reste por pagarse.
PARÁGRAFO ÚNICO. Las Partes renuncian a los requerimientos judiciales o extrajudiciales para constituirse en mora de esta obligación, por consiguiente, desde el momento de la infracción se deberán intereses legales moratorios sobre la anterior cantidad a la tasa máxima certificada por la Superintendencia Financiera de Colombia para cada período, y hasta que se verifique el pago total de la obligación.
CLÁUSULA DÉCIMO SEXTA: TERMINACIÓN.
El presente acuerdo terminará por cualquiera de las siguientes causas:
| 1. | Por mutuo acuerdo entre las Partes, el cual constara en acta suscrita por las mismas. |
| 2. | Unilateralmente, por incumplimiento de alguna de las obligaciones derivadas del contrato. |
| 3. | Cuando se presente la disolución de la personería jurídica de EL CONTRATANTE o cuando se autorice u ordene su liquidación. |
| 4. | Cuando alguna de las Partes ceda total o parcialmente, este acuerdo sin la previa autorización de la otra Parte. |
| 5. | Por las causas previstas en la ley. |
CLÁUSULA DÉCIMO SÉPTIMA: CONFIDENCIALIDAD
Este contrato así como sus condiciones y términos e información suministrada en virtud del mismo son confidenciales, consecuentemente, las Partes no podrán, sin el consentimiento previo y por escrito de ambas Partes, comunicar o revelar a ninguna tercera persona la existencia o el contenido del presente contrato o cualquier otra información obtenida como resultado de la firma del presente, excepto a sus ejecutivos y directores, asesores legales y financieros , auditores, corredores de seguros y/o aseguradores, o cuando:
| A. | La información sea solicitada por una orden judicial, Tribunal o Corte competente; |
| B. | Sea presentada en cualquier proceso o litigio pendiente; |
| C. | Sea revelada de acuerdo con una ley o reglamento que tenga fuerza de ley; |
Página 9 de 11
|
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | ![]() |
| D. | Sea revelada de acuerdo con un requerimiento legal proveniente de cualquier autoridad competente, y al cual la parte reveladora está obligada a cumplir. Sin perjuicio de lo anterior las Partes podrán compartir sin requerir consentimiento previo, la información contenida en el convenio o cualquiera otra información adicional obtenida como resultado de la firma del mismo a su compañía controlante y a las que están bajo control común con ella incluidos los ejecutivos y directores, asesores legales y financieros, auditores, underwriters, corredores de seguros y/o aseguradores de cada una de ellas. |
En el caso de que cualquiera de las Partes sea requerido a través de una resolución administrativa o judicial dictada por autoridad competente, a divulgar cualquier información confidencial, deberá notificar dicha situación a la Parte que no sea requerida dentro de los siguientes cinco (5) días hábiles a partir de la fecha en la que haya recibido dicha notificación, con el objeto de que esté en condiciones de realizar aquellos actos que a su derecho convengan, incluyendo la obtención de una orden de protección adecuada, medida cautelar u otro recurso apropiado para prevenir la divulgación de la información confidencial requerida y deberá indicar a la autoridad requirente que conforme a los términos del presente convenio, debe observar un deber de confidencialidad.
Adicionalmente, las Partes se comprometen a mantener la debida reserva, no divulgar a terceros ni hacer uso para terceros o para operaciones distintas al objeto del presente contrato, de cualquier información de carácter técnico, comercial o de cuentas de cada uno de los extremos del contrato, que obtenga por razón de este contrato, o que le sea revelada por la otra parte del extremo contractual, así como de cualquier información sobre las operaciones, métodos, sistemas y procedimientos empleados por la otra Parte a la que tenga acceso o terceros en sus actividades. La obligación de guardar confidencialidad se mantendrá durante toda la vigencia del contrato, y en el evento que terminare por cualquier circunstancia, por un periodo de diez (10) años más posteriores a la terminación del presente contrato.
PARÁGRAFO PRIMERO. El incumplimiento de la presente cláusula será causal suficiente para la terminación unilateral del presente contrato, sin lugar a indemnización alguna a favor de la Parte cumplida. La violación al deber de confidencialidad tendrá una sanción de cincuenta (50) salarios mínimos legales vigentes, sin perjuicio de que la Parte afectada pueda perseguir la responsabilidad penal y/o daños y perjuicios que pudieran ocasionarse por la violación a dicha confidencialidad.
CLÁUSULA DÉCIMO OCTAVA: RESOLUCIÓN DE CONTROVERSIAS.
LAS PARTES harán todo lo posible para resolver mediante negociación directa cualquier disputa, controversia o diferencia que surja entre ellas, con relación a este Contrato.
En todo caso, aquellas disputas, controversias o diferencias que no puedan ser resueltas directamente o por medio de conciliación, serán sometidas a la jurisdicción ordinaria.
Página 10 de 11
![]() |
CONTRATO DE ENAJENACIÓN GLOBAL DE ACTIVOS CELEBRADO ENTRE MENTEL COLOMBIA S.A.S. Y CRECI FINANCE COLOMBIA S.A.S. | |
CLÁUSULA DÉCIMO NOVENA: DOMICILIO CONTRACTUAL.
Para todos los efectos legales derivados del presente Contrato, las Partes establecen como domicilio contractual la ciudad de Bogotá, Colombia.
CLÁUSULA VIGÉSIMA: LEY APLICABLE AL FONDO DEL CONTRATO.
Para todos los efectos legales derivados del presente Contrato, las Partes establecen como ley aplicable al fondo del contrato las leyes colombianas.
En fe de lo anterior, las Partes suscriben el presente Contrato, en dos (2) originales, a los cinco (5) días del mes de mayo del año dos mil veintiuno (2021).
| EL ENAJENANTE, | EL ADQUIRENTE, | |
| /s/ Andres Idarraga | /s/ Andres Idarraga | |
| ANDRES FELIPE IDARRAGA | ANDRES FELIPE IDARRAGA | |
| GIRALDO | GIRALDO | |
| C.C. No. 98.668.570 | C.C. No. 98.668.570 | |
| En representación legal de MENTEL | En representación legal de CRECI | |
| COLOMBIA S.A.S. | FINANCE COLOMBIA S.A.S. |
Página 11 de 11
Exhibit 11.1
Consent of Independent Auditor
Creci, Inc.
Wilmington, Delaware
We hereby consent to the use in the Offering Circular constituting a part of this Regulation A Offering Statement on Form 1-A of Creci, Inc (the “Company”) of our report dated October 12, 2021, with respect to the balance sheets as of December 31, 2020 and 2019, related statements of operations, stockholder’s deficit, and cash flows for the year ended December 31, 2020 and for the period from January 11, 2019 (inception) through December 31, 2019, and the related notes to the financial statements.
Fort Lauderdale, Florida
January 6, 2022
cbh.com
Exhibit 12.1
January 6, 2022
Creci Inc.
1201 North Market Street, Suite 111
Wilmington, DE 19801
Ladies and Gentlemen:
We have acted as special counsel to Creci Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission of a Regulation A Offering Statement on Form 1-A, as amended (the “Offering Statement”), relating to the offer and sale by the Company of up to $70,000,000 aggregate principal amount of notes (the “Creci Notes”). This opinion letter is being delivered in accordance with the requirements of Item 17(12) of Form 1-A under the Securities Act of 1933, as amended (the “Securities Act”).
You have requested our opinion as to the matters set forth below in connection with the offer and sale of the Notes. For purposes of rendering that opinion, we have examined: (i) the Offering Statement; (ii) the offering circular included in the Offering Statement; (iii) the form of Creci Note Investor Agreement; (iv) the form of Creci Note; (v) the Company’s Certificate of Incorporation dated January 11, 2019, (vi) the Company’s Bylaws dated January 11, 2019, and (vii) the corporate action of the Company’s Board of Directors which provides for the issuance of the Creci Notes. We have made such investigation of law as we have deemed appropriate. We have examined and relied upon certificates of public officials and such other documents and instruments as we have deemed necessary or advisable for the purpose of rendering our opinion. For the purposes of this opinion letter, we have made assumptions that are customary in opinion letters of this kind, including the assumptions that each document submitted to us is accurate and complete, that each such document that is an original is authentic, that each such document that is a copy conforms to an authentic original, and that all signatures on each such document are genuine. We have further assumed the legal capacity of natural persons. We have not verified any of those assumptions.
Creci Inc.
January 6, 2022
Page 2
Our opinion set forth below is limited to the laws of the State of Delaware.
Based upon and subject to the foregoing, and assuming that (i) the Offering Statement (and the offering circular included therein) complies with all applicable laws at the time the relevant Notes are offered or issued as contemplated by the Offering Statement (and such offering circular included therein); (ii) all Notes will be issued and sold in compliance with applicable federal and state securities laws and in the manner stated in the Offering Statement (and the offering circular included therein); (iii) the Company’s Board of Directors shall not have rescinded or otherwise modified its authorization of the issuance of the Notes; (iv) the Company shall remain at all times a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware; (iv) that each Notes constitutes a legal, valid and binding agreement of each of the parties thereto (other than the Company) and is enforceable against such parties in accordance with its terms; (v) that there is a reasonable basis for the choice of Delaware law to govern the Notes as provided in the Notes and the transactions described in, and relating to, the Notes have a substantial and material relationship with the State of Delaware; and (vi) the additional qualifications and other matters set forth below, it is our opinion that the Notes have been duly authorized by the Company and, upon the issuance of the Notes (in the form examined by us) against payment therefor in accordance with the terms of the Creci Note Investor Agreement, the Notes will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.
The opinion expressed above is subject to and limited by (i) the effect of bankruptcy, insolvency, fraudulent conveyance, reorganization, receivership, moratorium or other similar laws relating to or affecting the rights and remedies of creditors or secured parties generally, (ii) the application of general principles of equity (regardless of whether considered in a proceeding in equity or at law), including, without limitation, the possible unavailability of specific performance, injunctive relief or another equitable remedy, and (iii) concepts of materiality, reasonableness, good faith and fair dealing.
We express no opinion with respect to any provisions of the Notes: (i) waiving the benefits of statutory, regulatory or constitutional rights, unless and to the extent that the statute, regulation or constitution, as applicable, explicitly allows such waiver, and the waiving of other benefits to the extent that they cannot be waived under applicable law; (ii) permitting, by implication or otherwise, the collection of attorneys’ fees in excess of the limitation of 10 Del. C. § 3912, which statutory limitation permits reasonable attorneys’ fees not to exceed 20% of the amounts adjudged as principal and interest; (iii) providing for indemnification, exculpation, limitation of liability or a right to contribution; (iv) purporting to preclude modification of the Notes other than in writing; (v) purporting to provide for dispute resolutions, or (vi) purporting to bind a person or entity that is not a party to the Notes.
We hereby consent to the filing of this opinion letter with the SEC as Exhibit 12.1 to the Company’s Offering Statement and to the reference to our Firm in the offering circular under the caption “Legal Matters.” In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.
| Very truly yours, | |
| /s/ K&L Gates LLP |
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